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Summary
The dosimetry of the small and intensity modulated ﬁelds employed in radio-
therapy, with high dose gradients involved, is a quite demanding task. The need
for reliable measurements in these beams responds not only to quality assurance
requirements, but also to the legal regulations of Radiotherapy (in Spain, Real
Decreto 1566/1998 sobre Criterios de Calidad en Radioterapia, and also EU-
RATOM 97/43). The complexity of modern radiotherapy techniques led to an
extensive incorporation of thorough treatment dosimetric veriﬁcation in the hos-
pital quality assurance programs. This veriﬁcation, previous to the treatment,
is performed in order to check that the dose distributions delivered by the ra-
diotherapy machine match the corresponding planned dose distributions within
the required tolerances. One work performed in this thesis project consists in
the study of diﬀerent commercial detector arrays, devices widely employed for
dosimetric treatment veriﬁcation. The response of the detectors involved in these
devices is determined in order to study the impact of the detector size, technol-
ogy and layout on the measurement of intensity modulated dose distributions.
The capabilities of detector arrays for the detection of ﬂuence variations is also
studied, as this is one of the main objectives of treatment veriﬁcation.
On the other hand, also related with the quality assurance of radiotherapy, a
new dosimetry protocol is studied and applied to two modern radiotherapy ma-
chines, TomoTherapy and CyberKnife, for the determination of absorbed dose to
water. Until now, dosimetry protocols ensured the traceability of dose to water
through the measurement of 10 cm×10 cm radiation ﬁelds under charged particle
equilibrium, following the recommendations of conventional dosimetry codes of
practice, for example the TRS 398 of the International Atomic Energy Agency
(IAEA). Modern radiotherapy techniques involve the use of small radiation ﬁelds
and intensity modulated ﬂuencies to achieve higher conformation of the dose to
the tumour volume. Additionally, there was an increase in the radiotherapy ma-
chines involving this type of radiation ﬁelds that cannot reproduce the 10 cm×10
cm standard reference ﬁeld. This situation increases the uncertainty associated
to the determination of absorbed dose to water, compromising the quality of
vii
treatment planning in these machines. This prompted the creation a Working
Group of reference dosimetry on nonstandard ﬁelds through the collaboration
of IAEA and the American Association of Physics in Medicine, which published
recommendations for the development of a new dosimetry protocol: A new for-
malism for reference dosimetry of small and non-standard ﬁelds Medical Physics
Volume 35, Issue 11, p. 5179-5186 (November 2008). The application of the new
protocol to the above mentioned machines requires the deﬁnition of intermediate
calibration ﬁelds and the measurement and simulation of correction factors asso-
ciated to diﬀerent ionization chambers under these radiation ﬁelds, being one of
the scopes of this doctoral thesis.
Finally, alanine dosimetry is a secondary standard of absorbed dose to water in
the therapy dose range (1 to 20 Gy), oﬀered by primary laboratories like the
National Physical Laboratory (NPL) in UK, the National Institute of Stanta-
rds and Technology (NIST) in US, or the Physikalisch-Technische Bundesanstalt
(PTB) in Germany. This dosimetry system, which is tissue equivalent and ex-
hibits small energy dependence, involves the use of small detectors, being widely
used for small ﬁelds dosimetry and the calculation of ionization chamber cor-
rection factors. Another piece of work addressed in this thesis consists on the
development of an alanine dosimetry system, unique in Spain, through the quan-
tiﬁcation of the dosimeters signal by electron spin resonance and with traceability
to the secondary standard of absorbed dose to water of the Radiation Physics
Laboratory at the Universidade de Santiago de Compostela.
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Introduction
1.1 Radiation therapy
By 2012, around 20% of deaths in the European Region are produced due to
cancer, which constitutes the most important cause of morbidity and death
in Europe after cardiovascular diseases, and involves more than 3 million
new cases and 1.7 million deaths per year [1]. Among the diﬀerent strategies
currently followed to treat cancer, which include surgery, chemotherapy,
hormone therapy and inmunotherapy, ionizing radiation is employed to kill
or control malignant cells. This method, referred to as radiation therapy or
radiotherapy, should be applied to approximately 52% of cancer diagnosed
patients, as estimated by Delaney et al. [2], although the actual rate of
radiotherapy treatments varies widely among diﬀerent countries.
The interaction of ionizing radiation with biological tissues produces the
ionization and excitation of their constituent atoms and molecules, leading
to the formation of highly reactive radicals in the intracellular material that
can chemically break bonds in DNA. Although most of this damage can be
repaired by the cell, unrepaired damage to the cell DNA, consisting mainly
in double strand breaks, can lead the cell to lose its ability to reproduce
1
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or die. This is due to the loss of genes with associated functions that are
critical for survival, producing the death of the cell before reaching mitosis
or after having undergone one or several cell cycles [3]. Quickly dividing
tumor cells are generally more sensitive than other cells to ionizing radia-
tion, being the objective of radiotherapy to deliver the amount of radiation
needed to produce the desired cell killing and achieve tumor control, see
Figure 1.1.
Figure 1.1: Scheme of the physical, chemical and biological eﬀects of ionizing
radiation in biological tissues [4].
Radiation Therapy can be classiﬁed by the type of ionizing particles em-
ployed (photons, electrons, protons or ion beams), by the energy of these
particles (low, medium or high) and by the position of the radiation source
with respect to the patient (external or internal), being the objective of
this thesis centered in external radiotherapy of photon beams.
The amount of energy deposited in a medium by ionizing radiation per
unit mass is quantiﬁed by a magnitude called absorbed dose. The eﬀect of
radiation on biological tissues is in turn related with the dose. The goal
of radiotherapy will be to deliver certain amount of dose, prescribed by a
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radiation oncology doctor, to a planned target volume (PTV) surrounding
the tumor region, while the dose to the healthy surrounding tissue (referred
to as organs at risks, OARs) is maintained below certain levels of tolerance
as to minimize side eﬀects and preserve critical organs. For photon beams,
and based on the knowledge achieved through the years about dose response
and clinical error consequences, the International Commission of Radiation
Units and Measurements established in 1993 a desired accuracy for the dose
to the PTV lying within the range from 95% to 107% of the prescribed
dose [5]. Taking into account the sources of uncertainty associated to the
diﬀerent steps that, as we will see, must be followed for the delivery of a
radiotherapy treatment, the achievement of such an accuracy can result
quite demanding.
1.1.1 The radiotherapy process.
The radiotherapy process begins with the patient being diagnosed (site and
extent of the tumor, stage, etc) and the decision of treating the disease with
radiotherapy. Patient anatomical information and tissue composition are
then obtained through Computed Tomography (CT), where the delineation
of OARs and treatment target volumes is performed1. The radiation oncol-
ogist prescribes the dose to be delivered to the PTV, OARs dose constraints
and the radiation modality to be employed. A team of physicists addresses
then the treatment planning, which consists, for external radiotherapy, in
designing a combination of beams that fulﬁl the oncologist prescription [6].
For treatment planning, workstation software receiving the name of Treat-
ment Planning Systems (TPS) is employed to optimize the beam directions,
the geometrical shapes and the beam weights for the treatment. These tools
use the information in the patient CT and some parameters describing the
1The position and extent of the tumor and neighboring healthy tissue can be assessed with
other imaging techniques such as magnetic resonance imaging (MRI), single-photon-emission
computed tomography (SPECT) and positron emission tomography (PET). These images can
be correlated to improve the accuracy of volume delineation.
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radiation source to compute the dose that an hypothetical treatment would
deliver to the patient. Dose calculations are performed with diﬀerent ra-
diation transport algorithms depending on the TPS, the more recent ones
including Monte Carlo calculation engines. The radiation source model
inside the TPS is usually commissioned from ionometric measurements of
dose deposition in a phantom with electronic density and atomic composi-
tion similar to tissue, usually water.
Once a certain radiotherapy treatment has been chosen for delivery, dif-
ferent veriﬁcation procedures are adopted by clinical centers to check that
the planned treatment will lead to the expected dose deposition, gener-
ally through the delivery of the radiotherapy plan in the treatment unit
for the measurement of absorbed dose in one or several points of a phan-
tom. Treatment replanning may be needed before proceeding to treatment
delivery whenever the evaluation or veriﬁcation of a treatment is not sat-
isfactory. In some cases an analysis of the patient response between the
fractions in which a treatment is divided, or the detection of patient geom-
etry changes, may motivate treatment replanning for the improvement of
tumor control probability. Patients are also followed after the radiother-
apy treatment has been ﬁnished in order to analyze the outcome of the
treatment.
1.1.2 Radiotherapy techniques
External radiotherapy has been always performed confronting the fact that
the beam transport needed to deliver dose to the target locations in the pa-
tient involves also irradiation to healthy tissue, and thus important eﬀorts
have been focused on a better conformation of the dose to the PTV. For a
megavoltage photon beam entering a material, the dose deposited with the
depth of penetration exhibits a buildup region of increasing dose, main-
tained during the ﬁrst millimetres of penetration until transient charged
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particle equilibrium is reached in the material and the maximum dose level
is achieved (the depth of this maximum will depend, for the same material,
on the energy of the beam). For larger depths, the deposited dose decreases
following approximately an exponential attenuation law [7], see Figure 1.2.
Figure 1.2: Percent depth dose distributions in water for a 10 cm×10 ﬁelds
at 100 cm source to surface distance for a 60Co beam and megavoltage photon
beams from 4 to 25 MV [7].
Taking into account that the photon beam deposits energy all along its
path through the patient, the strategy followed in radiotherapy involves the
use of several beams entering from diﬀerent directions. Beam incidences
are performed to have the intersection of the beams located in the PTV
region, where the desired dose will be achieved through the superposition
of the beams. Under this radiation delivery scheme, the dose to the healthy
surrounding tissue is minimized if compared with that obtained with one
single beam irradiation reaching the same dose level in the PTV.
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3D-Conformal radiotherapy
Rectangular beams were initially used for external radiotherapy, although
dose conformation in these old modalities was very limited. Improvement
in the conformation of the dose to the shape of the PTV was later achieved
by adjusting the shape of the beams to the cross-section of the PTV in
the incidence directions (beam eye view, BEV). This approach, receiving
the name of 3D-Conformal Radiotherapy, was at the beginning addressed
through the use of metal alloy patient-speciﬁc cast blocks, usually in 60Co
teletherapy units, see Figure 1.3, where the 1.25 MeV gamma emission of
this radionuclide is employed as radiation source2. In these radiotherapy
units, a gantry holding the radiation source rotates around a point, called
isocenter, where all the possible beam propagation axes intersect.
Figure 1.3: Left: Theratron 780 60Co radiotherapy unit. Right: cerrobend
blocks prepared from the beam eye view of the tumor of an speciﬁc patient
60Co units were however progressively replaced by electron linear accel-
erators in developed countries. In a linear accelerator (Linac), electrons
2Kilovoltage X-ray units, useful for the treatment of superﬁcial lesions, were the ﬁrst equip-
ment employed for external radiotherapy, playing an important role in its early development
between 1910 and 1950. It was then when 60Co units, which provide more penetrating gamma
ray beams, were introduced becoming the predominant external radiotherapy for the next 30
years.
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are accelerated by high power radio-frequency ﬁelds in straight acceler-
ating cavities until they reach kinetic energies ranging from 4 to 25 MeV.
These electron beams can be used for external electron radiotherapy or they
can impinge a high atomic number target for the production, mainly by
bremsstrahlung, of photon beams with diﬀerent maximum energies. Linac
photon beam modalities are usually named after the accelerating poten-
tial applied to the electron beam, leading to 4, 6, 9, 12, 15, 18 and 23
megavoltage photon beams.
In 1990 commercial linear accelerators begun to be equipped with computer
controlled multileaf collimators, MLC. This devices consist in two sets of
high atomic number metallic leaves that can move independently, blocking
the radiation to achieve any beam shape subject to the width of the leaves,
see Figure 1.4. This collimation system not only served to achieve a faster
delivery of 3D-CRT treatments, it also favored the development and con-
solidation of a new delivery technique, the so called Intensity Modulated
Radiation Therapy (IMRT).
Figure 1.4: Multileaf collimator made of several independently moving op-
posed leaf pairs made of tungsten, typically projecting a 1 cm shadow at the
isocenter.
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Intensity Modulated Radiation Therapy
The intensity modulated technique introduced the delivery of more com-
plex ﬂuence patterns on each direction of beam incidence. This allows the
delivery of steeper dose gradients for a better dose conformation to the
target volumes. Potential highly uniform coverages are thus feasible even
for concave geometries, see Figure 1.5, leading to an improvement of TCP
at ﬁxed normal tissue complication probability. This treatment technique
can involve ﬁeld sizes being substantially smaller than those generally used
in 3D-CRT, with areas, at 100 cm from the source, that can go down to
5 square centimeters whereas conformal radiotherapy ﬁelds usually range
from 400 to 25 square centimeters. This and the steeper dose gradients
achieved can make the dose measurements of IMRT ﬁelds to be aﬀected by
larger uncertainties. Since ﬁrst proposed in the earlies 90s [8], the intro-
duction of this technique in hospitals was a slow process due to the modern
equipment required for both treatment planning and delivery as well as the
demands of complex quality assurance procedures.
There are diﬀerent operational modes that can lead to the delivery of an
intensity modulated ﬂuence, mainly:
• Segmented IMRT mode, or step-and-shoot mode: in this modality
the intensity modulated ﬂuence of every incidence is achieved by se-
quentially delivering open ﬁelds with diﬀerent shapes (segments). The
linac beam is turned oﬀ while the MLC leaves move to conform the
ﬁelds of an incidence.
• Dynamic MLC mode, or sliding window mode: this modality involves
the movement of the MLC leaves while the beam is on. Leaves change
their speed in diﬀerent regions to provide the modulated ﬂuence de-
sired for every incidence.
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Figure 1.5: Example of IMRT treatment for a prostate cancer, where the
PTV (prostate) and one OAR (rectum) are disposed in concavity. A ﬂuence
castle" is constructed through superposition of beams involving inhomoge-
neous ﬂuences (Fl.1 to Fl.3) coming from diﬀerent incidence directions (Inc.1
to Inc.3).
• Intensity modulated Arc Therapy (IMAT): in this modality the ra-
diation is delivered with the gantry moving continuously around the
isocenter, in one or more rotating arcs, while the MLC yields seg-
ments in a dynamic mode (ﬁelds at diﬀerent angles are deﬁned to be
connected geometrically). This modality involves higher costs both
on hardware and software and increased complexity in planning and
quality assurance than the latter two IMRT modalities. However, ex-
tending the discretized radiation incidence to a continuous arc can
lead to a better dose conformation to the target with lower dose to
OARs, and in the case of single arc IMAT, treatment delivery times
can be reduced compared with other IMRT modalities [9].
Diﬀerent IMAT linacs are available from diﬀerent manufacturers:
RapidArc R© (Varian Medical Systems Palo Alto, CA), SmartArc (Phi-
lips, Fitchburg, WI), and VMAT (Elekta AB, Stockholm, Sweden),
all them allowing non coplanar arcs and some oﬀering variable dose
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rate during treatment. Finally, developed in parallel with IMAT, To-
moTherapy (Accuray Inc., Sunnyvale, CA) oﬀers a diﬀerent approach
to the arc therapy [10]. This technique involves a compact linac,
mounted on a CT ring, rotating around a patient coach that moves
into the ring for an helical delivery of radiation. Conformation and
modulation of a fan beam is in this case provided by a fast binary
collimator.
Radiosurgery
Other relevant radiotherapy technique, employed to irradiate small regions
with high accuracy is radiosurgery. Initially developed for the treatment
of brain lesions in a single fraction delivery scheme through the use of
very small ﬁeld sizes (down to 0.1 cm2), radiosurgery has evolved to treat
other regions, like the lung or the spinal cord, in fractionated schemes, and
with intensity modulated ﬂuencies. Radiosurgery treatment units can be
of diﬀerent nature, like standard isocentric linacs equipped with special
MLCs of tight mechanical tolerance (i.e. Novalis), or dedicated treatment
units like GammaKnife R© (which uses 201 stationary single-point-focused
cobalt 60 sources) or CyberKnife R© (a single modality linac mounted on a
industrial robotic arm).
Finally, most modern units do not have a ﬂattening ﬁlter in their linac
head. Some of these units will be extensively studied in Chapter 4, where
we will discuss the main diﬀerences between them and standard linacs using
ﬂattening ﬁlter.
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1.2 Dosimetry
1.2.1 Physical basis
The term ionizing radiation is used to refer to both indirectly and directly
ionizing radiation. Non-charged particles (neutrons, uncharged pions, neu-
trinos, etc) and short wavelength electromagnetic radiation (X rays and γ
rays) are recognized as indirectly ionizing radiation as they transfer energy
to materials in a two step process. In the ﬁrst one, the non charged par-
ticles, for example photons, transfer energy to charged particles through
diﬀerent processes like photoelectric eﬀect, Compton interaction, pair pro-
duction, etc. Secondly, these charged particles produce further excitation
and ionization in the material. On the other hand, directly ionizing radi-
ation, conformed by charged particles (electrons, positrons, protons, ions)
impart energy directly through excitation and ionization in the material,
mainly through Coulomb collisions with electrons and nuclei. Regardless
the type of ionizing radiation entering a material, the total imparted energy
is equal to the addition of all the energy entering the volume correspond-
ing to the mass m minus all the energy that goes out in diﬀerent forms
(Bremsstrahlung photons, annihilation photons and electrons or incident
radiation going out). This balance must include all the conversion of mass
to energy and energy to mass processes such as pair production and electron
positron annihilation, leading to the expression [11]:
 = in − out +
∑
Q (1.1)
Where in is the sum of the energies (excluding rest energies) of all the
directly and indirectly ionizing particles entering the volume, out is the
sum of the energies (again excluding rest energies) of all the directly and
indirectly ionizing particles leaving the volume and
∑
Q represents the net
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energy derived from rest mass (in any transformation of nuclei or elemen-
tary particles) in the volume.
Dosimetry is the metrologic discipline that studies the measurement of dose,
a magnitude deﬁned as the mean energy imparted by radiation to certain
amount of mass, this is:
D =
d
dm
(1.2)
Where d is the mean energy imparted by ionizing radiation to a mass, dm,
that should be as close a possible to a point although big enough to avoid
statistical ﬂuctuations aﬀecting the mean energy3. Dose is expressed in gray
(Gy), by deﬁnition a joule (J) per kilogram (kg). For clinical applications
(radiology and radiotherapy), reference dose is evaluated in water, as there
is a precise knowledge of radiation transport in this material that allows to
obtain accurate results. Additionally, the human body, consisting in 70%
water and with an average density close to 1 g cm−3, has mass radiation
interaction coeﬃcients similar to those of water, being the dose to these
two materials closely related.
The measurement of dose is performed with a dosimeter, an apparatus in
which the eﬀect of radiation can lead to a reading M that is linked to
the dose D delivered to the dosimeter active volume V . The calibration
of a dosimeter consists in the determination of a coeﬃcient that converts
the dosimeter reading M , which can require several corrections depending
on the physical properties of the measurement system and conditions, into
dose. Additionally, it may result necessary to evaluate, from the dose to
the dosimeter sensitive medium, the dose to a material of interest, usu-
ally water. Under certain conditions and whenever the dosimeter does not
3While the energy imparted  is a stochastic quantity, the dose can be considered in many
situations as a non stochastic magnitude that can be described by a continuous point function
in a volume of interest [12].
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exhibit response variations with the radiation energy spectrum and irradi-
ation conditions, dosimeter reading ratios, M1/M2, can result equal to dose
ratios, D1/D2, being this methodology referred to as relative dosimetry.
Absolute determination of dose in one of the points involved in a relative
dosimetry study can serve to derive the dose in the rest of the distribution.
1.2.2 Dosimeters
Physical eﬀects arising from the interaction of radiation and matter re-
sulting useful for the measurement of dose are quite varied, and include
temperature change, luminescence, diﬀerent chemical changes, conductiv-
ity, etc. Besides the diﬀerent physical detection principles, dosimeters can
also be classiﬁed as active or passive depending on whether they can yield
real time measurements or not, see Figure 1.6. Without going into much
detail, the characteristics of an ideal dosimetry system have been recognized
to be: repeatability and reproducibility, accuracy and precision, sensitiv-
ity, adequate dose range, linearity with accumulated dose, independence
of response as a function of energy, spatial resolution, and insensitivity to
inﬂuence quantities such as dose rate, temperature, pressure, etc. [3]. In
practice all dosimeters will exhibit certain limitations, that should be al-
ways considered with respect to any speciﬁc application in order to choose
the most adequate system for every measurement.
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Figure 1.6: List of dosimeter types, classiﬁed as active or passive in terms
of their real time or delayed read out. The physical magnitude measured by
every dosimeter type is shown in parentheses.
Primary standards of dose
Only three types of dosimeters are considered to be primary standards
for absorbed dose, as they are widely acknowledged as having the highest
metrological qualities, leading to values that are accepted without refer-
ence to other standards of the same quantity, under certain conditions
and through the application of certain conversions and corrections. For
a dosimetry system to be a primary standard, the measured magnitude
arising from the radiation eﬀect must be related to absorbed dose to water
through a relationship involving fundamental quantities that can be known
with a low uncertainty. To obtain absolute dose measurements, all other
systems must be traceable to one primary standard of dose, which can be:
Calorimetry
This method is based on the heating eﬀect of radiation in materials, using
the temperature change of an absorber for the measurement of deposited
energy. The main technical diﬃculty of this dosimetry system lies in the
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construction of a thermally isolated segment in which to measure the tem-
perature change. The most extended absorbers or active mediums are water
and graphite, a material with radiation absorption characteristics similar
to those of water, being graphite calorimetry much extended due to the
diﬃculties of working with a liquid system [13]. In water calorimetry, a
direct measurement of absorbed dose to water is given by the temperature
rise (after the application of some corrections related with heat defect due
to water radiolysis and heat transport) and the knowledge of the speciﬁc
heat capacity.
Frycke dosimetry
This a chemical dosimetry system where the dose is determined through the
measurement of the chemical changes produced in the sensitive medium.
Fricke solution can be prepared by combining 1 mmol/L ferrous ammo-
nium sulphate with 1 mmol/L sodium chloride and 0.4 mol/L sulfuric acid
in double distilled water. Irradiation of this solution will oxidize the fer-
rous ions Fe+2 into ferric ions Fe+3, and concentrations of the latter will
be proportional to the absorbed dose to water. Ferric ions exhibit a strong
absorption in the near ultraviolet (λ=304 nm), and thus ferric ion con-
centration can be determined measuring the change in absorbance of the
solution by spectrometry. In this technique the chemical radiation yield
has some sensitivity to the beam quality. Additionally, water to Fricke
mass energy absorption ratio varies signiﬁcantly with photon energy (≈
2% for 0 to 10 MeV), consequently requiring delicate correction factors for
the calculation of dose to water [14].
Air ﬁlled ionization chambers
Ionization chambers are the reference instrument most used in clinical rou-
tine for both absolute and relative dose measurements due to its accuracy,
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robustness, long term stability, negligible recombination losses and the deep
knowledge that has been developed through the years about its response.
It consists in a air ﬁlled cavity in which an electric ﬁeld is applied between
two electrodes to collect the ionization charge produced in the medium.
There are basically two types of ionization cavity chambers, cylindrical
(also known as thimble) chambers, represented in Figure 1.7, and plane
parallel chambers. For thimble type ionization chambers the geometry
consists of conductive outer walls and a central collection electrode, being
these two elements separated by an insulator to reduce leakage currents
when a polarizing voltage is applied. A guard ring is usually included to
further reduce leakage and improve the ﬁeld uniformity in the active volume
of the chamber.
Figure 1.7: Sketch of a Farmer thimble type air ionization chamber showing
typical length and diameter, PTCFE standing for polychlorotriﬂuoroethylene.
The external electrode can be covered by a PMMA layer to make the detector
waterproof.
The detection mechanism involves the ionization eﬀect of radiation: an ion-
izing particle crossing the active volume produces electron-ion pairs along
its path. The electric ﬁeld produced through the polarization of the cham-
ber electrodes makes these charge carriers to drift towards the electrodes,
inducing a current that can be read out by an electrometer. Measurements
are usually carried out with the ionization chamber placed in water and
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the collected charge can be related to dose to water. Details about this re-
lationship are explained in Section 1.2.3.2. The Bragg-Gray cavity theory
is employed to calculate dose to water from dose to air in the ionization
chamber when the presence of the chamber does not perturb the ﬂuence of
electrons in the measurement medium[15]. This is fulﬁlled when the range
of electrons in air is considerably larger than the dimensions of the cavity,
which is generally the case in megavoltage photon and electron beams for
regular size air ionization chambers and large ﬁeld sizes4. However, actual
measurements deviate from ideal Bragg-Gray conditions. Perturbations in
the electron ﬂuence usually arise, and certain corrections are necessary due
to: the ﬁnite size of the chamber displacing some volume of the surrounding
medium (water) and modifying the attenuation of the beam at the mea-
suring point; the non water equivalence of the chamber wall and electrode
materials; the presence of the chamber stem, etc.
Ionization chambers are usually vented, namely air is in contact with the
exterior, which implies that temperature and pressure corrections have to
be applied to account for changes in the mass of air inside the cavity arising
from ambient condition changes.
Given that the sensitive medium is air at atmospheric pressure, with a
mass density 700 times lower than water, the signal strength will be always
smaller than that of solid-state detectors. For megavoltage beam dosimetry,
the size of the ionization chambers active volume generally ranges from 0.01
to 1 cm3, being the larger ones not suitable for small ﬁeld measurements due
to averaging eﬀects, whereas the smallest ones exhibit lower signal to noise
ratios, which aﬀect the stability of the detector. Free air and air ionization
chambers are one of the primary standards for air kerma in diﬀerent beam
4Small cavity chambers, considered to be so with respect to the radiation ﬁeld size, are
well described by the Spencer-Attix modiﬁcation of the Bragg Gray theory. The eﬀect of high
energetic electrons abandoning the cavity are here considered through the use of restricted mass
stopping powers. Intermediate size cavities are better described by Burlin cavity theory. In
this case, a factor is introduced to take into account the electron ﬂuence generated by photon
interactions occurring within the cavity [15].
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qualities. Old dosimetry codes of practice were based on the measurement
of air kerma for the ionization chamber calibration [16, 17]. However, ad-
ditional uncertainties introduced for the determination of dose to water in
clinical applications lead to use a new dosimetry protocol based on dose to
water calibration [18, 19] within the medical physics community. For the
measurement of this magnitude, diﬃculties arising in the determination
of ionization chamber volumes with the required accuracy make ionization
chambers to be generally used for radiotherapy purposes with a calibra-
tion factor obtained from cross calibration with other absolute dosimetry
system [3].
Other dosimetry methods
Diode
These solid state semiconductor detectors are p-n union type diodes. In this
case, electron-hole pairs induced by radiation in the bulk of the dosimeter
diﬀuse to the depletion region, where they drift due to the intrinsic ﬁeld
leading to an inverse mode current in the diode. Diodes present the advan-
tage of exhibiting high signal to noise ratios due to the high mass density of
silicon. They can be thus built with very small sizes, ≈ 10−3 mm3, provid-
ing good spatial resolution. The high atomic number of silicon make diodes
to exhibit energy dependence, over responding at low energies, compared
to water, due to the higher photoelectric eﬀect in silicon. They present also
dependence with temperature, dose rate and radiation incidence direction.
The diode sensitivity changes with integrated dose due to radiation dam-
age, reason for which these dosimeters are more commonly used for relative
dosimetry than for absolute dosimetry purposes.
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Diamond
Natural high purity type IIa diamonds are a dielectric material which can
be used as dosimeters, usually working similar to air ionization chambers:
electrons and positive holes are produced in the diamond by radiation, mov-
ing free through the crystal and producing a current proportional to dose
when a polarization voltage is applied. Dosimeters are built by sandwiching
the crystal with two electrodes and polystyrene capsule. Other diamond
dosimetry method consists in measuring the thermoluminescence of this
material after irradiation: light emitted in the UV range when the dosime-
ter is heated [20]. Diamonds exhibit high signal to dose ratios, being again
constructed with small dimensions for the sake of spatial resolution. They
are tissue equivalent, although 3.5 times denser than water, and present
low energy dependence (compared to water), and high resistance to radia-
tion damage. However, they exhibit certain dose rate dependence, require
pre-irradiation and are certainly quite expensive5.
Alanine
Alanine, CH3CH(NH2)COOH, is an amino acid with simple molecular struc-
ture. Highly stable radicals are induced in this dielectric and tissue equiva-
lent material by ionizing radiation in a concentration that can be quantiﬁed
by electron spin resonance. Alanine dosimeters are built in polycrystalline
aggregate presentations including ﬁlms, rods and small pellets (v ≈ 0.05
cm3), the latter resulting very useful for the measurement of small radiation
ﬁelds. An alanine/ESR dosimetry system will be presented in Chapter 3.
Liquid ionization chamber
Ionization chambers using non-polar dielectric liquids as active medium,
usually isooctane, present certain advantages. Liquid densities are closer
5Much progress has been achieved in the development of high purity single crystal diamonds
by chemical vapor deposition, and synthetic diamonds exhibit now excellent electrical properties
for their use as dosimeters [21].
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to water, having a higher tissue equivalence and mass stopping power and
energy absorption coeﬃcient ratios, to water, that remain very constant
in the range of energies used in standard radiotherapy. Furthermore, the
higher mass density of the active medium compared to air increases the
signal to noise ratio of these dosimeters, allowing the construction of active
volumes down to 0.5 mm3. Ion mobilities in liquid ionization chambers are
however moderate, leading to important volume recombination eﬀects [22],
which imposes careful dosimetric characterizations for their use as absolute
dosimeters.
1.2.3 Absorbed dose determination in external beam
radiotherapy
1.2.3.1 Calibration
Megavoltage photon beams generated by electron linear accelerators (linacs)
have become the most used clinical photon beams for external radiotherapy
in developed countries. In electron linear accelerators, the calibration of a
photon beam consists on the determination of the absorbed dose to wa-
ter that corresponds to the delivery of one linac monitor unit (MU). This
measurement is performed under certain preﬁxed conditions established as
reference and described below in this section, Table 1.1. The MU is deﬁned
by the charge collected by two redundant transmission ionization cham-
bers, called monitor chambers and located in the head of the linac, due to
the ionization produced by the ﬂuence of the linac in the chambers active
medium. The monitor chamber signal is related with the absorbed dose to
water in the above mentioned reference conditions, and the so deﬁned MU
is then used for the determination of the dose in radiotherapy treatment
planning and delivery.
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Ionization chambers can provide dose measurements with small associated
uncertainties and are very easy to use, which has made them the dosime-
ter usually employed for photon beam calibrations and in clinical routine.
Standard Dosimetry Laboratories (SDL) provide the clinical institutions
with the ionization chamber calibration coeﬃcients that are needed to con-
vert chamber readings into absorbed dose to water under reference condi-
tions. Determination of calibration coeﬃcients at dosimetry laboratories
involve the comparison of the detector reading and the known value of a
certain magnitude, established as the dosimetry standard, through a high
quality metrological instrument that allows its determination with a veriﬁed
accuracy and traceability.
The detector traceability implies that an unbroken chain of comparisons
relate the detector measurement and the dosimetry standard, what can be
fulﬁlled through three main routes:
1. The dosimeter is directly calibrated by an Primary SDL (PSDL),
which has experimentally developed the primary standard.
2. The dosimeter is calibrated by a Secondary SDL (SSDL) using a sec-
ondary standard that has been calibrated against the primary stan-
dard of a PSDL.
3. The dosimeter calibration coeﬃcient is obtained by comparison with
another dosimeter that has been in turn calibrated by a PSDL, a
SSDL or an accredited dosimetry laboratory (ACDL), this procedure
is commonly referred to as cross-calibration.
The reference beam employed for the development of dosimetry standards
in high energy photon external beam radiotherapy is gamma radiation from
a 60Cobalt source. The suitability of this calibration lies on the reliability
of the 60Co radioactive decay and its gamma emission spectrum, with 1.17
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and 1.33 MeV photons, which is close to the mean energy of 6 MV photon
beams.
Additionally, dosimetry protocols or Codes of Practice (CoP) provide clin-
ical institutions with standardized recommendations, including the infor-
mation that is needed to measure absorbed dose to water in the user's
beam from the calibration coeﬃcient provided by the SDLs. These CoPs,
which contribute with their recommendations to the accuracy of the mea-
surement, are established to ensure that uniﬁed dosimetric methodologies
are followed by clinical institutions, being published by organisms like the
American Association of Physics in Medicine (AAPM) from the United
States, the International Atomic Energy Agency (IAEA) and national in-
stitutions like the German Institute for Standardization (DIN).
To this date two dosimetry standards have been employed by SDLs for high
energy photon radiotherapy: air kerma, adopted formerly, and absorbed
dose to water, introduced more recently, both measured under certain pre-
ﬁxed geometrical conditions. According to this, two types of dosimetry pro-
tocols exist depending on the dosimetry standard employed: while AAPM
TG-21 and IAEA TRS-277 CoPs were based on air kerma [16, 17], proto-
cols like AAPM TG-51 and IAEA TRS-398 are based on absorbed dose to
water standards [18, 19].
At hospitals, the measurement of absorbed dose to water using ionization
chamber calibration coeﬃcients of air kerma requires a series of steps that
increase the ﬁnal uncertainty of the measurement and involves chamber
type dependent correction factors that do not account for diﬀerences be-
tween individual chambers of a certain type. The change in the standard
employed for the dosimetry of high energy photon beams is justiﬁed by the
lower uncertainties achieved in the measurement of absorbed dose to water
(magnitude of interest at clinical institutions) when detectors are directly
calibrated in terms of this magnitude. Primary standards of absorbed dose
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to water have been thus developed at SDLs from 1990 until now and dosime-
try protocols based on this standard have been widely adopted by medical
institutions.
1.2.3.2 Absorbed dose to water standard formalism
As we have seen, the calibration of a linac photon beam consists in the
determination of the absorbed dose to water per MU under reference con-
ditions. In this section we will describe the methodology recommended by
the IAEA TRS-398 CoP [18] for the performance of clinical high energy
photon beam calibration using the ionization chamber calibration coeﬃ-
cient provided by a standard dosimetry laboratory.
Reference conditions and inﬂuence quantities
The absorbed dose to water, measured under reference conditions at depth
zref in a water tank, due to the delivery of a 60Co reference beam repre-
sented by the beam quality index Q0, is expressed as:
Dw,Q0 = MQ0 ·ND,w,Q0 (1.3)
where MQ0 is the ionization chamber reading, fully corrected for inﬂuence
quantities such as pressure, temperature and relative humidity, and ND,w,Q0
is the ionization chamber calibration coeﬃcient, in terms of absorbed dose
to water in the 60Co reference beam and under reference conditions, that
is provided by a SDL.
The calibration coeﬃcient, ND,w,Q0 , is determined in the SDL as the ratio of
the dosimeter reading and the known value of the absorbed dose to water
under reference conditions. This value, referred to as conventional true
value, is developed as dosimetry standard through a dosimetric method of
guaranteed accuracy. The accuracy of the method is ensured through the
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Table 1.1: Reference conditions for the determination of absorbed dose to
water in 60Co and clinical high energy photon beams.
Inﬂuence quantity Reference value
Phantom material water
Chamber type cylindrical (or plane-parallel, pp)(a)
Measurement depth z
(b)
ref 10 g cm
−2 or 5 g cm−2 if TPR(c)20,10 <0.7
10 g·cm−2 if TPR20,10 ≥ 0.7
Reference point of chamber central axis at the cavity volume center
pp chambers: window inner surface center
Position of chamber reference point at the measurement depth zref
SSD or SCD(d) 100 cm (or 80 cm)
Field size(e) 10 cm×10 cm
(a)Optional reference values allowed for calibration in 60Co beams are included in brackets.
(b)Given the constancy of ND,w with depth, an ESTRO-IAEA report on Monitor Unit cal-
culations [23] recommend the use of a single reference depth zref= 10 g cm
−2 for all photon
beam energies. However, the use of the zref= 5 g cm
−2 reference depth used in the detector
calibration in the 60Co beam is also allowed by TRS-398 CoP. (c) TPR20,10 is deﬁned in
Section 1.2.3.2. (d)The reference Source to Surface or Source to Chamber Distance (SSD or
SCD) should be that used for clinical treatments. (e)The ﬁeld size is deﬁned at the surface
of the phantom for a SSD type set-up, whereas for a SAD type set-up it is deﬁned at the
reference depth in the water phantom, at the isocenter of the machine.
fulﬁlment of the corresponding standard of the International Organization
for Standardization6, and through the existence of a network of calibration
laboratories with intercompared standards.
Regarding the detector reading, MQ0 , the eﬀect of the above mentioned
inﬂuence quantities has to be taken into account. Inﬂuence quantities re-
fer to all the quantities that, not being the object of the measurement,
can produce an eﬀect on the measurement of the magnitude of interest.
Dosimetry protocols set some of these inﬂuence quantities to certain values,
establishing them as reference conditions, as this is the case, for example,
with the size of the radiation ﬁeld. These reference conditions, deﬁned to
6The ISO/IEC 17025 establishes the general requirements for the competence of calibration
laboratories.
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keep ﬁxed the maximum number of inﬂuence quantities as possible, serve
as a common experimental frame for intercomparison between calibration
laboratories, allowing traceability and providing a scenario for the use of
dosimetry protocols in clinical institutions. In practice, reference conditions
deﬁne the geometrical conﬁguration of the measurement, the material and
size of the phantom, the radiation ﬁeld size and the source distance. The
IAEA TRS-398 code of practice establishes the reference conditions pre-
sented in Table 1.1 for the measurement of absorbed dose in 60Co beams
and in clinical high energy photon beams, ensuring that conditions very
close to CPE are achieved to guarantee a correct does determination.
The remaining inﬂuence quantities, not ﬁxed as reference conditions, are
of multiple nature and will be sometimes uncontrollable by the user, as
for example the detector aging and the laboratory humidity, pressure and
temperature. Examples of inﬂuence quantities controllable by the user
are the ionization chamber polarization voltage, and in some cases, the
dose rate and the beam quality. The use of correction factors associated
to the inﬂuence quantities is required for the determination of absorbed
dose to water whenever any of them vary from those established during
the calibration coeﬃcient evaluation. These factors are introduced in the
dosimetry protocol as a set of multiplicative factors,
∏
i ki, assuming that
the associated inﬂuence quantities aﬀect the measurement independently
from each other, and thus the detector reading is corrected as indicated in
Equation 1.4.
M = Mraw · kTP · kh · ks · kelec · kpol (1.4)
The included factors correct for changes in temperature and pressure, kTP ,
relative humidity, kh, incomplete collection of charge (recombination ef-
fects) in the chamber, ks, changes in the electrometers calibration factor,
kelec, and polarity eﬀects associated to the chamber, kpol.
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Among all the inﬂuence quantities there is one, characteristic of every ra-
diation ﬁeld, that is considered separately in the formalism of dosimetry
protocols due to its special relevance: the beam quality, related with the ﬂu-
ence spectral distribution of the photon beam. In order to summarize and
represent the beam quality, a single quantity, referred to as beam quality
index, Q, is used as beam quality descriptor, being deﬁned and measured
for every radiation beam. Dosimetry protocols include the correction fac-
tors associated to a wide range of ionization chambers as a function of the
beam quality index, being employed for clinical photon beam calibration
whenever the clinical beam quality diﬀers from that employed for the de-
tector calibration at the SDL. These correction factors, referred to as beam
quality correction factors, will be presented in the following section.
Beam quality correction factors
Whenever an ionization chamber measurement is performed in a beam qual-
ity diﬀerent from that in which the chamber calibration coeﬃcient was ob-
tained, a correction factor must be added to Equation 1.3 in order to obtain
the absorbed dose to water as:
Dw,Q = MQ ·ND,w,Q0 · kQ,Q0 (1.5)
whereMQ is the ionization chamber reading in the beam quality Q, ND,w,Q0
is the ionization chamber calibration coeﬃcient provided by the standard
laboratory for the reference beam quality Q0, under reference conditions,
and kQ,Q0 is the ionization chamber beam quality correction factor associ-
ated to the beam quality Q, diﬀerent from the reference beam quality Q0.
In this expression, the ionization chamber readingMQ is fully corrected for
any inﬂuence quantity according to Equation 1.4.
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For high energy photon beams, the beam quality index Q deﬁned by TRS-
398 is the tissue-phantom ratio, TPR20,10, calculated as the ratio of ab-
sorbed dose in axis, at 20 cm and 10 cm depth in a water phantom, with a
constant source to chamber distance (SCD) of 100 cm and a 10 cm×10 cm
square ﬁeld deﬁned at the chamber plane, see Figure 1.8.
Figure 1.8: Geometry for measurement of TPR20,10 under a square ﬁeld of
side, AP , equal to 10 cm. (a) Geometry for the measurement of dose at point P
and depth z1 = 20 cm in a water phantom; (b) Geometry for the measurement of
dose at point P at depth z2 = 10 cm in a water phantom. The distance between
the source and the point of measurement is SSD1 + z1 = SSD2 + z2 = 100
cm for both (a) and (b).
The TPR20,10 gives, like the beam quality descriptors chosen by other
dosimetry protocols, a measurement of the eﬀective attenuation coeﬃcient,
characterizing the approximately exponential decrease of the photon depth-
dose curve beyond the depth of maximum dose. The TPR20,10 has been
claimed however to present certain advantages over other quality descrip-
tors, like the %dd(10)x, due to its independence on electron contamination
in the incident beam, the simplicity of the measurement, and its low sensi-
tivity to SCD changes arising from positioning errors [18].
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If we take into account that the ionization chamber calibration coeﬃcient
at a beam quality Q can be deﬁned as:
ND,w,Q = Dw,Q/MQ (1.6)
The beam quality correction factor can be expressed as the ratio of calibra-
tion coeﬃcients at the beam qualities under consideration, where Q stands
again for the user beam and Q0 for the calibration or reference beam:
kQ,Q0 =
ND,w,Q
ND,w,Q0
(1.7)
The Spencer-Attix formulation of the Bragg-Gray theory expresses dose to
water, Dw, as the product of dose to air in the ionization chamber, Dair,
and the ratio of water to air restricted mean mass collision stopping power,
(L/ρ)waterair , which depends on the beam quality. Under departure from
ideal Bragg-Gray detector conditions, a perturbation factor that depends
on beam quality and the ionization chamber model, pQ, is needed to express
dose to water as a function of dose to air. This factor accounts for ﬂuence
variations due to the presence of the cavity, pcav, the eﬀect of taking the
chamber eﬀective point of measurement at the center of the cavity, pdis,
the non water equivalence of the chamber wall, pwall, and the eﬀect of the
central electrode, pcel. The global perturbation factor is thus the product
of all these contributions, pQ = pcav · pdis · pwall · pcel, and dose to water can
be expressed as:
Dw = Dair · (L/ρ)waterair · pQ (1.8)
On the other hand, the dose to air can be obtained from the mean photon
energy required to create an electron-ion pair in air, Wair/e, which is con-
sidered to remain constant for energy photons up to 25 MeV [24], and the
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exposition, X, or charge produced in air per unit mass, expressed by the
corrected mass normalized detector reading M/m:
Dair = X
Wair
e
=
M
m
Wair
e
(1.9)
Equations 1.6, 1.8 and 1.9 lead to the expression of the beam quality correc-
tion factor as a function of the water to air restricted mass stopping power
and perturbation factors ratios, which also vary with the beam quality:
kQ,Q0 =
Dw,Q/MQ
Dw,Q0/MQ0
=
[(L/ρ)waterair · p]Q
[(L/ρ)waterair · p]Q0
(1.10)
Although the formalism here presented follows the methodology proposed
by the TRS-398 CoP, other protocols like AAPM TG-51 follow very simi-
lar formalisms including the establishment of reference conditions and the
application of beam quality correction factors. Slight diﬀerences, arising
for example from diﬀerences in the deﬁnition of the beam quality index,
are minimized through the well known relationships between them, which
allows the CoPs intercomparison to test the protocols equivalence and con-
sistency [25].
1.2.3.3 Nonstandard ﬁeld dosimetry
As we have seen, IAEA TRS-398, and also AAPM TG-51, recommend the
determination of absorbed dose to water in high energy photon beams us-
ing an ionization chamber calibrated in terms of absorbed dose to water
in a reference beam quality Q0 and under standard reference conditions,
which are usually a 10 cm×10 cm square ﬁeld and 100 cm source-to-surface
distance (SSD) or source-to-axis distance (SAD), Table 1.1. These codes of
practice established a robust path for the determination of absorbed dose
to water in external radiotherapy standard beams during the decades of
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1980's and 1990's, when conformal radiotherapy, involving large radiation
ﬁeld sizes compared with the range of secondary particles in water, was the
predominant external radiotherapy technique employed in clinical institu-
tions. However, the introduction in Europe and the USA of commercial
multileaf collimators in 1990 [3] and the development and widespread in
the clinic of IMRT by the late 1990's led to a huge increase in the use of
small ﬁelds in clinical treatments. Additionally, a new generation of linear
accelerators and special delivery techniques speciﬁcally designed for stereo-
tactic deliveries and IMAT has been introduced, including treatment units
like:
• Leksell GammaKnife R© (Elekta Instrument AB, Stockholm, Sweden),
• CyberKnife R© Robotic Radiosurgery system (Accuray Inc., Sunnyvale,
CA)
• TomoTherapy R© Hi-Art R© (Accuray Inc., Sunnyvale, CA),
• VMAT (Elekta Instrument AB, Stockholm, Sweden).
The radiation delivery of these machines is mainly performed with non-
standard ﬁelds, a term used to refer either to:
1. Small ﬁelds, with transversal sizes of the same (or less) magnitude as
the range of secondary electrons in the medium, which present unfa-
vorable measurement conditions whenever there is a partial occlusion
of the radiation source or if the detector employed for the measure-
ment is large compared with the ﬁeld size.
2. Intensity modulated ﬁelds involving small ﬁelds, or extensive ﬁelds
with steep dose gradients.
In these ﬁelds, departure from charged particle equilibrium conditions arise
and volume averaging eﬀects can become important for many detectors due
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to the steep dose gradients and multileaf collimator penumbras, substan-
tially increasing the uncertainty and/or error associated to the measure-
ment of absorbed dose to water when compared with measurements in
standard ﬁelds.
Although reference conditions can be established in some of these modern
treatment units and dosimetry protocols can still be applied, the departure
from standard ﬁeld dosimetric conditions in the clinical delivery raised con-
siderable concerns in the medical physics community [2629]. On the other
hand, some new treatment units cannot fulﬁll the standard reference con-
ditions deﬁned in dosimetry protocols. Determination of absorbed dose to
water was initially performed in these machines following the recommenda-
tions provided by the manufacturers and through the application of certain
approximations.
Since the use of nonstandard ﬁelds became extensive in clinical practice
in Europe and USA, a uniﬁed methodology for the measurement of ab-
sorbed dose to water under these ﬁelds was considered a necessary step for
the quality assurance of the radiotherapy dosimetry chain. This situation
prompted the collaboration of the International Atomic Energy Agency
and the American Association of Physicists in Medicine Therapy Physics
Committee for the creation of an international working group on reference
dosimetry of small and nonstandard beams. A new formalism for small and
composite ﬁelds reference dosimetry was proposed by Alfonso et al. [30]
with the intention of complementing and extending the recommendations
and methodologies contained in existing CoPs.
In this section, we present the new formalism for the dosimetry of nonstan-
dard ﬁelds. The concept of intermediate calibration ﬁeld is introduced in
this formalism to deﬁne a ﬁeld that can be delivered by the machine and
stands close to the reference conditions or to the clinical delivery and the
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speciﬁc delivery technique associated to the machine. Two types of interme-
diate calibration ﬁelds, comprising both static and composite ﬁeld dosime-
try, are deﬁned with their associated beam quality correction factors. These
intermediate calibration ﬁelds are the machine-speciﬁc-reference ﬁeld, fmsr,
and the plan-class-speciﬁc-reference ﬁeld, fpcsr, that we proceed to brieﬂy
present here.
Intermediate calibration ﬁelds
Machine speciﬁc reference ﬁeld
Whenever a measurement in reference conditions is not possible due, for
example, to the geometrical design of the treatment unit, a static ﬁeld,
referred to as machine speciﬁc reference ﬁeld, fmsr, is deﬁned as close as
possible to the conventional reference ﬁeld. The fmsr ﬁeld size should be
larger that the range of secondary electrons in the medium (water), and
the measurement should be performed with a relatively small ionization
chamber to ensure eﬀective lateral charged particle equilibrium in the vol-
ume of interest. Associated to the fmsr, an ionization chamber correction
factor, kfmsr,frefQmsr,Q , is then introduced in the previously explained reference
dosimetry formalism, Equation 1.5, in order to account for the diﬀerences
in geometry and beam quality between the machine speciﬁc measurement
conditions and the conventional reference conditions denoted by fref . Ab-
sorbed dose to water in the machine speciﬁc reference ﬁeld is then given
by:
Dfmsrw,Qmsr = M
fmsr
Qmsr
·ND,w,Q0 · kQ,Q0 · kfmsr,frefQmsr,Q (1.11)
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Plan class speciﬁc reference ﬁeld
The plan class speciﬁc intermediate calibration ﬁeld, fpcsr, is a composite
ﬁeld including unit-speciﬁc delivery features, deﬁned with the purpose of
reproducing dosimetric conditions similar to those of clinical treatments.
This ﬁeld would ideally deliver a homogeneous dose distribution to an ex-
tended and geometrically simple target volume, and the absorbed dose to
water in this ﬁeld can be expressed as:
D
fpcsr
w,Qpcsr
= M
fpcsr
Qpcsr
·ND,w,Q0 · kQ,Q0 · kfpcsr,frefQpcsr,Q (1.12)
where kfpcsr,frefQpcsr,Q is a factor to correct between the diﬀerences between the
pcsr and the conventional reference ﬁeld.
This kfpcsr,frefQpcsr,Q factor can be also expressed as the product of the machine
speciﬁc reference ﬁeld correction factor and a factor correcting for the dif-
ferences between the plan class speciﬁc and the machine speciﬁc reference
ﬁeld:
k
fpcsr,fref
Qpcsr,Q
= k
fpcsr,fmsr
Qpcsr,Qmsr
· kfmsr,frefQmsr,Q (1.13)
Clinical dosimetry
Once intermediate calibration ﬁelds are deﬁned, the determination of ab-
sorbed dose to water in nonstandard beams can be addressed. The dose of
a clinical ﬁeld can be obtained from the dose in either fmsr or fpcsr through
the introduction of a ﬁeld factor Ω as:
Dfclinw,Qclin = D
fmsr(pcsr)
w,Qmsr(pcsr)
· Ωfclin,fmsr(pcsr)Qclin,Qmsr(pcsr) (1.14)
where,
Chapter 1. Introduction 34
Figure 1.9: Scheme of the dosimetry routes introduced by the machine spe-
ciﬁc and plan class speciﬁc reference ﬁelds for the measurement of absorbed dose
in nonstandard ﬁelds. Examples of possible intermediate calibration ﬁelds for
machines like Tomotherapy, Cyberknife and GammaKnife. Plan class speciﬁc
intermediate calibration ﬁelds are deﬁned to deliver uniform dose distributions,
in gray, with simple geometries (cylinders, spheres), to simple geometry phan-
toms represented by the white volumes.
Ω
fclin,fmsr(pcsr)
Qclin,Qmsr(pcsr)
=
M fclinQclin
M
fmsr(pcsr)
Qmsr(pcsr)
· kfclin,fmsr(pcsr)Qclin,Qmsr(pcsr) (1.15)
If the intermediate calibration ﬁelds are representative of the clinical prac-
tice, kfclin,fmsrQclin,Qmsr and k
fclin,fpcsr
Qclin,Qpcsr
correction factors are close to unity and the
ﬁeld factors can be approximated as the ratio of chamber readings. On the
other hand, in the practical case of a static ﬁeld dosimetry, these Ωfi,fjQi,Qj
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would be equal to the standard output factors.
Figure 1.9 shows a schematic representation of the paths proposed for the
measurement of absorbed dose to water in nonstandard ﬁelds through static
and dynamic intermediate calibration ﬁelds.
Scope of the nonstandard ﬁelds new formalism
The new formalism for the dosimetry of nonstandard ﬁelds was originally
presented in Medical Physics [30] as a proposal for the standardization of
the dosimetry procedures in the above mentioned IMRT and other spe-
cial techniques. But the aim of that letter was not only to present the
new dosimetry formalism but also to encourage the debate of the scientiﬁc
community about the proposal. The working group on nonstandard ﬁelds
also recalled that, although some static ﬁeld dosimetry data were already
available for many of the modern radiotherapy techniques, a lot of research
work was to be done in composite ﬁeld dosimetry in order to check the
capabilities of plan class speciﬁc reference ﬁelds to study how they should
be deﬁned. Since then, several works about the dosimetry of nonstandard
ﬁelds have been published [24, 31], and the topic is still subject of central
attention in international medical physics conferences [32].
For the study of the new formalism, the experimental determination of
ionization chamber correction factors associated to intermediate calibra-
tion ﬁelds is an important task that requires the measurement of absorbed
dose to water under nonstandard conditions. Taking as an example the
machine speciﬁc reference ﬁeld, it directly follows from Equation 1.11 that
the kfmsr,frefQmsr,Q correction factor can be obtained from the measurement of
absorbed dose to water under the nonstandard ﬁeld, Dfmsrw,Qmsr , the fully cor-
rected ionization chamber reading under the same ﬁeld, M fmsrQmsr , and the
calibration coeﬃcient at the reference beam quality and reference condi-
tions, ND,w,Q0 :
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k
fmsr,fref
Qmsr,Q0
= k
fmsr,fref
Qmsr,Q
· kQ,Q0 =
Dfmsrw,Qmsr
M fmsrQmsr ·ND,w,Q0
(1.16)
Under nonstandard conditions, the lack of charged particle equilibrium and
the importance of volume averaging eﬀects in many detectors make the
measurement of absorbed dose to water very demanding. A small volume
dosimeter with good water equivalence and low energy dependence would
be the most appropriate choice for this purpose. Alanine/ESR dosimetry,
calibrated in terms of absorbed dose to water and traceable to a primary
standard, has been widely employed in small ﬁeld dosimetry studies and is
recognized as a valuable independent dosimetry validation [3335].
1.3 Quality assurance
Radiotherapy Quality Assurance (QA) is, according to World Health Orga-
nization (WHO), concerned with all those procedures that ensure consis-
tency of the medical prescription and the safe fulﬁllment of that prescription
as regards dose to the target volume, together with minimal dose to nor-
mal tissue, minimal exposure of personnel and adequate patient monitoring
aimed at determining the end result of treatmen [36].
In order to ensure an optimized treatment delivery with maximized tumor
control probability and minimum injury to normal tissue, QA aims the
general reduction of uncertainties through the whole radiotherapy process,
trying also to minimize and correct errors, and for this a series of actions
must be followed. Guides for the implementation of radiotherapy quality
assurance systems have been published by institutions like WHO, ESTRO
and AAPM [3638], usually suggesting the need for the deﬁnition of re-
sponsibilities and organization, documented procedures, accurate record
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keeping, system failure control, internal and external audit of procedures
and education and training.
In the establishment of QA procedures, one key element is the deﬁnition of
tolerance limits based on the clinical accuracy requirements. The analysis
of dose eﬀect relationships and tumor control probability models has lead
to the establishment of these global requirements as7:
• 3% on the absorbed dose delivered to the speciﬁcation point.
• 5% on the dose at all other points in the target volume.
• 4 mm on the position of ﬁeld edges and shielding blocks in relation to
the PTV.
It is important to note that whatever the required accuracy is, tolerance lim-
its have to be established taking into account the real accuracy achievable
in practical radiotherapy, which has been continuously improving through
the years but has been observed to be some times lower than the limits
stated above [39].
Radiotherapy QA programs are divided in individual QA steps aﬀecting
each contributing part of the whole radiotherapy process, and in these
individual steps greater accuracies are required for the ﬁnal recommended
values to be achieved. Focusing on the tasks of the medical physicist staﬀ,
some of this steps are presented in the following subsections.
1.3.1 Treatment equipment quality assurance
Sophisticated equipment such as the treatment machine must undergo a
commissioning phase and acceptance test before being clinically used. Mea-
surements, adjustments and tests are performed taking into account the
7This accuracy requirements are given at the level of one standard deviation (k=1).
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equipment speciﬁcations to optimize its performance and check the accu-
racy and capability of the system to meet the clinical requirements. Peri-
odic QA checks and audits can later ensure that the original characteristics
do not change inadvertently. Regarding megavoltage equipment, measure-
ment of the radiation output and output stability is a fundamental step of
QA. Beam calibration, or the determination of dose at reference conditions,
plays a very important role here, where the required accuracy is 1.5% at
a level of one standard deviation [18]. Ionization chambers are the rec-
ommended instruments for this purpose, and calibration coeﬃcients have
to be determined against SSDLs regularly (with 1 to 3 years intervals),
stability checks have to be performed and beam quality correction factors
determined with the highest possible accuracy.
1.3.2 Treatment planning quality assurance
This block includes the patient data acquisition systems, such as CT, and
computerized treatment planning systems, which must both undergo the
above mentioned commissioning processes and acceptance tests.
Regarding the CT QA, appropriate calibration on electronic density should
be ensured, as well as its capability to reproduce actual dimensions of
objects, absence of distortion, reproducibility and accuracy of the slice
position and thickness, accuracy of gantry rotation and adequate alignment
of positioning devices. Additionally, as data acquisition must allow the
same patient position to be used in further steps of the process (delivery),
immobilization and repositioning devices are of central attention.
In computerized treatment planning system, thorough commissioning of
the beam has to be performed in order to ensure that TPS calculated dose
distributions reproduce the output of the treatment machine. Special at-
tention should be given to dose calculations in material inhomogeneities
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or whenever steep dose gradients are encountered [40, 41]. Correct inter-
pretation of the patient data and accurate methods for the delineation of
PTV and OARs is also required. TPS tolerance levels are typically set to
2-3 mm for geometry and 2-3 % for doses, although diﬀerent criteria are
applied depending on the clinical objective.
1.3.3 Treatment delivery quality assurance
This ﬁnal step, usually referred to as treatment veriﬁcation, is a global
QA strategy trying to ensure that the treatment to be delivered matches
the dose distributions of the planned treatment. In addition to all the
procedures that check the treatment machine delivery and its consistency
with the TPS, this QA step was extensively incorporated to QA programs
with the introduction of IMRT in clinical institutions.
Highly conformed beams involved in IMRT techniques impose tighter con-
trols in the MLC and patient positioning. Moreover, the higher demanding
accuracy in TPS algorithms used for new treatment modalities imply more
complex commissioning and sophisticated acceptance tests. Another com-
plication is related with the small radiation ﬁelds and steep dose gradients
involved in IMRT and other techniques, where transient charged particles
equilibrium is not established and important volume averaging eﬀects can
arise in ionization chamber measurements. Moreover, as we commented
before, ionization chamber beam quality correction factors are tabulated in
dosimetry protocols for standard reference ﬁelds. Due to all these factors,
the uncertainty of dose measurement of IMRT ﬁelds increases and errors
up to 10% can arise [42].
From its introduction, many publications appeared discussing diﬀerent as-
pects related with IMRT, and several institutions (ICRU, AAPM, ESTRO)
published recommendations and guides for the clinical practice [43]. The
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Figure 1.10: (a) Conceptual pyramid including the diﬀerent levels of treat-
ment delivery QA, each level being based on the stability of the underlying
levels. For the veriﬁcation of one clinical treatment, the procedure could begin
at the top of the pyramid through the performance of a 3D dosimetric veriﬁca-
tion, descending to lower pyramid levels whenever unacceptable discrepancies
with treatment planning are encountered. (b) Methodology and dosimetry
tools appropriate for every level [43].
variability and diﬀerent complexity of the techniques implemented by dif-
ferent institutions makes however diﬃcult the establishment of common
procedures and criteria, and codes of practice have not been published es-
tablishing deﬁnitive procedures for this technique. This situation increases
the importance and need for a pre-treatment veriﬁcation to make a ﬁnal
evaluation of how the propagation of the diﬀerent sources of uncertainly
involved in the radiotherapy process aﬀect the dose distribution ﬁnally de-
livered to the patient.
Departments applying complex radiotherapy techniques usually check indi-
vidual plans by comparison between measurements and TPS dose distribu-
tions, at least until consistent accurate results are obtained in a center, and
this can be performed in diﬀerent ways. For each modulated beam, each
beam setting can be applied with the gantry at 0◦ (in vertical incidence) to
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a rectangular phantom, where the dose distribution is measured and com-
pared with that calculated by the TPS for the same setup. Another option
is to compute and measure the dose delivered by all beams, again with
the gantry at 0◦ or through the real delivery, using a simple geometrical
phantom. It should be noted that individual beam measurements, where
the detector may be only partially irradiated, can give results signiﬁcantly
diﬀerent than those obtained through the combination of beams, where
diﬀerences are usually smoothed.
Regarding dose measurements, diﬀerent approaches can be also followed.
Absolute dose measurements can be performed in one or several points (i.e.
ionization chamber measurements in diﬀerent points of a phantom or water
tank). However, as the use of inhomogeneous ﬂuencies is a relevant feature
of IMRT, studying dose deposition in two or three dimensions results of par-
ticular interest. Two dimensional spatial dose distributions are measured
with relative dosimetry using passive and active methods, usually combined
with one absolute dose measurement from which absolute dose values can
be obtained. Among the ideal characteristics of general dosimeters, detec-
tion systems used for IMRT veriﬁcation will require good spatial resolution
and low uncertainty in order to ensure eﬀective treatment veriﬁcation [3].
The types of dosimeters most employed for treatment veriﬁcation will be
summarized in the following sections.
1.3.3.1 Electronic portal imaging dosimetry (EPID)
Portal imaging systems consist of a radiation detector that is mounted op-
posite to the linac head, usually attached to the gantry, which detect the
radiation transmitted through the patient and treatment couch. The de-
tection mechanism varies with the system, being most extended the EPID
systems based on ﬂuoroscopic detectors, ionization chamber detectors and
amorphous silicon detectors [7]. EPID systems produce two dimensional
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computer based images that are processed and analysed providing a rep-
resentation of the attenuation properties of the diﬀerent structures crossed
by the radiation, being of central importance the contrast, resolution and
noise of the device.
The use of EPID systems for treatment veriﬁcation formerly included record-
ing the integrated ﬂuence from the treatment radiation beams and extract-
ing information about the motion and position of the MLC leaves. EPID
image information can be also used to derive the dose to the EPID, which is
then compared with the calculation of the TPS at the EPID plane. Meth-
ods have been also developed to translate EPID images into primary ﬂuence
maps used as input in a TPS to recalculate 3D dose distributions using a
phantom or patient CT data. Alternative approaches use backprojection
algorithms to derive the dose to the patient from the EPID images [43].
1.3.3.2 Film dosimetry
Film dosimetry is in principle an ideal system for IMRT veriﬁcation, reg-
istering two dimensional dose distributions with high spatial resolution.
Films are usually placed in water equivalent phantoms at depths of inter-
est, usually those of the PTV and OARS, see Figure 1.11. The relative
dose distributions obtained can be scaled to absolute values through cross-
calibration with a small ionization chamber measurement.
Radiographic ﬁlm
Radiographic ﬁlm consist on a radiation sensitive emulsion coated on a
transparent polyester base. The emulsion contains silver halide crystals
(95% silver bromide and 5% silver iodide suspended in gelatin for Kodak
XTL and XV ﬁlms), which under exposure to ionizing radiation undergo
certain transformations related with the ionization of silver bromide and
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the accumulation of silver ions in impurity regions leading to the darken-
ing of the ﬁlm. Uncertainty levels with this dosimetry system depend on
the irradiation conditions, the ﬁlm processing, scanning, the calibration
curve and the data analysis. One drawback is the non tissue equivalence
of the dosimeter materials, which introduces energy dependency with over-
response at low energy, inducing depth and ﬁeld size dependent sensitivity.
Radiographic ﬁlm has been however the dosimeter most extensively em-
ployed for IMRT veriﬁcation for many years, being considered an accurate
system whenever appropriate procedures and careful sensitometric calibra-
tion are performed [44].
Figure 1.11: Sketch of an anthropomorphic phantom used for ﬁlm dosimetry
(CIRS IMRT Thorax Phantom, CIRS Norfolk, VA, USA), where ﬁlm dosime-
ters are placed in the transversal planes of interest for the measurement of dose
distributions.
Radiochromic ﬁlm
Radiochromic ﬁlms are made of several thin layers of plastic (mylar) sheet
glued in sandwich with a radiosensitive gel that modiﬁes the visible light
absorbance with dose. It does not need chemical developing processing and
presents some advantages as higher tissue equivalence and lower energy
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dependence. First radiochromic systems exhibited uniformity and repro-
ducibility problems that have been improved in subsequent developments,
although its cost remains quite high for massive clinical applications [45].
1.3.3.3 Detector arrays
Increase in the amount of patients being treated with a complex radiother-
apy technique is a common situation encountered in clinical centers once
that its implantation process is successfully achieved. Speeding up treat-
ment veriﬁcation procedures allows then to respond to the clinical demand,
and getting dose distributions without the need of slow processing and scan-
ning for their latter comparison with TPS dose distributions can greatly
help to attain it. In this context detector arrays can result very useful, as
these devices are easy to use and they are directly connected to computers
allowing not only the fast measurement of one, two or three dimensional
dose distributions but also its rapid incorporation into the clinical depart-
ment computing network.
Figure 1.12: Two commercial detector arrays: Delta 4 detector array from
Scandidos, Sweden, where diode detectors are arranged in a matrixx along two
orthogonal planes to provide three dimensional dose distributions (left) and
LA48 Linear Ion Chamber Array from PTW-Freiburg, Germany (right).
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Diﬀerent commercial detector arrays appeared through the last decade re-
sponding to the clinical demands and consisting usually in a number of
detectors placed at ﬁxed positions in a water equivalent phantom. The
dosimetric mechanisms more extended in detection arrays are the ioniza-
tion chamber and the diode, as they are robust, can be easily calibrated
and can measure with low associated uncertainty. Diﬀerent aspects related
with these kind of detectors will be analyzed in detail in Chapter 2, where
a study of diﬀerent commercial solutions will be presented.

Chapter 2
2D detector arrays for IMRT
veriﬁcation: the inﬂuence of
chamber response function
In this chapter we will study the use of two dimensional detector arrays for
standard radiotherapy treatment veriﬁcation. A detector response model
will be presented that will allow us to reproduce the measurement of the
detector under the incidence of an arbitrary ﬂuence and quantify the ef-
fect introduced by such response. The performance of some of the most
extended commercial solutions will be analyzed through the same method-
ology in order to compare their capabilities for IMRT veriﬁcation and draw
some conclusions about the optimal design for these kind of devices.
2.1 Introduction
The veriﬁcation of complex treatments with composite ﬁelds, like those
of IMRT, was initially performed using radiographic ﬁlm dosimetry. The
47
Chapter 2. 2D detector arrays for IMRT veriﬁcation 48
technological trend in dosimetry and medical imaging has imposed a lim-
ited availability of radiographic ﬁlm for radiotherapy departments. Other
passive alternatives, such as radiochromic ﬁlm, present poor repeatability
and dose uncertainty, and require time for ﬁlm processing. Accordingly,
in the last ten years most manufacturers of therapy dosimetry instruments
have developed detector arrays for the measurement of dose distribution in
planar and cylindrical geometries.
There are two main elements in the design of a detector array that deter-
mine the global performance of the device for treatment dosimetry veriﬁ-
cation, namely:
(a) The detection technology employed: semiconductor diode, air ioniza-
tion chamber, diamond etc, together with the size of the detector.
(b) The spatial distribution of detectors in the array, referred to as detector
sampling frequency.
Although measuring with an acceptable degree of accuracy also depends on
some other factors like pre-irradiation requirements and long term stability,
it is the choice of the detection technology, the design (size, shape and
materials employed) and the array sampling what determines the intrinsic
performance of the array, aﬀecting:
i) Sensitivity to ﬂuence variations: Depends on the signal to dose ratio
exhibited by the detection technology, and the relationship between
detector size and detector spacing in the array, which sets the smallest
dose/ﬂuence variation that can be detected by the device.
ii) Repeatability: Deﬁned as the precision in repeated measurements per-
formed under equal irradiation conditions.
iii) Accuracy: Deﬁned as the degree of closeness of the array dose mea-
surements to the true value of dose at the detectors reference points.
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Other important characteristics of the device are, as for any dosimetry
system, the linearity in the response with dose, the dose rate and energy
dependence and the anisotropy in the response to radiation from diﬀerent
directions, which can be partially corrected for but is desired to be intrin-
sically minimal. The electronics acquisition time can also play a role for
example in the veriﬁcation of the collimator leaves movement in dynamic
radiotherapy modalities.
Several commercial detector arrays were developed during the last years,
which employ diﬀerent combination of detection technology and spatial
sampling, achieving considerable success for fast and accurate veriﬁcation
of complex treatments. Most of them can perform absolute dosimetry mea-
surements through the use of a calibration coeﬃcients, generally measured
for the central detector, and an array of correction factors that compensate
for the inter-detector response variations through the device [46].
Most detector arrays present a two dimensional, or planar, geometry, like
PTW729 (PTW-Freiburg, Germany), MapCHECK (Sun Nuclear Corpora-
tion, Melbourne FL) or StarTrack and MatriXX (IBA Dosimetry, Louvain-
La-Neuve, Belgium), while three-dimensional arrays, designed with their
detectors distributed in several planes, have been later released, like Arc-
Check (Sun Nuclear Corporation) and Delta4 (Scandidos, Uppsala, Swe-
den). By the time this study was conducted, planar arrays were more
extended in clinical practice and it was by far easier to have them bor-
rowed either from the vendor or from medical institutions than the three
dimensional solutions. Given that the physical principles and factors af-
fecting the performance of both two and three dimension detector arrays
are the same, we decided to focus our study on diﬀerent designs of planar
arrays.
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Figure 2.1: Commercial detector arrays studied in this chapter: a)
MapCHECK2, b) PTW729 and c) MatriXX.
The detector arrays chosen for this study were:
a) MatriXX (IBA Dosimetry):
An array of 1020 cylindrical ionization chambers of 4.5 mm diameter
and 5 mm height, arranged in a 32×32 grid with 7.62 mm center-to-
center detector distances, covering an area of 24.4 cm×24.4 cm. The 0.3
cm thick buildup plate is made of Tecaran ABS (density 1.06 g cm−3),
while the backscatter plate is made of RW3 (98% Polystyrol, 2% TiO2,
density 1.045 g cm−3) and has a thickness of 2.2 cm.
b) MapCHECK2 (Sun Nuclear Corporation):
An array made of 1527 n-diode detectors with a depletion region of 0.8
mm×0.8 mm transverse area. Detectors are distributed with a center-
to-center detector distance of 1 cm in every row, with adjacent rows
being laterally displaced by 0.5 cm, thus the shortest detector distance
is 0.707 cm. The total area covered by the array is 36 cm×26 cm, and
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Array Field (cm×cm) Detector Type Detector size (mm) Spacing (cm)
MatriXX 24.4×24.4 Ionization chamber 4.5 diam×5 height 0.76
MapCHECK2 26×32 Diode 0.8×0.8 0.71
PTW729 27×27 Ionization chamber 5×5×5 1
Table 2.1: Summary of the main characteristics of MatriXX, MapCHECK2
and PTW729 detector arrays.
the buildup and backscatter plates, of Polymethyl Methacrylate, have a
mass thickness of 2 and 2.75 g cm−2 respectively.
c) PTW729 (PTW-Freiburg):
An array of 27×27 cubic ionization chambers of 5 mm side, embedded
in a Polymethyl Methacrylate plate (density 1.12 g cm−3) with 0.5 cm
ridges between them. The center-to-center detector distance is 1 cm and
thus the array covers a square area of 27 cm×27 cm side. The buildup
and backscatter plates, also made of Polymethyl Methacrylate, have a
thickness of 0.5 and 2 cm respectively.
2.1.1 Previous work and motivation
All the commercial detector arrays just presented are widely used for treat-
ment veriﬁcation in many clinical institutions, and had been thus object
of thorough characterizations before our study. Amerio et al. and Stasi
et al. [47, 48] dealt with the characterization of MatriXX initial versions,
speciﬁcally studying the eﬀect of the spatial resolution on the evaluation of
the dose map. Spezi et al. [49] presented a characterization of PTW729, an
array which was further studied by Poppe and collaborators [50, 51], show-
ing a good performance and reliability. Jursinic and Nelms [52] presented
a characterization study of the MapCHECK2 array and Banci Buonamici
et al. [53] compared its performance with ﬁlm dosimetry.
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Other works have been more focused on the spatial response of these devices
to radiation beams, as it can play a signiﬁcant role in their use for dose
veriﬁcation. Ionization chambers spatial response functions were studied by
Poppe et al. [50] through pencil-beam irradiation. A response maximum
was observed when the beam impinges on the detector wall, or on the
ridges between detectors, at a distance from the cavity surface within the
range of secondary electrons, although the response function was ﬁnally
approximated to a trapezoidal shape for the characterization of the device.
Diode detectors, with a size smaller than the maximum range of secondary
particles in the surrounding media, present a diﬀerent response in shape
and width than that of air ionization chambers [54]. Finally, other studies
have used Fourier analysis and sampling theory to investigate the response
functions of diﬀerent detectors [51, 55].
The existing literature addressed the characterization of detection arrays,
testing their suitability for treatment veriﬁcation usually by comparison
with ﬁlm dosimetry. However, the diﬀerent approaches followed in those
investigations make inter comparison between devices diﬃcult. In order
to avoid this, our work simultaneously studies the aforementioned com-
mercial solutions, covering both diodes and ionization chambers detection
technologies and following a uniﬁed methodology (all devices under equal
conditions), with the objective of providing comparable data to users and
obtaining conclusions about the optimal design of detection arrays [56].
2.2 Detector ﬂuence response function
The spatial response function of a detector can be characterized by the
signal, S, registered when the detector, placed at a ﬁxed depth z in a
phantom, is irradiated with an inﬁnitesimally narrow pencil beam of unit
ﬂuence, ψδ(x′, y′) ≈ δ(x′−x, y′−y), perpendicular to the phantom surface,
at an incidence position (x, y) on this plane.
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Fψ(x, y, z) = Sδ(x, y, z) (2.1)
This response of the detector to an ideal perfectly collimated incident ﬂu-
ence function, referred to as energy ﬂuence response function, Fψ, allows to
express the response of the detector to an arbitrary incident energy ﬂuence
through its convolution with the ﬂuence distribution [57]:
S(x, y, z) =
∫ ∞
−∞
∫ ∞
−∞
ψ(x′, y′)Fψ(x− x′, y − y′, z) dx′ dy′ (2.2)
For an air ionization chamber, the ﬂuence response function depends on
the cavity geometry and the properties of the materials surrounding it.
The ionization signal is dominated by the ﬂuence of secondary electrons
generated in the plate above the active volume and the ridges between
detectors [58] (usually chosen to be water equivalent), which leads to a
lateral response peaking at the detector wall position, see Figure 2.2, as it
was already observed for PTW729 detectors by Poppe et al. [50]. Diode
detectors exhibit a much narrower lateral response due to their smaller
size and higher density with respect to the surrounding materials. The
diode detector signal drops thus more drastically when the pencil beam
targets the rigdes between detectors with no response peaks associated to
the change of material.
2.2.1 Measurements
The ﬂuence response function of PTW729, MatriXX and MapCHECK2
were measured with a methodology resembling that adopted by Poppe [50].
Some diﬀerences in the collimation and scanning procedures were intro-
duced with the objective of measuring narrower and more intense peaks at
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Figure 2.2: Schematic representation of the PTW729 array showing the con-
tribution to the signal of the charged particles originated in the materials sur-
rounding the air cavities. R stands for the electron range.
the ionization chamber walls as it would be expected from point-like pencil
beams. Our collimated pencil beam, of 0.5 mm×0.5 mm size, was obtained
from a 2 cm×2 cm radiation ﬁeld of a 6 MV Siemens Mevatron linac by
using two pairs of confronted cerrobend blocks (of 6 cm×5 cm×10 cm each)
separated by 0.5 mm.
The spatial response of the detectors was measured with the array mounted
on a stepper motorized platform. Detector arrays were placed on the plat-
form with PMMA buildup plates on them to place all detectors at 5 g cm−2.
A PMMA plate was also placed below the arrays to ensure full backscatter
contribution to the detectors. For the measurement of Fψ, one single detec-
tor, usually the central one, was scanned with the pencil beam in 0.5 mm
steps. Figure 2.3 shows a sketch of this experimental set-up and Figure 2.6
shows the measured ﬂuence response functions under this method.
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Figure 2.3: Experimental set-up for the measurement of the detector energy
ﬂuence response function Fψ. The incident beam is collimated by two pairs of
cerrobend blocks (a) conforming a 0.5 mm×0.5 mm pencil beam. The detector
array (c) is mounted under slabs of water equivalent buildup slabs (b) on a
stepper motorized platform (d) to scan one single detector and register Fψ.
2.2.2 Monte Carlo simulation
The width of the measured ﬂuence response function depends on the size
and penumbra of the beam used to scan the detector, which should be
as narrow as possible to reproduce the deﬁnition of Equation 2.1. The
eﬀect of measuring Fψ for ionization chambers like those of MatriXX and
PTW729 with a 0.5 mm×0.5 mm pencil beam is small due to the large
size of these detectors. The peaks associated to the ionization chamber
walls are softened, but the width of Fψ is much closer to the real one than
that obtained for a diode detector when using the same method, the reason
being that in this case, the pencil beam size is not negligible compared with
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the detector size. The eﬀect of the pencil beam size on the measurement of
Fψ was studied with Monte Carlo. The geometry used for the simulation of
each detector array consisted in a set of 5×5 detectors located at a depth
of 5 cm in a phantom. Ionization chambers were represented as simple air
cavities within water for the simulation of MatriXX and within PMMA for
the simulation of PTW729. For the simulation of the MapCheck2 array,
geometry and materials of the diode detector were provided by the vendor,
see Figure 2.4.
Figure 2.4: Scheme of the geometry and materials employed for the Monte
Carlo simulation of a) the MapCHECK2, b) PTW729 and c) MatriXX (the
buildup and backscatter plates of this device were approximated by water,
given the similar mass and electronic density of Tecaran, RW3 and water).
Response functions were calculated, again for the central detector of our
simulation geometries, using the EGSnrc code [59] and the C++ class li-
brary [60].
Chapter 2. 2D detector arrays for IMRT veriﬁcation 57
Transport Parameters
The range rejection variance reduction technique was applied to electrons
with energies above 1 MeV, using 0.512 and 0.01 MeV cutoﬀ energies for
electrons and photons respectively. Presta I boundary crossing algorithm
was employed with a skin depth of three elastic mean free paths, with the
EXACT algorithm being employed beyond. Slowing-down of electrons was
simulated through the condensed history method using the EGSnrc algo-
rithm with a 0.5 default step-size and a maximum energy loss of a 25%.
For the Bremsstrahlung processes, NIST cross-sections were employed to-
gether with the Koch-Moth photon angular sampling. The SIMPLE pair
production angular sampling algorithm was chosen, while Rayleigh scatter-
ing, electron atomic relaxations and photo-electron angular sampling were
neglected. Spin eﬀects were considered for elastic scattering, and Bound
Compton scattering activated to account for the electronic bounding ef-
fects and Doppler broadening according to the impulse approximation.
Response Functions
In a ﬁrst step, ﬂuence response functions were simulated with a source try-
ing to reproduce the experimental pencil beam, which was represented by
a bi-dimensional Gaussian spatially distributed photon source. EBT ra-
diographic ﬁlm dosimetry was used to estimate the size and penumbras of
the pencil beams employed in the measurements, see Figure 2.5, yielding
FWHM of (1.18 ± 0.11) mm and (1.49 ± 0.13) mm in the x and y axis
respectively. The spectrum of the source was calculated at the axis of a 2
cm×2 cm ﬁeld of a Siemens PRIMUS linac in 6 MV modality simulated
with the BEAMnrc code [61] through the propagation of a monoenergetic
electron source of 5.75 MeV and Gaussian focal spot of 1.5 mm FWHM.
Fluence response functions calculated with this method found a good agree-
ment with the experimental results, Figure 2.6, providing a veriﬁcation
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Figure 2.5: a) EBT gafchromic darkening under the irradiation of the 0.5
mm×0.5 mm pencil beam and b) ﬁlm darkening quantiﬁcation proﬁles, mea-
sured at the central x and y axis, for the determination of the collimated dose
distribution.
for the Monte Carlo simulation procedure. The small discrepancies found
around the ionization chambers wall are thought to be due to diﬀerences
in the penumbra of the experimental and simulated radiation sources.
Figure 2.6: Measured (·) and Monte Carlo calculated (×), ﬂuence spatial
response functions from a 0.5 mm×0.5 mm pencil beam with a 6 MV modality
in a Siemens PRIMUS linac spectrum, MapCHECK2 (a), PTW729 (b), and
MatriXX (c).
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The widening eﬀect caused when measuring Fψ with a 0.5 mm×0.5 mm
pencil beam instead of an inﬁnitesimal collimation was analyzed. Two di-
mensional Fψ functions were calculated with a narrower radiation source: a
square pencil beam of 0.1 mm side with the same 6 MV Siemens PRIMUS
linac spectrum. Figure 2.7 (a) shows the response function obtained with
this collimation for MapCHECK2 diode detectors in comparison with the
measured Fψ, while Figures 2.7 (b) and 2.8 (a) and (b) show the two dimen-
sional response functions of the three detectors under study with a grid of
1 mm. The widths yielded by diﬀerent measurements and simulations are
summarized in Table 2.2, where we conﬁrm the small but noticeable eﬀect
of the experimental 0.5 mm×0.5 mm pencil beam in the measurement of
the ionization chambers response and an important widening in the diode
response.
Figure 2.7: (a) Measured (◦, · ) and Monte Carlo calculated (∗) MapCHECK2
Fψ response function from a 6 MV Siemens PRIMUS 0.5 mm×0.5 mm pencil
beam (pb). Monte Carlo calculated Fψ from a 0.1 mm×0.1 mm pencil beam
(). (b) MapCHECK2 diodes two dimensional Fψ calculated by Monte Carlo
simulation with a square pencil beam source of 0.1 mm side.
Finally, a full Monte Carlo study was conducted on the energy dependence
of the ﬂuence response of air ionization chambers. An inverse relationship
was observed between the energy of the beam and the height of the re-
sponse peak associated to the ionization chamber wall, see Figure 2.9 (a).
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Figure 2.8: a) PTW729 and b) MatriXX ionization chambers Fψ calculated
by Monte Carlo simulation with a square pencil beam source of 0.1 mm side
from a 6 MV Siemens PRIMUS linac.
Fψ FWHM MapCHECK2 PTW729 MatriXX
Measured (0.5 mm×0.5 mm) 0.146 0.872 0.665
Simulated (0.5 mm×0.5 mm) 0.140 0.821 0.648
Simulated (0.1 mm×0.1 mm) 0.083 0.700 0.640
Table 2.2: Width, expressed as FWHM in cm, of the detectors ﬂuence re-
sponse functions measured with a 0.5 mm×0.5 mm pencil beam, and width of
the response functions simulated under the incidence of a 0.5 mm×0.5 mm and
a 0.1 mm×0.1 mm pencil beams.
This behavior is understood to be a consequence of the decreased signal
contribution from the secondary electrons released in the ridges between
detectors (Figure 2.2) as the energy of the beam increases. We can also
observe that the ﬂuence response function Fψ of an ionization chamber in
a 60Co beam and in a 6 MV linac beam are very close due to the similar
average energy of these beam qualities. The relationship between the signal
peak and the beam spectrum is also described in Figure 2.9 (b), where the
normalized response peak is presented versus the inverse of the secondary
electrons CSDA range for diﬀerent spectra. A good linear correlation is
observed between these two magnitudes.
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Figure 2.9: (a) Fψ response function, normalized to central response, for a 0.5
MeV monoenergetic photon beam (∗), 60Co (+), 6 MV Siemens PRIMUS (◦)
and 1.25 MeV (·), 3 MeV (×) and 6 MeV () monoenergetic photon beams. (b)
The response at the detector lateral wall position plotted against the inverse
of the secondary electrons CSDA range.
2.3 Detector dose response function
Once the ﬂuence response functions of MapCHECK2, PTW729 and Ma-
triXX have been studied, we proceed to analyze the impact that using these
detectors has on the measurement of dose distributions.
The dose deposition produced at a certain depth in a material under an
incident photon energy ﬂuence ψ(x, y) can be written as the convolution/
superposition of that ﬂuence with a dose deposition kernel K(x, y, z) that
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accounts for photon scatter, primary and secondary electron transport and
beam broadening with depth in the material.
D(x, y, z) =
∫ ∞
−∞
∫ ∞
−∞
ψ(x′, y′)K(x− x′, y − y′, z) dx′ dy′ (2.3)
If a detector is employed to measure this dose, the signal registered by
the detector can be expressed as the convolution of the dose distribution
at a depth z, calculated as in Equation 2.3, with a new detector response
function FD(x, y), referred to here as `dose response function'. If we note
with the symbol ⊗ the convolution integral with respect to transversal
coordinates, the response S(x, y, z) of the detector is given as:
S = D ⊗ FD = ψ ⊗ Fψ = ψ ⊗K ⊗ FD (2.4)
As the ﬂuence response function Fψ studied in the last section can be
expressed as:
Fψ = K ⊗ FD (2.5)
The dose response function FD can be obtained through the deconvolution
of Fψ with the dose deposition kernel, although it is important to observe
that Equation (2.5) is only veriﬁed for realistic ﬂuence response functions
and dose deposition kernels.
In our work, the pencil beam dose deposition kernel was assumed to follow
a single parameter Lorentz function, K(x, y, z) = λ(z)
2pi
[x2 + y2 + λ2(z)]−
3
2
with λ = 1.3 mm for 6 MV photon beams at 5 cm in water [57]. FD was
then obtained with an iterative algorithm deconvolving the Monte Carlo
calculated Fψ functions (those obtained from the 0.1 mm×0.1 mm pencil
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MapCHECK2 PTW729 MatriXX
Fψ 0.083 0.700 0.640
FD 0.077 0.630 0.500
Table 2.3: Comparison of ﬂuence and dose response functions widths, ex-
pressed as FWHM in cm.
beam exhibit more realistic widths and are thus more appropriate for the
calculation of FD) and the Lorentzian dose deposition kernel.
The dose response functions derived from the ﬂuence response functions of
MatriXX, MapCHECK2, and PTW729 detectors are shown in Figure 2.10.
The dose deposition kernel corresponding to the measurement at 5 g cm−2
mass depth causes a reduction in the width of FD compared to that of Fψ,
presented in Table 2.3.
Figure 2.10: Dose detector response functions, FD, obtained through the Fψ
dose kernel deconvolution for MapCHECK2 (◦), MatriXX (·) and PTW729 (×)
detectors.
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Once the detector dose response function FD has been calculated, the signal
yielded by the detector for an arbitrary dose distribution can be modeled
if a reference dose distribution with high spatial resolution is available [62].
2.3.1 Veriﬁcation of the methodology
The methodology above presented can be used to test the capability of
the devices to measure dose distributions with steep gradients, evaluating
the importance of the volume averaging eﬀect in ionization chambers. But
before proceeding with this analysis for the three arrays under study, a
consistency test was performed to check the presented formalism, trying
to conﬁrm that the convolution of the dose response function, FD, of a
detector with a reference dose distribution leads not only to an accurate
representation of the detector signal, but also to a better result than what
would be achieved through the use of Fψ.
The FD model was tested both in one and two dimensions using several
radiosurgery radiation ﬁelds, with 1.8 cm×1.8 cm, 4.2 cm×4.2 cm and 11.2
cm×11.2 cm sizes, from a Siemens PRIMUS linac with a BrainLab MLC
in 6 MV modality. Lateral proﬁles were measured with a PTW60016 diode
detector in steps of 1 mm at 5 cm depth in water. These measurements were
then used as reference dose distributions and convolved with the PTW729
ionization chambers FD to obtain a model of the response of this device.
The results, as well as those obtained through the convolution of the dose
distribution with the Fψ of the same detector, were then compared with
real measurements of the PTW729 array for the same ﬁelds.
Figure 2.11 shows the results of these comparisons. The diﬀerences found
between the models involving the convolution of Fψ or FD with the refer-
ence dose distribution are small, but we can observe an overestimation of
the detector averaging eﬀect when the convolution with Fψ is performed.
The accuracy achieved by the two models is quantitatively represented by
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Figure 2.11: Radiosurgery lateral proﬁles for a) 1.8 cm×1.8 cm, b) 4.2
cm×4.2 cm and c) 11.2 cm×11.2 cm beam sizes. Measurements with
PTW60016 diode (dashed line) are used as reference dose distribution to obtain
detector response models through their convolution with FD (solid line) and
Fψ (×), for their comparison with PTW729 detector array measurements (∗).
Local relative diﬀerences for both convolution models Fψ (+) and FD () are
also shown.
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the local percent dose diﬀerences between the models and the PTW729
measurements. These percent dose diﬀerences are also shown. A higher
agreement was found in all the studied cases between the FD model and
the PTW729 measurements, with local relative deviations below 1%.
The same test was performed for a simple intensity modulated ﬁeld made
by superposition of three ﬁelds with the above mentioned ﬁeld sizes, see
Figure 2.12. In these case, the diﬀerences between the models involving the
convolution of Fψ or FD with the dose distribution are smaller, probably due
the positioning of the PTW729 array with respect to the radiation beam.
In this measurement, the positioning of the PTW729 array caused the
detectors to be placed either in ﬂat dose zones or in the middle of penumbra
regions, where the detector averaging eﬀect is low and diﬀerences between
the Fψ and FD convolutions are more diﬃcult to detect. The discrepancies
between the two models are minimal in these regions, as shown in Figure
2.11 for the single ﬁeld study. A small but noticeable improvement is
nevertheless observed for the convolution with FD.
The tests here presented were considered to serve as a validation for the
formalism presented in Section 2.3 for ionization chamber type detectors,
and thus measurements were not repeated for the MatriXX array. Regard-
ing MapCHECK2, this methodology should not be followed because the
active area of PTW60016 diode (1 mm2 circular) is bigger than that of
MapCHECK2 detectors (0.8 mm×0.8 mm). We nevertheless rely on our
methodology and use as diode FD the function obtained from the Monte
Carlo calculated Fψ after deconvolution with the dose deposition kernel.
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Figure 2.12: Radiosurgery IMRT beam created by the superposition of 1.8
cm×1.8 cm, 4.2 cm×4.2 cm and 11.2 cm×11.2 cm ﬁelds: a) Reconstruction
of the beam in two dimensions as measured with a PTW60016 diode; b) Lat-
eral proﬁle measured with the PTW60016 diode (dashed line), PTW729 array
measurements (∗) and response models obtained through the convolution of Fψ
(×) and FD (solid line) response functions. Relative local diﬀerences between
PTW729 measurements and Fψ (+) and FD (·) models are also shown.
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2.4 IMRT veriﬁcation.
In this section we present a general study about the performance of the
arrays for IMRT veriﬁcation. We analyze how the response of the detectors
aﬀects the measurement of dose distributions, ﬁrst disregarding the array
detectors sampling and then taking it into account. Besides, we test the
capability of the arrays to measure ﬂuence variations arising from small leaf
displacements in a treatment.
2.4.1 Eﬀect of the detector FD on IMRT veriﬁcation.
The standard approach followed by clinical institutions for treatment ver-
iﬁcation consists in the comparison of a dose distribution obtained with
a measurement system, here a detector array, with a reference dose map
generally obtained from the Treatment Planning System. This compari-
son is usually performed through the Gamma function [63], a cost function
that do not only considers relative dose diﬀerences between distributions
but also their spatial matching. The Gamma function takes the following
value:
γ(re) = min{Γ(re, rr)} ∀{rr} (2.6)
Where the Γ function is given by:
Γ(re, rr) =
√( | re − rr |
∆d
)2
+
(
De(re)−Dr(rr)
∆D
)2
(2.7)
In the above equations rr and re are the spatial coordinates of the reference
and measured dose distributions, and ∆D and ∆d are dose and distance
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tolerances. The matching of both distributions is measured by the percent
of points with γ < 1.
The methodology of this section for the study of capability of the arrays on
IMRT veriﬁcation follows the clinical institutions' approach. Our analysis
uses ﬁlm dosimetry as reference dose distribution due to the higher reso-
lution achieved with this dosimetry system, being more appropriate for its
convolution with the dose response functions.
The eﬀect that the response of the detectors has on the measurement of a
dose distribution can be isolated from other eﬀects, like the detector spacing
in the array or the accelerator repeatability, through the comparison of the
ﬁlm dosimetry of an IMRT dose distribution with the model of the detector
response for the same ﬁeld. The response obtained through the convolution
of the detector dose response function FD and the ﬁlm dosimetry leads
to a detector model with the ﬁlm sampling or grid, avoiding the eﬀect
introduced by the array discretization. The distribution so obtained would
be equivalent to a set of array measurements displacing the device with the
ﬁlm grid step (i.e. 0.5 mm in our case) between consecutive measurements.
A demanding incidence of a real IMRT head-and-neck clinical treatment
was chosen for this study. This modulated ﬁeld consists of 38 diﬀerent
segments with sizes ranging approximately from 1 cm×3 cm or 0.5 cm×10
cm to 5 cm×20 cm, see Figure 2.13. This dose distribution includes steep
gradients and ﬂat regions, the maximum dose is 1.98 Gy and dose gradi-
ents range from 0 to 4.9 Gy/cm, being for our purpose considered as a
representative IMRT dose distribution. A Siemens PRIMUS linac in 6 MV
modality with an OPTIFOCUS multileaf collimator (MLC) was used to
deliver the incidence at 0◦ ﬁxed gantry position, with the detector arrays
placed at 5 cm depth in a Solid Water phantom. The radiographic ﬁlm
dosimetry was performed at the same depth, leading to a dose distribution
with 0.5 mm resolution suitable for the convolution with the detector dose
response function, FD, to evaluate the detector array measurement.
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Figure 2.13: TPS Pinnacle 8.0h dose distribution calculated at a depth of 5
cm in water for the IMRT incidence used in our study (38 segments delivered
at 0◦ gantry ﬁxed position).
Models of the detector response to this incidence were obtained and com-
pared with the ﬁlm dosimetry by means of the Gamma function, see scheme
in Figure 2.14 for clariﬁcation. This analysis allows uncoupling the eﬀect of
the detector response from other eﬀects arising in the measurements with
the real devices (noise from the ﬁlm and array measurements, accelerator
repeatability, etc) that can lead to reduced Gamma passing rates.
Figure 2.14: Scheme of the procedure followed to obtain a model of the
detector response to the IMRT incidence. The eﬀect of the detectors response
is studied through the comparison of ﬁlm dosimetry and the arrays response
model by means of the Gamma function.
Chapter 2. 2D detector arrays for IMRT veriﬁcation 71
Figure 2.15 shows the percentage of points in the response models yielding
Gamma values below one for diﬀerent spatial and dose Gamma tolerances.
A higher accuracy can be observed for the MapCHECK2 diode measure-
ments, as expected given its narrow response function. On the other hand,
the eﬀect of MatriXX and PTW729 ionization chamber responses is higher,
although it leads to passing rates above 96% for Gamma tolerances equal
or above 1.5%-1.5 mm. We can here see how the detection type and active
volume determine the behavior of a detector in the conditions of lack of
lateral charged particle equilibrium found in IMRT. For the tolerance lev-
els generally adopted in treatment veriﬁcation programs, 1.5%-1.5 mm or
higher, the ionization chamber averaging eﬀect is however negligible when
the overall ﬂuence of an IMRT treatment incidence is analyzed.
Figure 2.15: Gamma passing rates for diﬀerent dose and distance toler-
ances, obtained from the comparison of the detector array response model
of MapCHECK2 (·), MatriXX (∗) and PTW729 (◦) with the radiographic ﬁlm
dosimetry for the IMRT incidence under study.
The global performance of the detector arrays was also investigated through
the comparison, again in terms of the Gamma function, of the arrays real
measurements and the ﬁlm dosimetry, which yields the passing rates pre-
sented in Figure 2.16(a). The eﬀect of the above mentioned detector spacing
Chapter 2. 2D detector arrays for IMRT veriﬁcation 72
and the linac, ﬁlm and detectors repeatability are, in this way, included in
the analysis. It is important to note that while Gamma evaluation in Figure
2.16 is restricted to the number of detectors in the array, values reported
in Figure 2.15 were computed using a much higher number of points.
Figure 2.16: a) Gamma passing rates resulting from the comparison of the
arrays measurement and ﬁlm dosimetry for the studied IMRT dose distribution,
MatriXX (), PTW729 (·) and MapCHECK (◦). The arrays measurements are
also compared with our response models, shown in full lines with uncertainty
bars, for MatriXX b), PTW729 c) and MapCHECK2 d), respectively.
The arrays measurements were also compared with our response models,
results shown in subplots b), c) and d) of Figure 2.16. Passing rates ob-
tained for the ﬁlm-array comparisons are included to serve as reference.
Lower passing rates can be observed in the comparison of the arrays mea-
surements and the response models. We should realize that Gaussian noise
in ﬁlm dosimetry, with an estimated 1.3% relative uncertainty, can con-
tribute to increase the Gamma passing rates in Figure 2.16(a), as well as
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the sensitivity of the Gamma function to small spatial misalignments be-
tween dose distributions, with an uncertainty that was estimated to be
around 0.5 mm. The uncertainty bars associated to the Gamma passing
rates, which were obtained through the introduction of small displacements
between dose distributions following a Gaussian distribution with 0.5 mm
standard deviation, show that our response model is compatible with the
detector array measurements. The reduced noise exhibited in the response
model dose map compared to that of the original ﬁlm map would explain
the systematic slightly lower passing rates obtained for our models.
2.4.2 Sensitivity to ﬂuence variations
As we have seen, dose veriﬁcation consists in the comparison of a treatment
planned dose with the dose distribution delivered by the linac to check
whether the discrepancies encountered are relevant or not. Whichever it
is the dosimetric system employed for that purpose, it is of major concern
to study its capability to detect ﬂuence variations, as this determines the
thoroughness of the dosimetric veriﬁcation performed with that dosimetric
system.
In order to study the sensitivity to ﬂuence variations of the detector ar-
rays, diﬀerent ﬂuence changes were introduced in several segments of the
IMRT head-and-neck treatment incidence presented in section 2.4.1. These
intentional ﬂuence variations were introduced mainly through leaf misplace-
ments, an example of which is shown in Figure 2.17 (a), and changes in the
monitor units of some of the segments. The ﬂuence modiﬁcations, shown
in Table 2.4 with the position of the ﬂuence variations within the dose
map, consisted on a leaf displacement of 4-5 mm in 5 of the 38 total seg-
ments, and a diﬀerence of 12 MU in one segment with no leaf displacement.
TPS Pinnacle 8.0h dose calculations were performed to register the dose
variations produced at 5 cm depth in water shown in Table 2.4.
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X axis (cm) Y axis (cm) Monitor Units ∆Dmax (cGy)
[−2,−1.5] [9.5, 10.5] 21 6.9
[−0.5, 0.5] [6.5, 11.5] 12 19.0
[5, 5.4] [9.5, 10.5] 53 18.4
[7, 7.5] [5.5, 6.5] 34 8.2
[−2,−1.6] [1.5, 2.5] 51 15.1
[5.5, 5.9] [−9.5,−10.5] 57 17.9
Table 2.4: Position in the XY plane, change in Monitor Units and maximum
dose diﬀerence registered by the treatment planning system for the ﬂuence
variations introduced in the IMRT incidence.
Figure 2.17: (a) MLC projection on the PTW729 surface showing a 5 mm
leaf displacements in one segment, and (b) dose distribution, in gray scale,
of the IMRT incidence under study: the stars positions indicate the spatial
localization of the ﬂuence changes introduced for the sensitivity study.
The sensitivity of the arrays to ﬂuence changes was analyzed in a detector
by detector basis. The signal variation registered in every detector when the
array is irradiated by these two incidences (original and manually modiﬁed)
was considered to be the most appropriate quantity to study, because the
detector spacing in these commercial arrays does not allow the use of the
Gamma function without dose interpolation, which we preferred to avoid.
Several array measurements were acquired for the normal and modiﬁed
incidences, to check the repeatability achieved in the signal changes arising
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from the intentional ﬂuence perturbations. Although other perturbations
were studied, only those summarized in Figure 2.17(b) and Table 2.4 are
presented here due to the similar results obtained in all the studied cases.
The position of detectors exhibiting signal changes higher than 3% of the
dose maximum are highlighted in Figure 2.18 for the three arrays. It can
be observed that the ﬂuence perturbations involve signal changes in a small
number of detectors, and although a higher occurrence of signal variations
can be noticed in MapCHECK2, not all these variations are located in
positions where ﬂuence perturbations were intentionally introduced.
Figure 2.18: Comparison of arrays measurement for the normal and modiﬁed
IMRT incidences. White squares show the position of the detectors exhibiting
dose changes greater than 3% of the maximum dose.
On the other hand, the fraction of detectors having a threshold signal
over the 10% of the array maximum signal and exhibiting signal varia-
tions greater than 1.5% of the maximum signal is 1.9% for MatriXX, 1.7%
for PTW729 and 17% for MapCHECK2. This general analysis would not
alert about the occurrence of critical perturbations, since many veriﬁcation
procedures consider as acceptable dose distributions exhibiting 5% of their
total points in discrepancy with the reference distribution with a tolerance
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of 3% of the maximum dose [64, 65], something that would not happen
in our case. The variation in the signal of the detectors was found to be
Figure 2.19: Percentage of change in detector response versus the magni-
tude of the induced ﬂuence variations (mean value of repeated measurements)
MapCHECK2 (∗), PTW729 (+) and MatriXX (◦).
clearly related with the ﬂuence change, quantiﬁed by the product of the area
in the segment suﬀering variations and the monitor units variation. This is
shown in Figure 2.19, where the ﬂuence perturbation is plotted against the
change in array readout (the experiment was repeated twice for every de-
vice, and mean values are reported). We can see that the readout diﬀerence
increases with the ﬂuence change, although there seems to be an indication
of a low sensitivity plateau for ﬂuence perturbations below 20 MU×cm2. A
slightly higher sensitivity to the treatment ﬂuence changes was observed for
the air ionization chamber arrays, which is related with the larger eﬀective
(active) area covered by these devices, see Figure 2.20. The array ﬁll factor
was here quantiﬁed as the ratio of the area covered by the FWHM of the
detector spatial response function Fψ, referred to as active area in Figure
2.20, and the cell area deﬁned by the detector grid. Fill factors amount to
55%, 44% and 8% for MatriXX, PTW729 and MapCHECK2 respectively.
Chapter 2. 2D detector arrays for IMRT veriﬁcation 77
Arrays with higher ﬁll factors exhibit higher sensitivity to ﬂuence variations
which are not located at the detector center positions.
Figure 2.20: Schematic representation of the detectors active area and the
array cell for the devices under study: a) PTW729 detectors represented by
grey squares, b) MapCheck 2 detectors represented by points and c) MatriXX
detectors represented by gray circles. The array cells are represented by dashed
line squares and active areas are inscribed inside the solid line.
The sensitivity and predictivity of the arrays to ﬂuence variations was also
studied in terms of the Positive Predictive Value, PPV, a magnitude usually
employed in radiology tests. The PPV is deﬁned for a given threshold as the
number of `true' positives to total positives ratio. In our case, the `true'
positives stand for the number of detectors that register a signal change
that is actually related with any of the intentionally introduced ﬂuence
variations, and the total positives is the number of detectors exhibiting
readout variation above threshold.
Figure 2.21 shows the higher PPV values obtained for the ionization cham-
ber arrays (as expected from Figure 2.18), while higher percentages of false
positives were found for the diode array. It should be however noticed that
for detectability thresholds above 5% of the maximum dose, the number of
detectors included for MapCHECK2 PPV calculations is small: PPV val-
ues diﬀering from unity are due to two or three detectors usually located
at the beam penumbras. On the other hand, PPV values are observed to
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Figure 2.21: Positive Predictive Value obtained at diﬀerent detectability
thresholds for MapCHECK2 (∗), PTW729 (+) and MatriXX (◦).
decrease sharply when detectability thresholds are below 1%, 2% and 4%
of the treatment maximum dose for MatriXX, PTW729 and MapCHECK2
respectively.
2.4.2.1 Sensitivity to MLC leaf displacements
The diﬀerent results obtained for the ionization and diode arrays motivated
a speciﬁc investigation about the MapCHECK2 `false' positives.
The hypothesis that these signal variations could due to (small) missposi-
tionings of the multileaf collimator between measurements was investigated.
The collimator employed in the treatment under study has a leaf position-
ing accuracy around ∼1 mm, which would lead to small ﬂuence variations
in the segments delivered within a treatment that could be detectable by
the diodes.
In order to demostrate this, the MapCHECK2 array was irradiated with a
8 cm×12 cm Siemens PRIMUS linac ﬁeld. The array was placed to have
a row of diode detectors aligned with the penumbra of the beam to reg-
ister the maximum signal variation arising from the MLC leaf positioning
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mechanical accuracy. Two sets of 10 measurements were performed, deliver-
ing 50 MU per irradiation, the ﬁrst one maintaining the MLC leaf positions
steady between measurements, and the second by moving the leaves to con-
form the ﬁeld before each irradiation. This repeatability study also allowed
discarding drastic miss-calibrations in any of the 1527 detectors.
Figure 2.22: Relative standard deviation (rsd) obtained in 10 MapCHECK2
measurements of a 8×12 cm2 Siemens PRIMUS ﬁeld with 50 MU when: (a)
the ﬁeld is conformed before every irradiation and (b) leaves are kept in steady
positions.
The set of measurements with the MLC leaves remaining steady exhibited a
relative standard deviation, rsd, with respect to the maximum signal in the
array for this ﬁeld, that reached a 0.5%, while the measurements involving
the leaves repositioning showed rsd values up to a 3.5% for the detectors
located at the beam penumbra, as shown in Figure 2.22.
When sets of two measurements are compared, as it is done to obtain the
signal diﬀerence registered when the array is irradiated by the normal and
modiﬁed incidence, rsd values up to 0.9% are observed for the study with no
MLC movements, while variations up to 7% are observed when leaves are
moved to conform the same beam between measurements. The sensitivity
of MapCHECK2 diode detectors to leaf position variations of ∼1 mm was
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thus conﬁrmed, and the lower PPV values obtained for MapCHECK2 com-
pared to ionization chamber arrays could be then associated with the de-
tection of systematic small leaf displacements between segments employed
in the repeated deliveries of the studied incidence. It could be then argued
that the high resolution and sensitivity of the diode array can result coun-
terproductive for treatment veriﬁcation. The low ﬁll factor of these devices
can lead to important ﬂuence changes involving large signal deviations in a
small number of diodes, making diﬃcult to distinguish these perturbations
from 1 mm leaf positioning errors of lower relevance. This would be the
case of the second modiﬁcation, see Table 2.4, where only two diodes show
a discrepancy higher than 3%, see Figure 2.18. On the contrary, ionization
chambers volume averaging eﬀect minimizes the signal variations originated
from MLC displacements of ∼1 mm. The discrepancies exhibited by the
ionization chambers located in regions without important ﬂuence pertur-
bations are thus smaller, leading to the higher PPV values observed in our
study. This lower sensitivity to small leaf misplacements makes the ion-
ization chamber arrays veriﬁcation more predictive to important ﬂuence
perturbations.
2.5 Conclusions
In this chapter we have presented a study about detector arrays for dosimet-
ric treatment veriﬁcation, focusing on PTW729, MatriXX and MapCHECK2
commercial solutions.
Energy ﬂuence detector response functions, Fψ, were measured in water
for the three arrays under 6 MV linac modality and with a 0.5 mm×0.5
mm scanning pencil beam. Monte Carlo response functions were also cal-
culated reproducing the experimental measurements and allowing a Monte
Carlo energy dependence study and the calculation of more realistic ﬂuence
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response functions for narrower collimation. Dose detector response func-
tions, FD, were then calculated as the deconvolution of Fψ and the dose
deposition kernel for the depth at which the ﬂuence response function was
measured. A formalism was then presented to model the response of de-
tector arrays to arbitrary incident ﬂuences through the convolution of the
corresponding reference dose distribution and the detector dose response
function. This model, satisfactory validated in several radiosurgery beam
measurements, was shown to avoid the overestimation of the detector ef-
fect that would result from the convolution of the dose distribution and the
ﬂuence response function.
Our model served to isolate and study the eﬀect of the detectors response on
the measurement of a representative IMRT dose distribution. The results
show that highest accuracy is achieved with diodes, although the perturba-
tions introduced by the ionization chambers due to volume averaging or the
lateral wall response peak remain negligible for Gamma function tolerances
higher than 1.5%-1.5 mm. The global performance of the devices including
detector spacing was also analyzed, pointing out the impact on the Gamma
test of small spatial misalignments and noise in the dose distributions under
comparison.
Finally, the sensitivity of the arrays to treatment ﬂuence changes was stud-
ied in a detector by detector basis. A correlation was found between ﬂu-
ence variation and detectors response above certain threshold. The Posi-
tive Predictive Value (PPV) indicator was also calculated showing a higher
predictivity to ﬂuence variations in the ionization chamber arrays for all de-
tection thresholds. The larger sensitive area of ionization chambers would
allow these devices to eﬀectively detect ﬂuence variations located at certain
distances from the detectors positions. The point-like response of diode de-
tectors, combined with the diode arrays sampling leads to a low ﬁll factor
that does not allow the detection of some ﬂuence variations, depending on
their position, which could be only avoided with a drastic decrease in the
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device detector spacing, a situation that might be technically unachiev-
able. Diodes are however more sensitive to small leaf positioning errors, as
those arising from the MLC mechanical accuracy, while ionization chambers
cannot detect them due to their volume averaging eﬀect. This sensitivity
to smaller ﬂuence variations lowers the predictivity of the MapCHECK2,
with respect to that of ionization chamber arrays, to more important ﬂu-
ence variations, like the 0.4 cm×1 cm ﬂuence perturbations studied in our
work. It is worth pointing out that the high sensitivity of MapCHECK2 to
small ﬂuence leaf displacements would not be reﬂected in Gamma passing
rates using standard tolerances, while its lower sensitivity to large ﬂuence
perturbations could have indeed consequences in Gamma passing rates for
conventional tolerances.
Our results show that the ideal detector array for IMRT veriﬁcation would
not necessarily require point-like detectors, as the averaging eﬀect of rel-
atively large detectors, for example air ionization chambers, enhances the
sensitive area of the device compared to that of the studied diode array.
Although it is clear that small detectors yield a more accurate reproduction
of dose in general IMRT conditions, the task of increasing the number of
detectors in an array to obtain a high ﬁll factor presents great design and
production diﬃculties. On the contrary, the averaging eﬀect of air ioniza-
tion chambers implies that a high ﬁll factor can be achieved in an array
constructed with an aﬀordable amount of detectors. Ionization chamber
arrays can thus oﬀer a good sensitivity to ﬂuence variations across the
whole area of a detector, which is the most important requirement of any
dosimetry system employed for treatment veriﬁcation.
The methodology followed in this work to study the arrays under the same
conditions and through a common analysis allowed us to obtain compara-
ble results to study the diﬀerences between them. With this work we have
contributed to the understanding of IMRT QA requirements, helping to
focus on the improvements that can lead to optimal detector array designs.
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Considering our results, a detector array involving medium size detectors,
for example ionization chambers with cross section areas of v 0.25 cm2,
and distance between detectors leading to ﬁll factors around 50% or above
would be an appropriate tool for IMRT treatment veriﬁcation. Recent de-
tection technologies, like LICs, may allow the construction of arrays with
high sensitivity and ﬁll factor. When our study was addressed, several
works had been already published related with these kind of devices, ﬁrst
for a LICs linear array [6668] and lately for a two dimensional LIC array
covering a 100% sensitive area of 3 cm×2 cm [69]. Linear arrays involving
LICs had been developed by PTW-Freiburg for ﬁeld veriﬁcation purposes
[66] and by mid-2012, PTW-Freiburg also began to commercialize a 2D
LIC array, the Octavius 1000 SRS R©, with Stereotactic RadioTherapy and
Radiosurgery veriﬁcation purposes. The latter device covers a 10 cm×10
cm total area, with a 100% ﬁll factor in an inner area of 5.5 cm×5.5 cm
and a ' 25% ﬁll factor beyond. This device became commercially available
well after this study was completed, and therefore could not be investigated
here. Although only a few studies have been published to this date dealing
with the characterization of this commercial solution [7072], the knowl-
edge currently available about this detection technology and the potential
capability to build LIC arrays with small detectors size (cross section areas
v 0.04 cm2, active volumes v 0.002 cm3) and full sensitive areas (100%
ﬁll factor) results very promising for the ﬁeld of radiosurgery treatment
veriﬁcation.

Chapter 3
Development of an ESR alanine
dosimetry system for the study
of nonstandard ﬁelds
3.1 Principles of alanine/ESR dosimetry
3.1.1 Introduction to alanine dosimetry
Alanine, an organic compound, is one of the simplest alpha amino acids
present in nature regarding molecular structure, being CH3CH(NH2)COOH
its chemical formula1. Under the incidence of ionizing radiation, radicals are
formed in alanine molecules, its number being proportional to the absorbed
energy for a wide range of doses, and this property is the basis of alanine
dosimetry.
There are several stable radical species that are now known to be present in
irradiated alanine crystals. During many years the predominant radiation
1The amino acids that have both the amine and carboxylic acid groups attached to the ﬁrst
(alpha-) carbon atom have particular importance in biochemistry and they are known as alpha-,
or α-amino acids.
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induced reaction was thought to be the removal of the amine group, leading
to the CH3CHCOOH radical with an unpaired electron. Additionally, a
radical species formed by hydrogen abstraction from the central carbon
atom and another minority radical species not yet unambiguously identiﬁed
have been observed in irradiated alanine, Figure 3.1. Some aspects like
the radicals radiation response, their thermal properties and diﬀerences in
fading properties between radical species are still under study [73, 74].
Figure 3.1: a) Alanine molecular structure, b) Alanine radical R1 formed
by the deamination of alanine, c) Alanine radical species R2 and d) Alanine
radical species R3 [73].
The presence of unpaired electrons in the alanine radical species can be
measured by electronic spin resonance spectroscopy, ESR, which yields a
signal consisting in the overlapping of the spectra from all the radical species
present in the sample, with an amplitude proportional to the total number
of radicals. The measurement of radical concentrations by ESR can be
thus used for the determination of the absorbed dose in the alanine sample
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Dal,Q.
(IESR)Q,T = K ·GQ,T ·m ·Dal,Q (3.1)
Where IESR is the intensity of the ESR alanine signal, K is a proportionality
factor that depends on the spectrometer sensitivity, m is the mass of the
dosimeter and GQ,T is the alanine radiation yield, deﬁned as the number of
radicals generated per unit of absorbed energy in the alanine for a certain
beam quality Q and irradiation temperature T.
The demonstration around 50 years ago by Box and Freund, Bradshaw et
al. and Rotblat and Simmons [7577] that the alanine amino acid could be
used as a solid state dosimeter by electronic spin resonance spectrometry
was the ﬁrst step of a successful research line that soon improved the tech-
nique for high precision measurement [78] and established the alanine/ESR
system as a reference dosimeter for industrial irradiation applications in
the kGy dose range. During the 1990s, several metrology institutions like
the National Physical Laboratory, NPL, in the UK, and the National In-
stitute of Standards and Technology, NIST, in the USA, developed the
alanine/ESR technique as secondary standard for absorbed dose to water
in the kGy dose range [79, 80].
The intrinsic properties that make alanine a good dosimeter for industrial
applications also stand for its use as a reference dosimeter in radiotherapy.
However, the signal to noise ratio exhibited by alanine dosimeters drops
drastically in the therapy dose range (approximately from 1 to 20 Gy),
increasing the sensitivity requirements of the spectrometer and making un-
avoidable to keep thoroughly controlled all the inﬂuence quantities that are
involved in the alanine/ESR dosimetry.
As it was commented in the introduction, the recommendation of achieving
a global accuracy of ±5% in the delivery of absorbed dose to water to tar-
get volumes of radiotherapy is usually established in the quality assurance
documents emitted by international institutions. Taking into account the
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multiple steps conforming the radiotherapy chain and their contribution to
the ﬁnal uncertainty, this is usually translated into a desired uncertainty of
1-1.5% [18, 43] for the determination of absorbed dose to water in reference
conditions. Lowering the uncertainty of the alanine dosimetry in the ther-
apy dose range to the limits required by radiotherapy applications became
the objective of the many studies performed during the last decade. These
research eﬀorts ended up successfully, being several the metrology institutes
worldwide that nowadays use alanine/ESR dosimetry as secondary stan-
dard in the therapeutic dose range: NPL, NIST, Physikalisch-Technische
Bundesanstalt, PTB, in Germany, etc. In Spain no laboratory or institute
had yet developed an alanine dosimetry service, and the alanine dosimetry
campaigns that are performed in this country must be sent abroad to get
the dosimeters readout and certiﬁcates. The possibility of developing an
alanine dosimetry service was opened in 2011 at the Universidade de Santi-
ago de Compostela with the creation of a secondary standard laboratory of
absorbed dose to water at the Radiation Physics Laboratory and the avail-
ability of an ESR laboratory in-house (Servicio de Resonancia Magnética,
Rede de Infraestruturas de Apoio á Investigación e ao Desenvolvemento
Tecnolóxico da Universidade de Santiago de Compostela).
The solid alanine dosimeters manufactured nowadays generally consist in a
polycrystalline α-alanine aggregate sealed by a high melting point paraﬃn
that serves as a partial binder. Dosimeters can be produced under diﬀerent
presentations including pellets, rods, cables, ﬁlms and pure alanine powder
without any binding process [81], being the pellets the physical presentation
chosen for our work due to some advantages that will be later exposed.
Once a device has been demonstrated to be able to measure, either directly
or indirectly, a magnitude related with ionizing radiation, in our case ab-
sorbed dose to water, the most important properties that characterize the
dosimeter are: dose linearity, dose rate dependence, energy dependence,
response isotropy and the resolution of the detector. All these properties,
Chapter 3. Alanine Dosimetry 89
aﬀecting the repeatability and global uncertainty of the measurement, will
be presented here for alanine.
1. Unusual stability of the radiation-induced radicals
The formation of radiation induced radicals in organic substances is
quite a general process and there are many substances that could be
investigated as potential dosimetry detectors. The temporal evolu-
tion of radicals in organic substances after irradiation is however an
important characteristic that conditions the ESR signal acquisition
procedure and aﬀects the signal repeatability, and it is here where the
alanine amino acid makes the diﬀerence. The discovery that poly-
crystalline alanine is among the organic substances with the highest
stability in their radical species converted alanine in the most used
molecule for ESR dosimetry. Alanine radiation induced radicals are
nevertheless not perfectly stable and tend to recombine slowly, lead-
ing to a fading in the ESR signal with time. Radical recombination
depends on several correlated parameters like the water content of
the alanine probes (related to ambient air humidity) and the dosime-
ters storage temperature. Since the paraﬃn binding partially isolates
the alanine aggregate from the ambient air, these eﬀects vary with
the dosimeters manufacturing process. As a guide, rates of fading of
approximately a 4% over a 17 month period under normal labora-
tory conditions, 20 ◦C temperature and 55% relative humidity, have
been reported for the alanine dosimeters in pellet presentation that
are employed in this work [82].
2. Linear signal response over a wide range of radiation doses.
The linear relationship between absorbed dose to water and the con-
centration of radicals in an alanine probe is a feature that further
simpliﬁes the use of alanine as a dosimeter. The calibration pro-
cedure that allows to measure absorbed dose to water from alanine
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ESR signal intensities involves the determination of the proportional-
ity factor linking these two magnitudes. In practice, this factor can
be calculated as the slope, CQ,T , of the linear ﬁt of dose-ESR signal
intensities for a batch of alanine dosimeters that have been irradiated
to diﬀerent values of dose to water, at temperature T and under a
beam quality Q. The relationship between absorbed dose to water and
absorbed dose to the alanine is directly obtained taking into account
Equation 3.1:
Dw,Q = CQ,T · (IESR)Q,T
m
= CQ,T ·K ·GQ,T ·Dal,Q (3.2)
It should be noted that an exponential saturation in the concentration
of radicals is well known to occur at high doses [77], but signal-to-dose
linearity has been observed for dose values between 0.5 Gy and 5 kGy
(residuals below 1%) [83], being thus guaranteed for the therapy dose
range covered in this work.
3. Small energy and dose rate dependence
The response of a dosimeter can be generally deﬁned as the ratio of the
detector reading (noted byM in Chapter 1, here ESR signal intensity,
IESR), and the value of the magnitude of interest, in our case absorbed
dose to water, Dw. This response usually changes with the energy
of the radiation beam, represented for high energy photons by the
beam quality index Q (see Chapter 1). Since the detector is always
calibrated at a certain energy/beam quality Q0, correction factors
have to be applied to determine the dose at diﬀerent energies/beam
qualities. The factor to correct for the change in the energy response
at diﬀerent beam qualities, calculated for the same value of absorbed
dose to water at Q0 and Q, can be expressed as:
FQ,Q0 =
(IESR/Dw)Q
(IESR/Dw)Q0
(3.3)
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This expression is equivalent to the ﬁrst identity of Equation 1.10,
with the beam quality correction factor kQ,Q0 given by the inverse of
FQ,Q0 . But we can better understand the alanine energy dependence
if we consider the proportionality between the detector reading, or
ESR signal intensity, and the absorbed dose to alanine, Equation 3.1,
which leads to the expression:
FQ,Q0 =
GQ
GQ0
(Dal/Dw)Q
(Dal/Dw)Q0
=
CQ
CQ0
(3.4)
We can here identify two eﬀects contributing to the energy dependence
and changing the slope in the alanine calibration curve, CQ: one given
by the change in the alanine radiation yield with the beam quality,
and the other given by the change in the alanine to water absorbed
dose ratio with the beam quality. Regarding this latter eﬀect, and
considering alanine dosimeters as medium size detectors when com-
pared with the range of secondary electrons in that material, Burlin
theory states that the deposition of energy in the detector is due to
electrons generated both in the surroundings of the dosimeter and in
the dosimeter itself [15]. Thus, stopping power of secondary electrons
and mass absorption coeﬃcients of the incident photons need to be
considered when studying the energy dependence of alanine dosime-
ters. The energy dependence of alanine to water ratios of these two
magnitudes is shown in Figure 3.2.
In practice, alanine to water dose ratios are usually calculated by
Monte Carlo simulation, and the global energy dependence of the
alanine is experimentally determined through the construction of cal-
ibration curves at diﬀerent beam qualities. Variations in the alanine
radiation yield with the beam quality can be thus inferred from them.
For X ray beams in the kV energy range, the alanine response is lower
than that at 60Co beams, ranging from 27% to 6.5% under-response
for X ray beams from 50 kV to 200 kV [81]. Monte Carlo calculations
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Figure 3.2: Alanine to water stopping power ratios and mass absorption co-
eﬃcients ratios considering only alanine, solid line, and the dosimeter material
including alanine and binder, dotted line. Results for alanine pellets manufac-
tured by Bruker (Bruker Corporation, Billerica MA, USA) [84].
show that alanine to water mass energy absorption coeﬃcients ratios
cannot account for all the eﬀect, and at least 5.7% of the under-
response at 150 kV has been found to be due to variations in the
radiation yield. Recent works oﬀer however diﬀerent results about
the contribution of the two factors involved in the energy dependence
to the global variation of the alanine response [85, 86].
On the other hand, in megavoltage photon beams from 6 to 25 MV, a
global under-response of approximately a 0.6% is observed in alanine
with respect to that in 60Co beams, which is mostly due to variations
in the radiation yield because no signiﬁcant energy dependence is
found between linac megavoltage modalities [87].
In summary, we can say that alanine can be considered to be nearly
water equivalent for photons with energies above 100 keV. This energy
dependence is small when compared with that of other detectors like
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ionization chambers, what will involve smaller uncertainties related
with beam quality variations in alanine dosimetry.
On the other hand, no signiﬁcant dose rate eﬀects have been observed
for alanine dosimeters irradiated to dose rates below 3 Gy/s [88]. The
dose rate can be thus completely disregarded in alanine dosimetry
campaigns performed in the therapy range.
4. The relatively small physical size of the dosimeter.
Alanine dosimeters can be produced in many physical presentations,
although manufacturers like Harwell Dosimeters Ltd., Gamma Service
(Synergy Health Radeberg GmbH) and metrology institutes produc-
ing their own dosimeters like the NPL, have usually chosen cylindrical
pellets of 0.5 cm diameter and 0.3 cm height. Even though smaller
pellets are manufactured, this detector size, with a volume of 0.06
cm3, is small if compared with many of the ionization chambers usu-
ally employed for radiotherapy measurements (Farmer type chambers
v ≈ 0.6 cm3, Semiﬂex chambers v ≈ 0.3 cm3). Small detector sizes
are required for measurements in the steep dose gradients that can be
found in small and intensity modulated radiotherapy ﬁelds, so that
ﬁeld disturbance eﬀects like volume averaging are minimized. In this
context, alanine dosimeters can be appropriate detectors for measure-
ments in new radiotherapy techniques where ionization chambers are
the most operative detector for routine measurements. Alanine can
provide here an alternative method for the determination of absorbed
dose to water in, for example, dosimetry audits and intercomparisons.
Additionally, alanine can be used for the determination of beam qual-
ity correction factors associated with ionization chambers in non stan-
dard ﬁelds, which has become a very important step of quality assur-
ance now that many modern radiotherapy machines cannot deliver
the 10 cm×10 cm ﬁeld required for the establishment of conventional
calibration reference conditions.
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5. Non-destructiveness of the ESR readout process.
Radiation induced radicals are not altered by the signal acquisition
process of ESR spectroscopy, and this implies that alanine dosimeters
can be read out as many times as desired provided that the dosimeters
mass is controlled so that possible signal variations associated with
mass losses can be corrected for. This is an advantage compared
with other methods like thermo-luminescent dosimetry, which allows
the performance of alanine dosimeter cumulative studies for in vivo
dosimetry of fractionated treatments, representing important savings
in the amount of pellets needed for some dosimetric studies.
6. Small dependence on ambient conditions.
Ambient conditions like relative humidity during the dosimeters stor-
age aﬀect the fading of radicals in alanine. Other factor to be taken
into account is the observed increase of the radiation yield with tem-
perature. The eﬀect is small and can depend on both the dosimeter
manufacturing process and ambient conditioning. For L-α-alanine
pellet presentations2, the radiation yield exhibits a linear variation
with a slope ranging from +0.1% ◦C−1 to +0.2% ◦C−1 for absorbed
doses up to 50 kGy and temperature values between -10 ◦C and 50
◦C [81].
The radiation yield at a temperature T can be derived from the ra-
diation yield at an arbitrary reference temperature, T0, and the tem-
perature coeﬃcient cT as:
GQ,T = GQ,T0 · [1 + cT (T − T0)] (3.5)
Where the slope, cT , takes a value of +0.11% ◦C−1, with an associated
relative uncertainty of 2.9%, for the Harwell alanine dosimeters that
are employed in this work [89].
2Among the two stereoisomers of alanine (D-α-alanine and L-α-alanine), L-α-alanine exhibits
a temperature dependence 50% lower than D-α-alanine, being thus preferred for dosimetry [81].
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In order to correct for radiation yield variations that can arise be-
tween the diﬀerent dosimeters involved in a measurement campaign,
a temperature correction factor, kT , is applied to the ESR signal. This
temperature correction is needed whenever the pellets are irradiated
at diﬀerent temperatures. The correction will be simply given by the
ratio of radiation yields at the dosimeter irradiation temperature T
and another temperature that is taken as reference, T0, and to which
we will refer all our ESR signal intensities:
kT =
GQ,T0
GQ,T
=
1
1 + cT (T − T0) ' 1− cT (T − T0) (3.6)
Additionally, alanine signal quantiﬁcation through ESR spectroscopy
is also aﬀected by the water content of the pellet and the temperature
and humidity of the laboratory, because the spectrometer sensitivity
varies with the amount of water hold by the resonator cavity. Stability
in the ambient conditions during ESR signal acquisition is required in
order to minimize undesired sensitivity variations, and the pellets are
usually stored open in laboratory conditions for some hours before
proceeding with the measurements to reduce changes in the water
content of the pellet during signal acquisitions.
The basic concepts just introduced are enough to identify the key factors
that will condition the quality of the measurement of absorbed dose to
water with an alanine/ESR system. We can classify these factors as being
associated to any of the two steps that must be followed for the construction
of the alanine calibration curve: a) irradiation of the alanine pellets and b)
quantiﬁcation of the dosimeters ESR signal.
On one hand, regarding the irradiation of the pellets, variations in the
alanine dosimeters radiation yield and fading must be minimized in order
to ensure that the same proportionality between radical concentration and
absorbed dose to alanine is maintained for all the dosimeters involved in a
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measurement campaign. This can be done with a systematic control in the
dosimeters ambient conditions before and after irradiation and through the
application of a temperature correction factor if necessary. On the other
hand, a good control on the ESR spectrometer is essential to ensure both
signal repeatability and the proportionality between signal intensity and
radical concentration. Taking into account that there are many parameters
involved in the spectrometer operation, the principles of ESR spectroscopy
have to be studied to ensure a proper understanding of the spectrometer
operation.
3.1.2 Basic ESR spectroscopy theory
The study of the absorption and emission of radiation by matter provides
information about energy diﬀerences between nuclear, atomic, molecular or
crystallographic states, and has been historically employed to investigate
the structure and dynamics of matter. In Electron Spin Resonance Spec-
troscopy, energy states are associated with the interaction between the
magnetic moments of unpaired electrons in a substance and an external
magnetic ﬁeld.
The pairing of electrons that occurs spontaneously in most stable molecules
due to Pauli exclusion principle can be disrupted by the presence of free rad-
icals, which are induced for example by radiation. If these radicals remain
stable with time, the material becomes paramagnetic due to the interaction
between the intrinsic magnetic moment of the unpaired electrons and any
external magnetic ﬁeld. In the simpliﬁed case of a free electron system,
the presence of a magnetic ﬁeld, B, aligns the electron intrinsic magnetic
moment, µ, with the magnetic ﬁeld, and the energy associated with this
interaction can be expressed as:
E = µ ·B (3.7)
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The intrinsic magnetic moment of the electron is in turn given by the
product of the electron spin, S, and the electron gyromagnetic factor γe =
e ge/2me, where e and me are the electric charge and mass of the electron
and ge is the g-factor of the electron, also known as Landé factor:
µ = γeS =
gee
2me
S (3.8)
Due to the quantization of spin levels, the electron intrinsic angular mo-
mentum, S = ~
√
s(s+ 1), can only have two projections in the direction
of the magnetic ﬁeld, chosen here (without loss of generality) to be aligned
with the z axis, i.e. sz = ~ms, with ms = ±1
2
and s =
1
2
. In this way,
the interaction between the external magnetic ﬁeld, B = (0, 0, B0), and
the electron magnetic moment leads to two energy states, receiving this
phenomenon the name of Zeeman eﬀect:
E = µ ·B = µzB0 = ~e
2me
gemsB0 = ±1
2
geµBB0 (3.9)
Where µB = ~e2me is the Bohr magneton.
The object of ESR is to measure the energetic transitions between these
two energy states, and for that purpose paramagnetic materials are placed
in a magnetic ﬁeld under the incidence of electromagnetic radiation with
the appropriate frequency, as represented in Figure 3.3. The energy diﬀer-
ence between the two states establishes a resonance condition for electronic
transitions ∆E = hν = geµBB0. In practice, ESR spectrometers involve
the use of an electromagnetic radiation source with a frequency that is kept
constant while the intensity of the magnetic ﬁeld varies until the resonance
condition is fulﬁlled and there is a net absorption of microwave radiation by
the sample. For most spectrometers the incident radiation is within the mi-
crowave X band region, between 9 and 10 GHz, and the external magnetic
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Figure 3.3: Energy splitting due to the two possible alignments of the elec-
tron magnetic moment and an external magnetic ﬁeld. The state of lowest and
highest energy occur when the moment of the electron µ is aligned with and
against the magnetic ﬁeld respectively. Transitions between these two states
occur through the emission/absorption of microwave radiation with the appro-
priate frequency.
ﬂux density ranges approximately between 0.32 T and 0.37 T (3200 to 3700
gauss) to fulﬁll the resonance condition. In order to fully understand para-
magnetic spectroscopy we have to consider that an ESR sample contains
many paramagnetic species and not a single electron. When a population
of radicals is in thermodynamic equilibrium, the ratio of paramagnetic cen-
ters in the upper and lower energy states, nupper
nlower
, can be described by the
Maxwell-Boltzmann equation as a function of the energy gap between the
two states, ∆E, the temperature, T and the Boltzmann constant, kB, as:
nupper
nlower
= exp
(
−∆E
kBT
)
(3.10)
For the X-band microwave frequencies employed in most ESR spectrometers
(ν ≈ 9.75 GHz), hν = 40µeV, and under standard conditions ( T = 298 K),
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kBT = 25.6meV, the spins are almost equally distributed between parallel
and anti-parallel with respect to the external magnetic ﬁeld, nupper/nlower ≈
0.998.
Polarization excess can be then expressed by:
P =
nupper − nlower
nupper + nlower
=
1− exp (−∆E/kBT )
1 + exp (−∆E/kBT ) = tanh
(
∆E
2kBT
)
(3.11)
When thermal equilibrium is reached under a static magnetic ﬁeld applied
in the z axis, B = (0, 0, B0), the equilibrium magnetization of the sample,
M0, calculated as the addition of all the magnetic moments per unit volume
v, is expressed as a function of this polarization excess:
M0 =
1
v
∑
i
µi =
1
2
~γeNPuz (3.12)
Where N=nupper + nlower is the total number of unpaired electrons.
Larmor theorem states that the rate of change in the magnetization, M ,
of the sample is equal to the torque produced by the magnetic ﬁeld:
dM
dt
= γeM ×B (3.13)
Taking into account that we are considering the static magnetic ﬁeld to be
parallel to the z axis, we will use Mz for the longitudinal magnetization
and Mx and My for the transverse components of the magnetization. Lar-
mor theorem indicates that the longitudinal magnetization is constant and
precesses around B with a frequency ω0 = γeB0, usually referred to as Lar-
mor frequency. If there is little interaction between the individual spins of
the spin system, the phase of the precession is random and the sum of the
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individual magnet moments contributing to the transverse magnetization
at equilibrium is zero.
In order to fully describe the motion of the magnetization vector, relaxation
eﬀects also need to be considered. Felix Bloch ﬁrst derived the famous
equation of motion which fully describes the evolution of the magnetization:
dM
dt
= γe (M ×B)−R (M (t)−M0) (3.14)
Where R is the relaxation vector R = (T−12 , T
−1
2 , T
−1
1 ), expressing the
rates at which the non-equilibrium magnetization, M = (Mx,My,Mz),
approaches to its thermal equilibrium value M0 = (0, 0,M0).
If B is a static ﬁeld applied in the z axis, B = (0, 0, B0), these equations
reduce to:
dMz
dt
= −Mz(t)−M0
T1
(3.15)
With solution:
Mz(t) = M0[1− exp (−t/T1)] (3.16)
And for the transverse components:
dMx
dt
= γeB0My − Mx(t)
T2
dMy
dt
= −γeB0Mx − My(t)
T2
(3.17)
With solutions:
Mx(t) = ω0 exp (−t/T2) cos(ω0t); My(t) = ω0 exp (−t/T2) sin(ω0t); (3.18)
Here we can see that if a static ﬁeld is applied, the magnetization ends up
reaching the equilibrium value M0 in the direction of the applied ﬁeld, and
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the transverse components of the magnetization will vanish. If the popula-
tion balance of the sample is perturbed, the spin system's interactions with
the surroundings results in an eventual return to thermal equilibrium. This
process, called spin lattice relaxation, is characterized by the time constant
T1. On the other hand, if there is a net transverse magnetization caused
by a perturbation of the system, the system relaxes back to zero transverse
magnetization, a process characterized by the transverse relaxation time
T2, or spin-spin relaxation, quantifying the time during which individual
moments contributing to the transversal magnetization remain in phase
with each other.
In this situation, the magnetization is time invariant and cannot be de-
tected. To allow detection, this alignment must be perturbed by applying
a short oscillating ﬁeld on the xy plane perpendicular to the static mag-
netic ﬁeld in the z-axis, this is, a circularly polarized microwave pulse B1
= (B1 sin(ωt), B1 cos(ωt), 0). The oscillating magnetic ﬁeld will make the
sample magnetization to nutate, as shown in Figure 3.4, and the spectrom-
eter detector will then measure the emitted microwave signal created by
the transverse components of the sample magnetization.
It is useful to deﬁne ω1 = γeB1 and ΩS = ω0 − ω. For on-resonant mi-
crowave irradiation, ΩS = 0, the eﬀective nutation frequency ωeff equals
ω1 and the magnetization vector precesses around an axis perpendicular to
z. On the other hand, the magnetization vector is hardly aﬀected when the
microwave frequency is far oﬀ-resonant. After the pulse the magnetization
returns to a state parallel to B through the spin-lattice relaxation, and
the corresponding relaxation time needs to be considered when extracting
signal from noise, where the experiment needs to be repeated several times,
as fast as possible. In order to repeat the experiment, one needs to wait un-
til the magnetization along the z-axis has recovered, because if there is no
magnetization in z direction, then there is nothing to tip into the xy-plane
to create a signiﬁcant signal.
Chapter 3. Alanine Dosimetry 102
Figure 3.4: a) Precession of the magnetization vector M around an external
magnetic ﬁeld B0 parallel to the z axis. b) Nutation of the magnetization vector
during irradiation with a circularly polarized microwave ﬁeld with amplitude
ω1 = γeB1, see text below.
Saturation is observed in the signal when the microwave power is higher
than a given threshold. At the ﬁeld-frequency resonance position, B1 turns
the spins in a very small amount, and a voltage proportional to the angle by
which the spins were turned by B1 is induced in the spectrometer detector.
Under non saturating conditions T1 and T2 are short and relaxation back
to the z axis is fast relative to the other time constants of the experiment,
being the signal approximately at equilibrium. However, if the microwave
power is too high relative to the relaxation rates, B1 turns the spins so far
from the z axis that relaxation cannot return the magnetization back to the
z axis within the time range of the signal measurement. In this situation a
saturation eﬀect occurs.
During the microwave pulse, the total magnetic ﬁeld applied to the sam-
ple is B(t) = (B1 sin(ωt), B1 cos(ωt), B0), and the Bloch equations can be
written as:
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
dMx
dt
dMy
dt
dMz
dt
 =
 γe[MyB0 −MzB1 cos(ωt)]−
Mx
T2
γe[MzB1 sin(ωt)−MxB0]− MyT2
γe[MxB1 cos(ωt)−MyB1 sin(ωt)]− (Mz−M0)T1
 (3.19)
It will be useful to change to a coordinate system rotating in the xy plane
with frequency ω. If we deﬁne here the magnetization components as U =
Mx cos(ωt) −My sin(ωt) and V = Mx sin(ωt) + My cos(ωt), deriving and
using Equation 3.19, we can get:

dU
dt
dV
dt
dMz
dt
 =
(ω0 − ω)V − ω1Mz − U/T2− (ω0 − ω)U − V/T2
ω1V − (Mz −M0)/T1
 (3.20)
After a suﬃciently long continuous microwave irradiation, the magnetiza-
tion will reach a stationary state and the time derivatives of the magnetiza-
tion vector vanish. The Bloch equations will then become a linear system
of equations, with solutions:
U = −M0 ω1 T2
1 + Ω2ST
2
2 + ω
2
1T1T2
(3.21)
V = M0 ω1
ΩST
2
2
1 + Ω2ST
2
2 + ω
2
1T1T2
(3.22)
Mz = M0 − M0ω
2
1T1T2
1 + Ω2ST
2
2 + ω
2
1T1T2
(3.23)
The transverse magnetization components can be measured simultaneously
in a quadrature-detection scheme with two microwave reference signals
phase-shifted by 90◦ with respect to each other, which yields a complex
signal S = −U + i V .
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For low microwave powers, ω21T1T2 << 1, the transverse components are
proportional to ω1. The real part of S can be recognized as a Lorentzian
absorption line with an amplitude given by the sample magnetization under
equilibrium, M0, and the oscillating magnetic ﬁeld intensity (ω1 = γeB1),
and a width given by the inverse of the spin lattice relaxation time T2:
U = −M0ω1 T
−1
2
T−22 + Ω
2
S
(3.24)
On the other hand, the imaginary part V will correspond with a dispersion
Lorentzian line:
V = M0ω1
ΩS
T−22 + Ω
2
S
(3.25)
Since the dispersion line suﬀers from broad ﬂanks and decreased ampli-
tudes, only absorption lines are recorded, which oﬀer a better signal to
noise ratio (SNR) and a better resolution in presence of multiple lines.
For a free electron system, the ESR absorption and dispersion curves would
have thus the shape represented in Figure 3.5, and the ESR spectra is
commonly acquired as the ﬁrst derivative of the absorption curve. However,
real samples are not electron free systems, and the shape of the ESR spectral
line presents rather complicated structures. Electrons, normally associated
with one or more atoms, will have nonzero orbital angular momenta and
the value of their g-factors will diﬀer from ge. Moreover, interactions with
the nuclear spin of the atoms will lead to hyperﬁne couplings, splitting the
ESR resonance signal into doublets, triplets, etc.
Additionally, if a sample has diﬀerent radical species, this is, unpaired elec-
trons in diﬀerent environments, the observed ESR spectrum is the overlap-
ping of the ESR spectra from the diﬀerent radicals species. This is the case
of the alanine, for which the existence of the three radical species mentioned
in Section 3.1.1 produces the overlapping of three ESR lines conforming the
ﬁnal alanine spectrum shown in Figure 3.6.
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Figure 3.5: ESR energy absorption and dispersion lines of a free electron
system, top, and their ﬁrst derivative as acquired by the spectrometer, bottom.
Regarding alanine dosimetry applications, it is the ESR signal intensity
exhibited by the dosimeters what becomes the quantity of interest as it is
proportional to the total amount of radicals in the sample. For high doses,
this quantiﬁcation is usually done through the analysis of the peak-to-peak
intensity of the ESR spectrum, widely demonstrated to be a good estimator
for the concentration of radicals [90]. The ESR signal intensity measured by
a spectrometer is strongly dependent on the spectrometer sensitivity, which
is aﬀected by several parameters like the microwave power, the modulation
amplitude, etc. Other aspects of vital importance for the quality of the
measurement, like the noise in the signal and the stability of the instrument,
will also depend on the choice of some operation parameters.
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Figure 3.6: Alanine ESR spectrum, top, consisting in the superposition of
the ESR spectra for the three radicals species R1, R2 and R3 that are induced
by radiation in the alanine [74].
3.1.3 Spectrometer operation
All ESR spectrometers comprise four main components, namely a mi-
crowave radiation source, a magnet, a microwave resonant cavity where
the samples are placed, and a diode detector that measures the amount of
radiation absorbed or emitted by the samples. Most ESR spectrometers
can be classiﬁed as reﬂection spectrometers because they measure changes
in the amount of radiation that is reﬂected back from the cavity containing
the sample when the spectroscopic transitions occur. Figure 3.7 shows a
schematic representation of the spectrometer, and their main components
are described below.
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Microwave bridge:
The electromagnetic radiation source and the detector are in a box called
the microwave bridge.
Figure 3.7: Schematic representation of the main components conforming the
ESR spectrometer.
At the output of the microwave source there is an attenuator that controls
the ﬂow of microwave radiation, so that the microwave power entering
the cavity can be accurately tuned. Microwave radiation will then enter
a circulator, which ensures that the radiation coming from the microwave
attenuator is only directed to the cavity, while the radiation that is reﬂected
from the cavity is only directed to the detector.
The detector is a Schottky barrier diode that converts the microwave power
reﬂected from the cavity into an electrical current. The relationship be-
tween diode current and the microwave power is known to vary from a
linear proportionality to a square root dependence as the microwave power
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increases [91]. The optimal sensitivity required for signal intensity quan-
tiﬁcation is achieved when the diode operates in the region of square root
dependence, usually achieved for incident powers higher than 1 milliwatt.
The remaining component in the microwave bridge is a reference arm, which
supplies the detector with an extra microwave power to ensure that the
diode operates in the adequate region.
Cavity:
The sample to be studied by ESR spectroscopy is located inside of a mi-
crowave cavity consisting in a metal box with a rectangular shape that
resonates with the microwaves, amplifying weak signals from the sample.
In order to couple the microwaves into the cavity, there is a hole, called
iris, with a screw that can be moved up and down to control the amount
of microwaves entering the cavity, see Figure 3.8.
Figure 3.8: Sketch of the magnetic and electric ﬁeld patterns in a microwave
cavity, left, and scheme of the iris screw controlling the entrance of radiation
in the cavity from the waveguide, right.
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Although we will not elaborate this in much detail, resonance in the cavity
is achieved when a certain condition related with the iris aperture, and
the losses in the microwave source, cavity walls and sample, is fulﬁlled.
Under resonance conditions the cavity is critically coupled and microwaves
remain inside the cavity conforming standing waves, being the amount of
microwaves that are reﬂected from the cavity minimized. The eﬃciency of
every cavity to store the microwave energy is expressed by its quality factor,
QF , which is deﬁned as the ratio of energy stored and dissipated in the
cavity per cycle, being also related with the above mentioned parameters
of iris aperture, and the cavity and microwave source impedances.
When paramagnetic transitions occur, the absorption of a net microwave
energy by the sample changes the eﬀective impedance of the cavity, which
will be no longer critically coupled. The microwaves are then reﬂected back
to the circulator, reaching the diode detector, which yields an electrical
current conforming the ESR signal.
It is worth to note that the presence of water, a microwave absorber, in the
cavity lowers the QF and aﬀects the spectrometer sensitivity. Although
some amount of water inside the cavity is unavoidable due to the non
zero relative humidity of the air, changes in this water content should be
minimized during measurements for the sake of stability.
Regarding the positioning of the samples in the cavity, it must be taken into
account that most paramagnetic samples do not exhibit resonant absorp-
tion of microwaves via the electric ﬁeld, and as the electromagnetic waves
have their electric and magnetic components in opposite phase, samples
must be placed at a position of maximum magnetic ﬁeld. The non uni-
formity of the modulated magnetic ﬁeld and the distribution of standing
microwaves within the cavity leads to a drastic variation of sensitivity over
the intracavity space. The sensitivity usually reaches the maximum at the
cavity center, decreasing for points displaced either upwards or downwards
from there. Due to this, the same paramagnetic sample placed at diﬀerent
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positions inside the cavity leads to signals of diﬀerent intensities. As ala-
nine dosimeters are not point like samples, diﬀerent portions of the pellet
are located in regions of the cavity with diﬀerent sensitivities, contributing
diﬀerently to the total signal [83].
Signal channel, phase sensitive detector:
A strategy to separate ESR signal from noise and interferences, thus im-
proving the SNR, is usually employed in ESR spectrometers. This strat-
egy consists in introducing a sinusoidal modulation of the magnetic ﬁeld
strength that is seen by the sample.
When a spectroscopic transition occurs, the ﬁeld modulation sweeps the
signal and the microwaves reﬂected from the cavity are also modulated
in amplitude with the frequency of the modulated magnetic ﬁeld. The
ESR signal, which would be linear over a magnetic ﬁeld interval as wide
as the modulation amplitude, will instead have a sinusoidal shape with
an amplitude proportional to the signal slope. A lock-in ampliﬁer (phase
sensitive detector) suppresses then all the signals that do not have the
frequency and phase of the magnetic ﬁeld modulation, so that both noise
and electrical interference signals are eﬀectively suppressed. Additionally,
a low pass ﬁlter is coupled to the detector to remove some of the remaining
high frequency noise.
In Figure 3.9 we can see that the amplitude of the oscillating detected
signal increases with the slope of the absorption signal in the signal channel
(diﬀerence between the absorption at the extremes of the modulated ﬁeld),
being this the reason why ESR spectra are acquired as the ﬁrst derivative
of the absorption signal.
Among all the factors aﬀecting the spectrometer operation, the spectrom-
eter sensitivity is mainly determined by the resonator QF , the magnetic
ﬁeld modulation amplitude and the magnetic component of the microwave
ﬁeld.
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Figure 3.9: Schematic representation of the eﬀect produced by the ﬁeld mod-
ulation employed for phase sensitive detection of the ESR signal.
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3.2 Development of an Alanine/ESR dosimetry
system
3.2.1 Materials and experimental setup
The construction of an alanine calibration curve for the performance of ala-
nine dosimetry involves two main steps: the irradiation of the dosimeters
and the alanine signal ESR read out. In this section we will describe the ex-
perimental setup that was employed for the performance of these two tasks.
The alanine dosimeters employed in our work will be presented, including
some further considerations about how to manage the inﬂuence that am-
bient conditions have in the dosimeters and the spectrometer. Then, the
irradiation setup will be described, and we will conclude with a description
of the ESR spectrometer and a system that was speciﬁcally developed for
the alanine pellets positioning inside the ESR cavity.
3.2.1.1 The alanine pellets
The alanine dosimeters employed in this work are the cylindrical shaped
pellets manufactured by Harwell Dosimeters Ltd, see Figure 3.10, consisting
in 90.9% in mass of an alanine polycrystalline aggregate and a 9.1% of high
melting point paraﬃn. The diameter of the pellets is (4.83 ± 0.01) mm,
the height is (2.8± 0.1) mm and a nominal mass of (60± 2) mg is ensured
within a production batch.
One of the advantages of Harwell dosimeters is their low sensitivity to
changes in the environmental conditions when compared with the alanine
dosimeters from other manufacturers, which is thought to be due to the
high paraﬃn content of these pellets. The low porosity of Harwell dosime-
ters keeps the alanine rather isolated, minimizing variations in their water
content related with their exposure to ambient conditions. Additionally,
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Figure 3.10: Harwell alanine pellets, left, and Perspex irradiation holder,
right.
these pellets also further contribute to seal the quartz tube that holds the
pellet inside the ESR cavity reducing the air ﬂow through the cavity during
measurements, which minimizes perturbations in cavity sensitivity due to
changes in air temperature and relative humidity [92].
Another advantage of these dosimeters, shared with other manufacturers
that produce alanine pellets with similar dimensions, is the relative small
size of the pellets, which allows them to ﬁt in the region of uniform sen-
sitivity of the ESR cavities. Although one Harwell alanine pellet can ﬁt
inside this region, the positioning of the dosimeter in the cavity has to
be accurately controlled to ensure that they are all read out in the same
sensitivity region of the cavity. Besides, pellets with masses signiﬁcantly
deviating from the average can produce outlying mass-normalized signals.
Corrections consisting in mass normalization will only be valid in the vol-
ume of approximately uniform sensitivity that extends up to 2 mm from
the cavity center in each direction [83].
The formation of radiation induced radicals in alanine is temperature de-
pendent and this can have an eﬀect both on the construction of the calibra-
tion curve and on subsequent determinations of absorbed dose to water with
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those alanine dosimeters. In order to correct the ESR signal for radiation
yield variations, the temperature of the dosimeters during irradiation must
be known. All the pellets involved in a measurement campaign and the pel-
lets holder are placed at the irradiation room for temperature stabilization
some hours before irradiation. The temperature of the irradiation water
tank where the pellets are irradiated is then recorded in every measure-
ment, and it is later employed to correct the radiation yield by arbitrarily
choosing one of the pellets temperature as a reference.
Radiation induced radicals present also a short-term evolution after irradi-
ation that varies depending on the total dose absorbed in the pellet [93].
Variations are observed to become minimal approximately 72 hours after
irradiation for most dose levels. This period of time, after which high-
precision ESR measurements can be performed, is always respected in our
campaigns before proceeding with the dosimeters readout.
The moisture content of the pellets is another issue that needs to be con-
trolled, as water is a substance that absorbs microwaves and aﬀects the
resonator QF . Due to this, alanine pellets with diﬀerent moisture content
will lead to diﬀerent signal amplitudes. Variations in water content from
pellet to pellet, or even changes in the relative humidity of a single pellet
during ESR measurements, must be thus taken into account. The water
content of a pellet depends only on the ambient humidity of the environ-
ment where it is stored, and thus all pellets included in a measurement
campaign should be stored together or under identical conditions. In order
to control the pellets relative humidity, a saturated aqueous solution of a
particular salt is usually placed in a sealed recipient where the pellets are
stored, as for certain salts the relative humidity of the ambient air in the
recipient remains constant or varies slightly with temperature [94, 95].
In our work, a preconditioning was performed to the pellets employed in the
measurement campaigns: a saturated solution of sodium hydrogen sulfate
was placed inside a sealed desiccator where the pellets were stored for a
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month before irradiation, Figure 3.11. The air enclosed in the desiccator
was in this way maintained under a relative humidity of 65%.
Figure 3.11: (Top) Desiccant vessel containing 300 ml of a saturated solution
of sodium hydrogen sulfate, the alanine pellets are held on a plastic grid. To
get an airtight environment inside the desiccant, a silicon grease is applied to
the cap to get the vessel properly sealed. (Bottom) Temperature and relative
humidity were monitored by a data logger.
Additionally, variations in the alanine moisture during ESR measurements
will arise if the relative humidity of the dosimeters and the ambient hu-
midity of the ESR room diﬀer. As this would aﬀect the cavity QF , pellets
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are conditioned over-night for moisture content stabilization at the ESR
room conditions. The relative humidity in the ESR room should be kept as
constant as possible during ESR measurement campaigns, avoiding changes
in the laboratory air ﬂow (doors or windows openings, changes in the air
conditioning, etc).
3.2.1.2 Irradiation of the alanine pellets
The irradiation of the alanine pellets is an essential step in the alanine
dosimetry work-ﬂow for the construction of a calibration curve.
All the irradiations involved in this work were performed at the 60Co facil-
ity of the Radiation Physics Laboratory of the Universade de Santiago de
Compostela, a Secondary Standards Dosimetry Laboratory with ISO 17025
implanted and traceability to the PTB. For the construction of the calibra-
tion curve, the ESR signal amplitude of every irradiated alanine pellet has
to be associated with the dose that would be deposited in water under the
same incidence of radiation. In this way, the amount of radiation delivered
to the alanine pellets is quantiﬁed in terms of absorbed dose to water, which
is obtained from the dose rate of the 60Co unit under reference conditions.
Before the irradiation of the pellets, the dose rate of the 60Co unit is mea-
sured with a PTW TM30013 ionization chamber calibrated in terms of
absorbed dose to water. This dose rate measurement was performed with
the setup used for the calibration of ionization chambers in the laboratory:
a water tank prepared for horizontal radiation incidence with the gantry
position at 90◦, as it is shown in Figure 3.12. A 10 cm×10 cm radiation
ﬁeld deﬁned at a SSD = 75 cm and a SCD = 80 cm was employed for
this irradiation, and a dose rate of (0.349 ± 0.001) Gy/min (uncertainty
expressed with k=1) was determined under these conditions.
The irradiation of the alanine dosimeters is performed under the same
conditions, holding the pellets in a cylindrical water-tight Perspex insert
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Figure 3.12:
60Co unit irradiation setup involving a water tank and horizontal
radiation incidence (left) and alanine insert positioning inside the water tank
(right).
speciﬁcally machined for this purpose with the dimensions speciﬁed in Fig-
ure 3.10. The symmetry axis of the insert is placed perpendicularly to the
direction of the beam propagation and three alanine pellets are always allo-
cated in the holder to be irradiated together for repeatability studies. The
insert holding the pellets is placed with two motorized stepper platforms to
have the central pellet positioned at the position where the dose rate has
been determined in the water tank. The time needed to achieve the desired
value of absorbed dose to water is then calculated from the unit dose rate
and selected as irradiation time.
3.2.1.3 ESR setup
The spectrometer employed in this work is a Bruker EMX ER073 with
a standard st4102 cavity. Although other cavities with higher sensitivities
exist, st4102 seems appropriate for alanine dosimetry as it has been demon-
strated to be less aﬀected by changes in the environmental conditions than
high sensitivity cavities [92].
As we introduced in Section 3.1.3, for alanine dosimetry applications in
the therapy dose range, the sensitivity of the spectrometer should be kept
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constant to allow calibration and maximal given the low signal intensities
of alanine dosimeters at these dose levels. Considering these requirements,
a speciﬁc positioning setup aiming to provide a reproducible positioning of
the dosimeters in the cavity was developed based on the setups designed
by other dosimetry laboratories like the NPL [79].
Figure 3.13: Sketch of the setup employed for the positioning of the pellets
inside the ESR cavity. Concentric Suprasil tubes cross the cavity: the outer
tube is ﬁxed to the cavity while the inner tube can be displaced with a motorized
stage to place the alanine pellet at the cavity center to acquire spectra. A
vacuum pump ensures the pellets immobilization with respect to the inner
tube during rotation.
To hold the alanine pellet inside the cavity, two concentric tubes of high
purity fused quartz (Suprasil) are employed. The inner tube has an outer
diameter of Dinner,o = (4.2065 ± 0.0065) mm, slightly smaller than the
diameter of the pellet, Dpellet = (4.83±0.01) mm, so it can rest at the tube
top. The outer tube has an internal diameter of Douter,i = (5.0041±0.0065)
mm, slightly wider than the pellet diameter so it ﬁts inside the tube without
Chapter 3. Alanine Dosimetry 119
friction but being not much wider than the pellet to control its lateral
positioning inside the cavity. One of the ends of outer tube was ﬂared
during the manufacturing process to broaden its diameter and allow an
easier positioning of the pellet on the inner tube, as shown in Figure 3.13.
The tubes go through the cavity along its vertical axis, being the outer
tube ﬁxed to the top of the cavity with a Teﬂon screw piece.
The positioning in the cavity is as follows: the pellet is placed on the inner
tube at the top of the cavity with vacuum tweezers. The inner tube is then
displaced along the cavity by a linear motorized stepper stage to place the
pellet at the cavity center. The position of the pellet inside the cavity is
controlled with a precision of 0.025 mm. Studies of signal intensity versus
dosimeter position are then performed to ﬁnd the position of maximum
sensitivity where all spectra will be acquired with the required positioning
reproducibility. Additionally, the inner tube is coupled to a goniometer
that rotates the dosimeter inside the cavity to enable the acquisition of
spectra at diﬀerent orientations of the pellet. This is due to the anisotropy
of the alanine dosimeter signal, which will be studied in the next section.
A weak vacuum is applied to the inner tube to attach the pellet to it and
avoid relative movements between them during measurement.
Figure 3.14: Picture of the ESR positioning setup ﬁxed to the spectrometer
frame.
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Figure 3.14 shows the positioning setup, being the motorized stepper stage
mounted on a structure that is ﬁxed to the spectrometer frame. The use of
materials presenting ESR signal was avoided inside the cavity, so that the
empty cavity presents a signal suﬃciently weak compared with the signal
of a pellet irradiated to 50 Gy, see Figure 3.15.
Figure 3.15: Comparison of ESR signals of an alanine pellet irradiated to
50 Gy (solid line) and the ESR background signal exhibited by the positioning
setup itself, with no alanine pellet inside (dots).
3.2.2 ESR parameters optimization
Alanine dosimetry in the therapy dose range faces as major diﬃculty the
rather low ESR signal to noise ratio exhibited by the dosimeters, which
requires the spectrometer yielding maximum sensitivity in order to achieve
the highest signal quality. This requirement is not as strict in other applica-
tions where the study is focused in the shape of the sample ESR spectrum,
and thus the optimal spectrometer parameters in alanine dosimetry can
diﬀer from those used in other applications.
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As we already introduced, there are many tunable parameters related with
the spectrometer operation that aﬀect not only the sensitivity but also the
stability of the equipment. The spectrometer sensitivity will be determined
by the magnetic ﬁeld modulation amplitude, the magnetic component of
the microwave ﬁeld and the QF of the resonator, which is in principle a
characteristic of every cavity but becomes also aﬀected by the presence of
the sample.
On the other hand, variations in the spectrometer sensitivity can arise dur-
ing measurements due to changes in the laboratory ambient conditions,
variations in the water content of the dosimeters or the use of excessively
high microwave power and modulation amplitudes, which can lead to over-
heating in the cavity.
The ﬁrst step addressed for the development of an alanine/ESR dosimetry
system was to study the spectrometer operational parameters in order to
ﬁnd an optimal combination of them and to establish our measurement
protocol for alanine dosimetry applications. Increasing the signal to noise
ratio and determining the lowest achievable uncertainty associated to the
alanine dosimeters signal with our spectrometer was the main objective
of this optimization process. Pellets irradiated to 50 were employed in
most of these measurements. Signal quantiﬁcation through the peak-to-
peak intensity was adopted after subtraction of any possible slope in the
alanine baseline and after having applied a noise ﬁlter suppressing the high
frequency noise components of our spectrum.
3.2.2.1 Cavity positioning
First of all, a study of the cavity sensitivity versus the position of the alanine
samples inside cavity was performed. A reference position was chosen by
leveling the pellet, already placed on the top of the inner tube, with the
outer tube. Then, several spectra were acquired at diﬀerent positions of the
Chapter 3. Alanine Dosimetry 122
pellet along the vertical axis of the cavity using the motorized stage. As
expected, the ESR signal intensity exhibits a maximum around the cavity
center, diminishing with the square of the distance to this position, as it
can be observed in Figure 3.16.
Figure 3.16: ESR signal intensity versus the position of the alanine dosimeter
inside the cavity. The position of the pellet is expressed by the distance to a
reference position established by leveling the pellet with the outer quartz tube
of the positioning setup.
A parabolic ﬁt to the experimental data yielded the solution, with x in
millimeters:
y = 1− 0.0207 · (x− 97.34)2 (3.26)
Where y is the relative peak-to-peak signal normalized to the maximum
value. This ﬁt served for the determination of the position of maximum
sensitivity, found at 97.34 mm from the reference position of the pellet.
Measurements are performed at the position of maximum sensitivity in all
experiments. Although the data used for the ﬁt exhibits certain scatter and
the determination of the position with maximum sensitivity would have an
associated uncertainty, it does not aﬀect measurements providing that all
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the pellets involved in a campaign are measured at the same position, which
only depends on the stage repeatability. The uncertainty in the determi-
nation of the maximum aﬀect our capability to maximize the spectrometer
sensitivity in our measurements. It should be noted that since the position-
ing setup of the alanine pellets is sometimes removed from the spectrometer
for measurements related with other ESR applications, positioning recali-
bration is performed in every measurement campaign.
3.2.2.2 Sweep time
The sweep time, or time spent by the spectrometer to acquire a spectrum,
is the product of conversion time, ct, which is the diode integration time at
every value of external magnetic ﬁeld intensity, and the number of magnetic
ﬁeld intensities employed to acquire the spectrum.
The number of points acquired by the spectrometer can be set to 512, 1024,
2048, 4096 or 8192, and recommendations are usually given to have at least
10 data points within the narrowest line of the spectrum to be resolved. In
our case, for the 9.75 GHz frequency of the microwaves entering the cavity,
the alanine spectrum is centered at an external magnetic ﬁeld intensity of
approximately 3465 gauss, spanning for an interval of 125 gauss. As the
peak-to-peak intensity is employed for signal quantiﬁcation, signal peaks
are placed at the center of the alanine spectrum acquisition. We must
however acquire the alanine signal in a wide range of magnetic ﬁeld to
correct for possible slopes in the spectrum baseline, which can distort the
peak to peak intensity. Taking into account the sweep widths employed for
spectrometer operation at other institutions like the PTB and the NPL,
we decided to choose a sweep width of 250 gauss around the center of the
alanine spectrum. For this sweep width, the number of points acquired
per spectrum was set to 1024, which leads to approximately 25 data points
from peak-to-peak.
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Regarding the conversion time, the spectrometer allows setting it to 20.48
ms, 40.96 ms, 81.92 ms, 163.84 ms, etc. The impact of the conversion time
on the signal repeatability was studied by acquiring seven spectra of an
alanine pellet irradiated to 50 Gy at diﬀerent values of conversion time to
calculate the relative standard deviation of the signal intensities measured
at diﬀerent ct.
Figure 3.17: Improvement in the signal to noise ratio of the ESR spectrum as
the conversion time increases (left) and impact of the conversion time in signal
repeatability (right).
We can see in Figure 3.17 that as the conversion time increases, the signal to
noise ratio of the spectrum and the repeatability improve, a behavior which
was rather expected. However, if the conversion time is too long, possible
instabilities occurring in the spectrometer can only aﬀect a small part of
the spectrum, being diﬃcult to detect if they arise, for example, during the
acquisition of the narrow but most intense peaks of the spectrum. In a visit
to the alanine dosimetry laboratory of the NPL we were recommended to
avoid these kind of eﬀects by choosing a short conversion time, and thus we
decided to choose a ct of 20.48 ms. The election of both these conversion
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time and number of data points per spectrum determines a sweep time of
20.97 s per acquisition.
3.2.2.3 Time constant
The time constant, tc, is a parameter associated to the low-pass ﬁlter that
is coupled to the diode detector to suppress high frequency noise. This
ﬁlter basically slows down the spectrometer response time, being the signal
less aﬀected by noise as the time constant is increased. However, if the time
constant is too long with respect to the conversion time, signal distortions
and shifts in the magnetic ﬁeld of resonance can arise, and closely spaced
signal structures can be excessively ﬁltered presenting apparent lower in-
tensities.
Figure 3.18: Relative ESR signal intensity (normalized at tc = 20.48 ms)
versus the spectrometer time constant (left). Decrease in the noise exhibited
by the ESR spectra measuerd at tc = 163.84 ms with respect to that at tc =
1.28 ms, no signal distortion is appreciated (right). The conversion time was
20.48 ms in both cases.
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The optimization of time constant for the alanine dosimeters readout was
performed by measuring the ESR signal intensity of the pellet spectrum
with a conversion time of 20.48 ms and diﬀerent time constants ranging
from 1.28 ms to 163.84 ms. Excessive ﬁltering could be detected by the
decrease the peak to peak intensity of the alanine spectrum, but as we can
see in Figure 3.18, this was not the case in our measurements even for the
highest time constant studied, neither we observed any shifts in the ﬁeld of
resonance of the sample.
Trying to ﬁnd the best methodology for the data analysis, the application
an oﬀ-line noise ﬁlter to delete the high frequency components of the spec-
trum was studied, but changes in the frequency cut-oﬀ were observed to
introduce variations of around a 0.1% in the signal repeatability. As any of
the investigated time constants can be chosen without compromising the
quality of our ESR measurement, we decided thus to choose a 163.84 ms tc,
a rather long time constant, so we could suppress any further noise ﬁltering
from our data analysis.
3.2.2.4 Microwave power
The ESR signal intensity measured by the diode increases with the mi-
crowave power. However, if the microwave power is too high, the magne-
tization relaxation times become longer than the time between microwave
pulses and the signal saturates, being its intensity lowered and experiment-
ing a broadening distortion. Moreover, at high microwave powers, heating
eﬀects in the resonant cavity can adversely aﬀect the machine stability and
produce changes in the moisture content of pellets during measurement.
This implies that in order to measure spectral lineshapes, linewidths and
intensities accurately, the spectrometer should not operate in the satura-
tion regime. For power values below 1 mW the signal is proportional to the
microwave power, while a square root dependence is observed above that
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value until the saturation regime is reached. A compromise to get good
signal to noise ratios without signal distortion or spectrometer instabilities
is ensured through the spectrometer operation in the upper part of the
square root dependence region.
Figure 3.19: (Left) Peak-to-peak intensity of alanine ESR spectra versus the
square root of the spectrometer microwave power, the linear ﬁt performed with
low values of microwave power shows the departure from the square root regime
for power values above 2.53 mW,MA stands for modulation amplitude. (Right)
Improvement in the signal to noise ratio of the ESR spectrum from P=0.6 mW
to P=2.53 mW and distortion of the signal for P=25.26 mW.
An experimental determination of the optimal microwave power was ad-
dressed by measuring the signal intensity of a pellet irradiated to 50 Gy for
diﬀerent values of microwave power. Two values of modulation amplitude,
close to that employed for alanine dosimetry in the therapy dose range at
the NPL laboratory, were considered in this study given the correlation
between these two parameters.
Figure 3.19 shows the dependence of signal intensity on microwave power
as well as the improvement in the signal to noise ratio as the microwave
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power increases and the eventual distortion in the signal shape at very high
microwave powers.
As a high microwave power within the square root regime ensures a good
SNR with no signal distortion, consecutive linear ﬁts of signal intensity
versus the microwave power square root were performed, progressively in-
cluding higher microwave power values, in order to evaluate the departure
from the linear regime in the spectrometer operation. A microwave power of
2.53 mW was considered to ensure optimal spectrometer operation avoiding
saturation and was thus chosen for future measurements.
3.2.2.5 Modulation amplitude
The magnetic ﬁeld modulation employed in the phase sensitive detector to
ﬁlter electrical interference and noise aﬀects also the ESR signal intensity.
As the modulation amplitude (MA) increases so does the intensity of the
ESR signal, although above a certain threshold comparable to the signal
linewidth the signal broadens and becomes distorted. Undesired heating
eﬀects can also arise in the cavity at high modulation amplitudes, leading
to spectrometer instabilities and the drying of the dosimeters during mea-
surements. Modulation amplitude should be kept under the width of the
narrowest ESR structure that we want to resolve, noted here as ∆B (which
in the case of alanine dosimetry is the central peak-to-peak width). Taking
into account that our alanine signals have ∆B ≈ 8 G, spectral acquisitions
were performed with modulation amplitudes below 7 G, to check whether
the level of signal distortion remained acceptable. This study was under-
went for two values of microwave power due to the correlated contribution
of both parameters to the signal intensity.
As it can be seen in Figure 3.20, substantial decrease in the noise is observed
as the modulation amplitude increases, and no important distortions were
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Figure 3.20: (Left) Peak-to-peak intensity of alanine ESR spectra for diﬀerent
values of magnetic ﬁeld modulation amplitude. (Right) Improvement in the
signal to dose ratio of the ESR spectrum from MA = 2 G to MA = 7 G, no
signal distortion can be appreciated.
detected even for the largest value of modulation amplitude investigated
here.
3.2.2.6 Signal isotropy
Alanine is an orthorhombic crystal that exhibits diﬀerent ESR spectra de-
pending on its orientation relative to the three axes of the crystalline struc-
ture. Alanine polycrystalline powder made of randomly oriented small crys-
tals, with low granulometry (average grain size < 200 µm) and a suﬃciently
high number of grains, behaves as a liquid sample with stable radicals and
exhibits a sinusoidal theoretical intrinsic anisotropy with period pi [96].
Variations from this angular response arise however in alanine dosimeter
pellets (60 mg samples). On one hand, the number of grains is not high
enough and the sample does not behave as truly polycrystalline. Devia-
tions from the periodic sinusoidal response are supposed to be also due to
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inhomogeneities in the alanine-binder admixture and to the instability of
radicals at the surface of grains: rearrangements and transformations from
one radical into another are observed, being increased when the distance
between grain surfaces is decreased in the powder compacting process per-
formed during manufacturing [97]. This implies that diﬀerent anisotropies
can be found depending on the pellet manufacturing process.
The anisotropy of the alanine pellets is considered for ESR signal quantiﬁca-
tion through the acquisition of several ESR spectra at diﬀerent orientations
of the sample, by rotation of the dosimeter around the vertical axis of the
cavity. The intensity corresponding to diﬀerent orientations is then aver-
aged. The time required to acquire several spectra at diﬀerent orientations
per pellet is however a limiting factor, as it is preferable to complete a
measurement campaign, involving tens of dosimeters, in one single day to
avoid eﬀects in the measurements due to changes in ambient conditions.
Two pellets respectively irradiated to 90 and 60 Gy were investigated to
assess the anisotropy of our dosimeters. Several spectra were acquired
at 18 diﬀerent orientations per dosimeter (from 0◦ to 360 ◦ in steps of
20◦)3. The variation observed in the peak-to-peak signal intensity with the
orientation of the pellets is shown in Figure 3.21, where type A uncertainties
were calculated at each orientation from the standard deviation of ﬁve
repeated measurements. We can observe deviation from the theoretical
sinusoidal shape with period pi in the response of our pellets, although a
certain symmetry persists in the pellet irradiated to 90 Gy, which has lower
associated uncertainties. The eﬀect of using the average intensity from the
signal amplitude measured at a diﬀerent number of pellet orientations was
then analyzed considering two angular samplings, 180◦ or 360◦.
3We should note here that the orientations are relative to the initial positioning of the pellet,
which is totally arbitrary.
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Figure 3.21: Signal intensity of two alanine pellets irradiated to 90 and 60
Gy, top and bottom respectively, versus their orientation inside the ESR cavity.
Diﬀerent samples of average amplitudes were calculated considering up to 9
investigated angles. From a random initial position, the angular sampling
was performed considering from 2 to 9 equally spaced positions in a 180◦
or 360◦ interval. The average amplitude was then computed from the sig-
nal intensity corresponding to every sampled position through interpolation
from the measured signal, taking into account the type A uncertainty of the
measurements. This procedure was repeated 1000 times to calculate the
standard deviation associated to the average amplitude calculated for the
diﬀerent number of orientations, Figure 3.22. We can see how the standard
deviation of the mean amplitude decreases as the number of orientations
increases. An overall smaller standard deviation is achieved when the sam-
pling is performed in the 360◦ interval. When two pellet orientations are
considered the result is however diﬀerent, as here the 180◦ sampling leads
to a smaller standard deviation, probably due to the persistence of certain
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periodicity with pi in the anisotropy of the pellets.
Figure 3.22: Relative standard deviation of the average peak-to-peak signal
intensity of two alanine pellets, irradiated to 90 and 60 Gy respectively, versus
the number of pellet orientations employed for the signal quantiﬁcation, two
angular samplings are employed, 360◦ (◦) and 180◦ (∗).
As we said time is a limiting factor in the measurement of ESR signals from
a high number of alanine dosimeters, and thus we decided to include in our
measurement protocol the acquisition of spectra at two perpendicular ori-
entations per pellet. This is also the procedure at other alanine dosimetry
services [79, 98], although the acquisition of spectra at a higher number of
orientations is usually preferred [99]. If the time required for the measure-
ment process could be reduced, for example through the installation of an
automated sample changer in the spectrometer, the acquisition of spectra
at a higher number of orientations may be addressed.
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Spectrometer Parameters Before Optimization After Optimization
Sweep width 500 G 250 G
Resolution 2048 points 1024 points
Conversion time 81.92 ms 20.48 ms
Time constant 40.96 ms 163.8 ms
Microwave Power 1.006 mW 2.53 mW
Modulation Amplitude 5 G 7 G
Number of pellet orientations 1 2
Table 3.1: ESR spectrometer parameters employed before and after opti-
mization for alanine dosimetry applications in the therapy dose range.
3.2.2.7 Measurement protocol
A basic co-addition method for signal to noise ratio enhancement is also
included in the measurement protocol, involving the acquisition of three
spectra at each of the two orientations of the alanine pellet inside the
cavity. The spectrometer automatically averages the three values of adc
counts related with the absorption of microwaves by the sample at every
level of magnetic ﬁeld strength, yielding an average spectrum per pellet
orientation. Considering the resolution and conversion times selected, six
spectra are acquired in a total time of 125.82 s per pellet, although some
time is required for the rotation, re-coupling of the cavity, an data saving.
The optimization of spectrometer parameters addressed in this section al-
lows a substantial improvement, of a factor of approximately 7.7, in the
signal to noise ratio of the ESR alanine spectra, see Figure 3.23. Table
3.1 summarizes the changes introduced in the spectrometer parameters in
comparison to the initial ones, which would be appropriate for other ap-
plications where spectrometer sensitivity and stability are not that critical,
for example when the interest is focused in the shape of the ESR spectrum,
or even for alanine dosimetry applications at higher dose ranges (of the
order of kGy) that involve more intense alanine dosimeter signals.
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Figure 3.23: Improvement in the signal to noise ratio of the alanine ESR
spectrum obtained through the optimization of the spectrometer parameters.
3.2.3 Construction of the alanine calibration curve
Once the optimal ESR parameters for alanine dosimetry applications at
the therapy dose range are determined, we can proceed to construct the
ﬁrst calibration curve, which in this case included seven calibration points.
Alanine dosimeters were irradiated in the cobalt unit to achieve the de-
sired values of absorbed dose to water: 10, 20, 30, 40, 50, 60 and 90 Gy.
Three pellets were irradiated at every dose level for repeatability purposes,
leading to a total of 21 irradiated pellets. The recommended 72 h period
was respected before proceeding to the measurement of the ESR signals
to allow radical stabilization in the dosimeters. Measurements in the ESR
spectrometer were then carried out following the above mentioned mea-
surement protocol. Six spectra were acquired per pellet with a 90◦ rotation
of the pellet inside the cavity between the third and the fourth acquisi-
tion, and spectral acquisitions alternating pellets with diﬀerent values of
absorbed dose were performed in order to avoid possible changes in the am-
bient parameters of the laboratory to aﬀect only one part of the calibration
curve.
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3.2.3.1 Alanine background signal
The presence of a background signal in the alanine dosimeters spectra must
be taken into account for the construction of the calibration curve.
Several contributions are responsible for this background signal, also re-
ferred to as baseline. On one hand, the components of the setup placed
inside the cavity are made of materials speciﬁcally chosen to yield no ESR
signals, like the high fused quartz tubes. Measurable ESR signals can
however arise associated to them and to the presence of small amounts of
contamination inside the cavity. Additionally, unirradiated alanine dosime-
ters also exhibit a measurable ESR signal due to the existence of alanine
endogenous radicals, usually related with the dosimeters manufacturing
process. The signal of unirradiated dosimeters is observed to vary between
manufacturers and, to a much lesser extent, between dosimeters from the
same manufacturer.
The quantity of interest in alanine dosimetry is the signal intensity corre-
sponding only to radiation induced radicals thus subtraction of the back-
ground signal from the spectra of irradiated alanine dosimeters has to be
performed. Measurements of this weak background signal are highly af-
fected by spectrometer instabilities arising from temperature and humid-
ity variations, small diﬀerences in the water content of the pellets, and
the alanine dosimeters anisotropy, contributing all these factors to poten-
tial discrepancies between the signal measured for diﬀerent unirradiated
dosimeters. The measurement of the background signal was performed
through the acquisition of several spectra from three unirradiated pellets.
Two orientations and six acquisitions per pellet were again considered. A
fourth order polynomial ﬁt to the average of these background spectra was
employed to model the baseline as shown in Figure 3.24.
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Figure 3.24: Average alanine background spectrum, calculated from three
unirradiated alanine dosimeters (solid line) and 4th degree polynomial ﬁt em-
ployed for the modelization of the alanine baseline (·).
3.2.3.2 Alanine ESR signal quantiﬁcation
After the measurement of the pellets ESR spectra, which was performed
with the spectrometer parameters detailed in Table 3.1 and spectrometer
gain equal to 1.002 104, quantiﬁcation of the dosimeters ESR signal inten-
sity was performed in two diﬀerent ways. On one hand, the peak-to-peak
signal intensity was calculated after simple subtraction of the baseline from
the average spectrum of each dosimeter at each of the investigated ori-
entations. The other method used to quantify signal intensities involved
the comparison of a reference alanine spectrum with the signal of every
dosimeter involved in the calibration for the calculation of the proportion-
ality factor existing between them through a least squares minimization.
The reference spectrum here employed is the signal of an alanine dosimeter
irradiated to a high value of dose, 90 Gy in our case, exhibiting a high
signal to noise ratio. The baseline was also subtracted to this reference
spectrum before comparison with other spectra.
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Figure 3.25: Comparison of the reference spectrum obtained from a pellet
irradiated to 90 Gy, in dashed line, and the renormalized signal of a dosimeter
irradiated to 20 Gy, solid line. The normalization factor minimizing the reduced
Chi square is employed for signal quantiﬁcation.
This method, proposed by Sharpe et al. [79] and exempliﬁed in Figure
3.25, lies on the assumption that the alanine spectral shape is the same
independently of the dose deposited in the dosimeter. Comparison with
a clean reference signal can be thus of great help for signal quantiﬁcation
when the dose decreases below 10 Gy and the dosimeters signals become
more aﬀected by noise.
As the resonant frequency can vary between measurements due to diﬀer-
ences in the cavity QF arising from changes in the dosimeters water content
or laboratory ambient humidity [92], x-axis alignment with respect to the
reference signal is performed for all the dosimeters spectra by ﬁnding the
translation that maximizes the correlation between both signals.
For signal quantiﬁcation, the peak-to-peak ratio between the investigated
signals and the reference spectrum is initially employed as an approximated
proportionality factor, being this value varied until the reduced Chi-square
of the ﬁt, expressed by Equation 3.27, is minimized.
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χ2red =
1
n− 2
n∑
i=1
(fi − asi)2
σ2i
(3.27)
In this equation si and fi are the signal intensities of the investigated and
reference spectra respectively, and σ represents the noise amplitude, ob-
tained as the standard deviation of the experimental signal over 100 points
in a region with no signiﬁcant ESR signal.
For the construction of the calibration curve, some transformations have to
be still applied to the alanine dosimeter intensities determined through any
of the methods above described. First of all, and considering Equation 3.2,
normalization of the ESR intensities by the mass of the pellets has to be
performed. Taking into account that two orientations of every pellet with
respect to the cavity were investigated for every set of the three dosimeters
irradiated at each dose level, the mean, mass normalized ESR intensity
would be expressed as:
(
IESR
m
)
=
1
3
3∑
i=1
(IESR)i,0◦ + (IESR)i,90◦
2mi
(3.28)
Additionally, our calibration curve has to be referred to a single irradiation
temperature, T0, see Equations 3.5 and 3.6, arbitrarily chosen as reference.
Since the pellets corresponding to the diﬀerent dose levels were irradiated
at slightly diﬀerent temperatures, a temperature correction kT , described
by Equation 3.6, has to be applied to the mean value of the mass normalized
ESR intensities, leading to the expression:
Dw,60Co = C60Co,T0
(
IESR
m
)
60Co,T0
= C60Co,T0kT ·
(
IESR
m
)
60Co,T
(3.29)
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Corrections related with the dosimeters signal fading do not have to be
applied as long as all the dosimeters, not only those employed to construct
the calibration curve but also those employed to measure absorbed doses to
water through the calibration curve, were irradiated the same day, kept in
identical ambient conditions and measured in the ESR spectrometer within
the same day. Besides the fading, this methodology intends to minimize
spectrometer sensitivity variations related with changes in the laboratory
ambient parameters that are diﬃcult to correct. Other solutions have been
developed that involve the use of a sample, made of a reference substance,
that is placed in the cavity during the alanine dosimeter measurements to
correct for the spectrometer instabilities, as they can be detected by the
changes exhibited by the intensity of the reference sample [100].
3.2.3.3 Calibration uncertainty budget
All the uncertainties involved in this work were evaluated according to the
Guide to the Expression of Uncertainty in Measurement [101] and are here
expressed at one standard deviation (k=1). The sources of uncertainty
that have to be considered in the construction of the alanine calibration
curve can be easily classiﬁed as being associated to the determination of
the absorbed dose to water corresponding to the pellets irradiation or to
the quantiﬁcation of the ESR signal intensities.
Determination of absorbed dose to water associated uncertainties:
Regarding the deposition of dose in the pellets during their irradiation in
the 60Co unit, the uncertainty mainly comes from:
a. Dose rate determination.
The ionization chamber employed for the determination of the 60Co
unit dose rate was calibrated at the PTB primary standard, with a
relative uncertainty associated to the calibration coeﬃcient of 0.25%.
Chapter 3. Alanine Dosimetry 140
After appropriate corrections to the ionization chamber measurement,
due to polarization and ambient condition changes (kTP ), the global
uncertainty associated to the determination of dose rate is 0.3%.
b. Detectors positioning.
An estimated accuracy of 0.2 mm is considered for the positioning of
both the alanine holder and the ionization chamber in the beam prop-
agation axis, which will involve a corresponding standard uncertainty
upos equal to 0.16 mm considering a rectangular distribution. Addi-
tionally, the insert where the pellets are placed for irradiation has an
inner diameter of (5.435 ± 0.037) mm, and the pellets have a diameter
of (4.82 ± 0.01) mm, variations in the position of the pellets inside the
holder were thus supposed to follow a rectangular distribution with
full width (0.614 ± 0.038) mm. The total uncertainty associated to
positioning, obtained through propagation of the uncertainty in the
position of the pellets inside the insert and the positioning of the insert
itself, amounts to 0.39 mm. The 60Co dose gradient at 5 cm depth, of
0.50% mm−1, can be used to calculate the impact of the positioning
uncertainty in the determination of absorbed dose to water in every
pellet, estimated to be 0.2%. In the axis that are perpendicular to the
direction of beam propagation, the eﬀect of the positioning accuracy
is neglected given the high uniformity of the 10 cm×10 cm ﬁeld dose
proﬁle.
c. Irradiation time.
The irradiation times needed to achieve the desired values of absorbed
dose to water involved in the calibration curve were calculated from
the unit dose rate, 0.349 Gy/min for this calibration, once the 60Co
source is already placed at the irradiation position in the unit head.
An uncertainty of 0.5 s is estimated for the determination of the irra-
diation time, leading to an uncertainty in the dose of 2.9 ×10−3 Gy
(0.03% in 10 Gy).
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Additionally, it has to be taken into account that the path travelled by
the source from its shielded position at rest to the irradiation position
at the unit head has an associated dose rate that is not zero. The
pellets, already positioned in the water tank for irradiation during the
source transit, will receive an extra dose that has to be considered.
Assuming a linear increase in the dose rate during the source transit,
which lasts 2.4 seconds on average, this extra dose can be calculated
as the dose rate divided by the source transit time. This quantity,
amounting to a 0.14% in 10 Gy for the 0.349 Gy/min dose rate of
the 60Co during this calibration, could be included for the calculation
of the total absorbed dose to water. However, the time of transit of
the source can ﬂuctuate depending on the pressure of the pneumatic
system moving the source, and this extra dose to the pellets will be
thus considered as a maximum uncertainty for its inclusion in the
budget.
d. The radioactive decay of the 60Co source. Finally, the unit dose
rate decreases during an irradiation campaign due to the radioactive
decay of the 60Co source, half life (1925.20±0.25) d, diminishing ap-
proximately a 0.04% per day, independently of the dose rate [102].
The contribution of the source decay to the uncertainty in the deter-
mination of absorbed dose to water is negligible when compared with
the other sources of uncertainty, and it was therefore not taken into
account.
ESR signal quantiﬁcation associated uncertainties:
Regarding the quantiﬁcation of the ESR signals, the sources of uncertainty
will mainly come from:
a. Pellets temperature during irradiation.
The concentration of radicals in the alanine dosimeters depends on
the irradiation temperature. The preconditioning addressed in order
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to control the temperature of the pellets during irradiation was de-
scribed in Section 3.2.1.1 and consists in letting the pellets stabilize
to the irradiation room temperature. The water tank temperature is
registered during every irradiation and employed to correct the ESR
signal intensities for relative radiation yield variations. The tempera-
ture of the water tank is however between 0.7◦C and 1◦C lower than
that of the air in the room when both are in thermal equilibrium, but
we cannot let the pellets reach the thermal equilibrium with the water
tank since this would take hours and the time needed for a measure-
ment campaign would be unaﬀordable. Due to this, we can expect
variations within 1◦C in the temperature of the pellets with respect
to the temperature in the water tank during irradiation, which would
imply an uncertainty in temperature of a 0.29◦C. The uncertainty as-
sociated to the temperature correction, kt, that is applied to the ESR
readings, amounts in this case to 0.05%, a value that is obtained from
the uncertainty associated to the measurement of the temperature
and the uncertainty associated to the temperature coeﬃcient, cT , by
applying the laws of error propagation.
b. The mass of the pellets.
The alanine pellets were weighted with a microscale with 0.1 mg pre-
cision after having performed the ESR spectrometer measurements in
the ﬁrst calibration campaign. The relative standard deviation in the
distribution of masses within the 24 measured pellets was found to be
0.3%, a value that is considered to be low enough to discard the need
of preselecting the pellets by mass for the construction of the calibra-
tion curve. This check should have been done before irradiation to
avoid possible outliers, and that was the procedure implanted since
then. The uncertainty associated to the measurement of the mass of
the pellets was quantiﬁed from the precision of the micro scale and the
standard deviation of the mass measurements for every single pellet,
obtained by measurement repetition, which amounted on average to
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a 0.15% of the mass of the pellet. This lead to a total uncertainty
associated to the mass of the pellets of 0.16%.
c. The spectrometer.
The uncertainty associated to the measurement of the alanine ESR
signals in the spectrometer is due to diﬀerent contributions like the
positioning of the pellets in the vertical axis of the cavity, anisotropies
in the dosimeters remaining after having averaged the signal from
two positions of the pellet inside the cavity, Section 3.2.2.6, and the
stability of the spectrometer, which is aﬀected by the ESR parameters,
the water content of the pellets, and the temperature of the magnet
and bridge water cooling system. As separation of these contributions
would be rather complicated, they have been evaluated altogether
by performing several measurements and computing their standard
deviation. At each dose level, the size of a statistical sample made
of only six signals, two spectra corresponding to each of the three
pellets involved, could be questionable. However, the methodology
followed in this work was designed to obtain an alanine calibration
curve on one day of ESR measurements, and increasing the number of
replicate pellets to four at each calibration point would be excessively
time-consuming.
Table 3.2 presents a summary of the diﬀerent sources of uncertainty that
are considered for the construction of this alanine calibration curve.
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Uncertainty source Type ur (%)
1. Pellets irradiation
Dose rate determination B 0.3%
Positioning B 0.2%
Irradiation time B 2.9×10−3 Gy (0.03% in 10 Gy)
60Co source transit B 0.014 Gy (0.14% in 10 Gy)
2. ESR signal quantiﬁcation
Irradiation temperature B 0.05%
Mass of the pellets A 0.16%
Spectrometer A 0.9% or 0.6% in 10 Gy*
Table 3.2: Summary of the sources of uncertainty involved in the construction
of the alanine calibration curve, k=1. * The two uncertainties associated to
the measurement of the ESR signal are respectively obtained through the peak-
to-peak method for signal quantiﬁcation and through the method involving a
reference signal.
3.2.3.4 Calibration ﬁt
The calibration curve was constructed through a least squares linear ﬁt to
the several pairs, 6 in this case, of absorbed dose to water values, Dw, and
mass normalized and temperature corrected ESR intensities (IESR/m)60Co,T0 ,
noted here by Aesr for abbreviation.
Aesr = a+ b ·Dw,60Co (3.30)
Regarding the linear ﬁt, the ordinary least squares method assumes that
the abscissa values (dose to water here) have no associated uncertainty
and the ordinate values (ESR intensity) follow a normal uncertainty dis-
tribution. In our case, however, the uncertainties associated to the ESR
intensities increase, even when considered relative to dose, as the dose in
the dosimeters decreases.
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At high dose levels the uncertainty associated to the ESR signal of alanine
dosimeters has been observed to remain constant relative to dose [83], but
at low dose levels, specially below 10 Gy, this is no longer observed. In
this regime, measured signals are more importantly aﬀected by the spec-
trometer high frequency noise, and the signals baseline becomes aﬀected by
low frequency distortions arising from the cavity/holder and the dosimeter
itself, being this latter contribution variable from dosimeter to dosimeter
[79]. These contributions make the relative uncertainty associated to the
ESR intensity to increase as the dose level decreases.
Under this situation, the application of a weighted least squares method
for the ﬁt of the calibration curve would be adequate. Moreover, as the
uncertainties associated to the absorbed dose to water and to the ESR
intensities are of the same order of magnitude, a method weighting both
sources of uncertainty was considered to be the most appropriate strategy.
The least squares method proposed by York et al. [103] was followed for
the determination of the slope, intercept, and standard errors of our alanine
calibration ﬁt.
The alanine calibration curves that were built with the two studied meth-
ods of signal quantiﬁcation are shown in Figure 3.26. Signal intensities
corresponding to 60 Gy are normalized to unity for both methods to allow
comparison in the ﬁgure, although ﬁtting parameters, presented in Table
3.3, were obtained without such a normalization.
Very similar results are obtained in the ﬁts corresponding to the two meth-
ods of signal quantiﬁcation. The intercepts, a, yielded values compatible
with zero in both cases, u(a)/a=180% and u(a)/a=240% for the method
involving the reference signal and the peak-to-peak respectively, indicat-
ing that an eﬀective baseline subtraction was applied to the pellets for
the quantiﬁcation of the ESR signals. Errors associated to the slope are
however slightly lower for the method involving the comparison with the
reference signal, u(b)/b=0.76%, compared with the value u(b)/b=0.84%
Chapter 3. Alanine Dosimetry 146
Figure 3.26: Calibration curves constructed from the two methods for ESR
signal quantiﬁcation a) proportionality factors existing between the signals and
the reference signal fref and b) the peak-to-peak intensity of the signals. c)
Residuals obtained from the two linear ﬁts, expressed relative to the value of
AESR obtained with each respective ﬁt at every dose level.
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Signal Quantif. Method Peak-to-peak Prop. factor fref
a 66 adc 1.5×10−2
u(a) 121 adc 3.5×10−2
b 537.6 adc Gy−1 1.871×10−1Gy−1
u(b) 4.5 adc Gy−1 0.014×10−1Gy−1
cov(a, b) -4.64×10−2 adc Gy−1 -4.17×10−5Gy−1
Table 3.3: Parameters from the calibration obtained through the two meth-
ods of ESR signal quantiﬁcation.
obtained with the peak-to-peak method. This is due to the lower scatter
achieved in the signal quantiﬁcation through this method.
A check of the alanine signal-to-dose linearity can be performed through
the analysis of the residuals corresponding to these ﬁts, where a sample
of residuals following a normal distribution centred at zero would indicate
a good agreement between the linear ﬁt and the calibration data. Being
our sample rather small to perform a valid normality test, the distribution
of residuals is directly presented in Figure 3.26, with residuals lying below
and above zero from point to point and no systematic deviations observed.
Furthermore, a χ2 test performed to study the goodness of the ﬁt yielded
χ2 values equal to 0.72 and 1.25 for the calibration methods involving the
reference signal and the peak-to-peak intensities respectively. From them,
reduced χ2 values (χ2 over the number of degrees of freedom) of 0.18 and
0.31 can be obtained considering the four degrees of freedom in our ﬁt.
As the reduced chi square would be close to one whenever the estimated
uncertainties are an accurate representation of the error in the data, the
results here obtained, both below one, would suggest a small overestimation
in our uncertainties.
Chapter 3. Alanine Dosimetry 148
Determination of dose
Once a calibration curve has been established, the values of absorbed dose
to water corresponding to the ESR signal exhibited by irradiated alanine
dosimeters can be directly calculated using the ﬁt parameters a and b:
Dw,60Co =
1
b
· Aesr − a
b
(3.31)
The uncertainty associated to this indirect measurement of absorbed dose
to water can be expressed according to the laws of error propagation as:
u(Dw,60Co) =
1
b
√
u(Aesr)2 + u(a)2 +D2w,60Co · u(b)2 + 2 ·Dw,60Co · cov(a, b)
(3.32)
From our best linear ﬁt, uncertainties in the determination of absorbed dose
to water using irradiated alanine pellets and this alanine calibration curve
are estimated to range from 1.2% at 50 Gy to 2.8% at 10 Gy, although
this can slightly vary for other dosimeters, as for them the quantiﬁcation
of ESR signal would be aﬀected by slightly diﬀerent uncertainties.
3.2.3.5 Improvements in the system
After the construction of the ﬁrst calibration curve, several actions were
identiﬁed that could be addressed in order to reduce the uncertainty of the
measurement system.
a. The spectrometer.
One of the largest contributions to the uncertainty in the determina-
tion of dose with the alanine/ESR system comes from measurement
of the ESR signal, see Table 3.2, and enhancing the stability of the
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spectrometer can contribute to improve the quality of the ESR mea-
surement. The water cooling system used to avoid overheating in the
spectrometer magnet and bridge plays an important role in alanine
dosimetry applications, as changes in the temperature of the water can
aﬀect the spectrometer sensitivity. Due to this, many departments in-
stall heat exchangers to control the temperature of the cooling water
[92, 104]. In our institution, the water for this cooling system came
from the building main water supply, passing through the instrument
and being not recirculated. The water ﬂow changed depending on
the building water demands, leading to uncontrollable temperature
variations in the magnet and bridge that unavoidably aﬀected the
spectrometer stability. In order to minimize this, a new water cooling
system was installed for the recirculation of water from a water tank
of 75 L and a temperature control with a precision of 0.5◦C.
b. Irradiation time.
Regarding the determination of the dose delivered to the pellets dur-
ing irradiation in the 60Co unit, another reduction of uncertainties can
arise from the quantiﬁcation of the dose delivered to the pellets during
the transit of the 60Co source from its shielded position at rest to the
irradiation position at the unit head. In last section, an approximated
estimation of this extra dose was considered as an uncertainty asso-
ciated to the dose, but including this quantity as dose to the pellets,
with the corresponding associated uncertainty, would be a most accu-
rate determination of the dose. Repeated measurements of the dose at
the reference point during the source transit were performed with an
ionization chamber located at that point under reference conditions.
The ionization chamber current was measured every 0.5 second, regis-
tering the dose curve associated to the source transit. The integration
of the current curve over the time of source transit multiplied by the
dose rate with the source at the full unshielded position leads to the
dose associated to the source transit. This measurement was repeated
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several times and an average value of (0.017 ± 0.002) Gy was deter-
mined.
This is of special importance because the 60Co source of the Radiation
Physics Laboratory was replaced on November 2012 by one with an
activity two times higher than that of the old source. The dose rate
was, by the 7th of August 2013, equal to (0.758 ± 0.002) Gy/min
under reference conditions, what would have lead to an uncertainty
associated to the source transit equal to 0.031 Gy (0.3% in 10 Gy) if
the estimations addressed in Section 3.2.3.3 were repeated.
c. The mass of the pellets.
The uncertainty associated to the determination of the mass of the
pellets is another factor to take into account. For the ﬁrst calibration
curve, a microscale with 0.1 mg precision was employed, exhibiting a
repeatability of 0.15% in the measurement of 60 mg samples (mass of
the pellets). A microscale with the same precision but higher repeata-
bility became available for subsequent campaigns, leading to 0.09%
relative standard deviations in the measurement of the pellets. Pel-
lets to be used in the measurement campaign were chosen before irra-
diation leading to a relative standard deviation in the distribution of
masses equal to 0.2%. The uncertainty associated to the measurement
of the mass, quantiﬁed from the precision of the microscale and the
standard deviation of the measurements of every single pellet, lead to
a total uncertainty associated to the mass of the pellets of 0.09%.
A new calibration curve was established to check the eﬀect of the changes
introduced in the system to reduce the uncertainty. Groups of three pellets
were irradiated under reference conditions to dose levels similar to those
involved in the ﬁrst calibration curve: 8.017, 10.017, 20.017, 30.017, 40.017,
50.017, 60.051 and 90.034 Gy (60 and 90 Gy dose levels were achieved in
repeated irradiation and thus the dose contribution from the transit source
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has to be considered several times). The calibration point at 8 Gy was ad-
ditionally introduced to check the quality of the system at this lower dose
level. Moreover, a blind test was included to check the alanine/ESR cal-
ibration. This test consisted in the irradiation, by the Radiation Physics
Laboratory staﬀ, of two groups of three pellets to diﬀerent dose levels,
whose values were not revealed until the determination of dose was per-
formed through the calibration curve. The total number of pellets involved
in the campaign amounted now to 33, organized in 11 groups of 3 pellets
each, being seven the groups of pellets used as calibration points, other
group used for the 90 Gy reference signal, two groups corresponding to the
blind tests and another group of unirradiated pellets employed for ESR
background signal determination.
The method addressed for the measurement of the dosimeters in the ESR
spectrometer was analogous to that presented in Section 3.2.2.7, involving
the optimized operational parameters detailed in Table 3.1. However, the
spectrometer gain was now set to 4.48 105, instead of the 1.002 104 used in
the last calibration, being this value low enough to avoid saturation in the
most intense ESR spectra exhibited by the pellets irradiated to 90 Gy. The
quantiﬁcation of the ESR signal intensity was determined through the two
methods (peak-to-peak and proportionality factor to the reference signal)
presented in Section 3.2.3.2.
The uncertainty budget associated to this calibration is detailed in Table
3.4, where we can observe an improvement in the repeatability of the spec-
trometer after the installation of the recirculated water cooling system.
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Uncertainty source Type ur (%)
1. Pellets irradiation
Dose rate determination B 0.3%
Positioning B 0.2%
Irradiation time B 6.3×10−3 Gy (0.06% in 10 Gy)
Source transit B 2.8×10−3 Gy (0.03% in 10 Gy)
2. ESR signal quantiﬁcation
Irradiation temperature B 0.05%
Mass of the pellets A 0.09%
Spectrometer A 0.6% or 0.4% in 10 Gy*
Table 3.4: Summary of the sources of uncertainty involved in the construc-
tion of an improved alanine calibration curve, k=1, after improvement of the
system. * The two uncertainties associated to the measurement of the ESR
signal correspond to the peak-to-peak method for signal quantiﬁcation and the
method involving a reference signal.
Figure 3.27 shows the results of this calibration, with signal intensities
normalized to the signal at 60 Gy to allow comparison in the ﬁgure. Fitting
parameters, presented in Table 3.5, were again obtained without such a
normalization.
Signal Quantif. Method Peak-to-peak Prop. factor fref
a (a.u.) 3.2×103 adc 3.1×10−2
u(a) (a.u.) 3.1×103 adc 1.8×10−2
b Gy−1 2.363×104 adc Gy−1 1.866×10−1 Gy−1
u(b) Gy−1 0.015×104 adc Gy−1 0.011×10−1 Gy−1
cov(a, b) Gy−1 -3.7×105 adc Gy−1 -1.5×10−5 Gy−1
Table 3.5: Parameters from the calibration obtained through the two meth-
ods of ESR signal quantiﬁcation after improvement of the system.
We can observe an important diﬀerence between the ﬁtting parameters as-
sociated to the peak-to-peak quantiﬁcation method in the two campaigns
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Figure 3.27: Calibration curves constructed from the two methods for ESR
signal quantiﬁcation after improvement of the system a) proportionality factors
existing between the signals and the reference signal fref and b) the peak-to-
peak intensity of the signals. c) Residuals obtained from the two linear ﬁts,
expressed relative to the value of AESR obtained with each respective ﬁt at
every dose level.
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(ﬁrst column of Table 3.5 and Table 3.3). This is due to the change in
the spectrometer gain between the two campaigns, being the ratio of gains,
equal to 44.7, very close to ratio of the slopes associated to the two cali-
bration curves, which is 44. This values are not equal due to the deviation
from one in the slope of signal intensity versus the spectrometer gain.
On the other hand, the errors associated to the ﬁtting parameters are again
slightly smaller for the method involving the comparison with the reference
signal (u(b)/b=0.57% and 0.64% for the methods involving the reference
signal and the peak-to-peak respectively).
Intercepts, a, associated to the new calibration curves are not compati-
ble with zero, with relative uncertainties equal to 57% and 95% for the
reference signal and the peak-to-peak method respectively, reﬂecting that
the subtraction of background signal from the irradiated dosimeters was
not completely eﬀective in this case. The diﬃculties for background sub-
traction are however only encountered in the lower dose levels, as it was
observed that intercepts compatible with zero are obtained when the cali-
bration point corresponding to 8 Gy is not included to ﬁt the data. This
is thought to be due to the low signal exhibited by the dosimeter for dose
levels below 10 Gy, where radiation induced radicals become more drasti-
cally aﬀected by the background signal. Background subtraction diﬃculties
at low dose levels are conﬁrmed by the work of Sharpe et al. [79], where
an iterative method is applied to subtract dosimeter dependent base line
distortions, claimed to be of main importance at low dose levels. A similar
approach to suppress base line distortions could be applied in the future to
ensure that only random noise remains when the radiation induced signal
and the background signal are subtracted.
Residuals associated to the ﬁt, including the 8 Gy calibration point, are dis-
tributed above and below zero, and no systematic deviations are observed,
being all below 1% except that associated to the 8 Gy calibration point
in the ﬁt corresponding to the peak-to-peak signal quantiﬁcation. Finally,
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the χ2 test performed to study the goodness of the ﬁt yields now χ2 values
equal to 1.0 and 1.3 for the calibration methods involving the reference sig-
nal and the peak-to-peak intensities, with corresponding reduced χ2 values
of 0.17 and 0.21 respectively, suggesting again a small overestimation in
our uncertainties.
From these calibration, relative uncertainties in the determination of ab-
sorbed dose to water can be estimated to range, for the reference signal
quantiﬁcation method, from 1.7% to 0.8% for dosimeters irradiated from
10 Gy to 50 Gy. The peak-to-peak quantiﬁcation yielded estimated uncer-
tainties ranging from 2.2% to 0.9% for dosimeters irradiated from 10 Gy to
50 Gy.
Regarding the blind test, dose values were estimated from the two calibra-
tion curves. When the calibration curve obtained from the reference signal
quantiﬁcation method is employed, dose values amounted to (13.25 ± 0.18)
Gy, 1.4% relative uncertainty, and (15.02 ± 0.19) Gy, 1.3 % relative uncer-
tainty. Using the peak-to-peak calibration curve, dose values amounted to
(13.39 ± 0.22) Gy, 1.6% relative uncertainty, and (15.10 ± 0.27) Gy, 1.8%
relative uncertainty, uncertainties being expressed with k=2. All values
are compatible with the dose delivered to the pellets as registered by the
Radiation Physics Laboratory staﬀ, which were (13.341 ± 0.082) Gy and
(15.190 ± 0.092) Gy respectively.
In the determination of dose through the peak-to-peak quantiﬁcation method
a larger uncertainty was achieved for the blind test with the higher dose,
15.19 Gy, although the relative uncertainty of the alanine dosimetry system
is expected to decrease with dose. This was due to the higher type A un-
certainty associated to the peak-to-peak quantiﬁcation for the dosimeters
involved in this test, which amounted to 0.55%, while for the ﬁrst blind test,
of 13.34 Gy, remained of 0.23%. The use of a reference signal for the quan-
tiﬁcation of dose is mainly useful when applied to dosimeters with low dose
levels, which is conﬁrmed through the proportionality encountered between
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dose level and the type A uncertainty associated to this ESR quantiﬁcation
method at the lowest dose levels involved in our study.
The estimation of the uncertainty associated to the ESR signal quantiﬁ-
cation using the standard deviation from the measurement of three pellets
has been demonstrated to be an adequate approach leading to consistent
results [92]. A repeated construction of calibration curves, similar to that
addressed in the work by Anton et al., would serve to check that the varia-
tions obtained in the determination of dose are repeatedly compatible with
the uncertainty estimates.
3.3 Conclusions
In this chapter, a thorough study about alanine/ESR dosimetry systems
in the therapy dose range has been performed. An approximation to the
theoretical foundations of ESR detection has been addressed, as well as a
study about the ESR spectrometer operation.
The spectrometer sensitivity and stability required to achieve uncertainties
below 1% in the quantiﬁcation of ESR signal from alanine dosimeters ir-
radiated in the therapy dose range are quite demanding. The parameters
ensuring optimal spectrometer operation can deviate from those employed
in other ESR applications where the interest lies in the determination of
ESR spectral shapes instead of ESR signal intensity quantiﬁcation. Sev-
eral tests were performed to determine the combination of spectrometer
operation parameters resulting optimal for the measurement of the alanine
dosimeters, maximizing the spectrometer stability and sensitivity. The
development of a speciﬁc custom motorized system to accurately control
the position of the dosimeters in the cavity, as well as the study of the
anisotropy exhibited by the ESR signal of alanine dosimeters, allowed the
deﬁnition of an ESR measurement protocol.
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A ﬁrst calibration of alanine ESR signal intensity in terms of dose to water
was addressed through the irradiation of a batch of dosimeters to six levels
of dose to water in 60Co, serving for the investigation of two methods of ESR
signal quantiﬁcation and to study the subtraction of alanine background
signal from unirradiated alanine dosimeters. A general uncertainty budget
was established to estimate the uncertainty associated to this calibration,
which amounted to 1.2% for dosimeters irradiated to 50 Gy and 2.8% for
dosimeters irradiated to 10 Gy.
Improvements related with the stability of the spectrometer (installation
of a recirculated water cooling system in the spectrometer with a heat ex-
changer to control the temperature) and a more accurate determination of
the dose to water delivered to the dosimeters were introduced in the system
to reduce the uncertainty. Calibration of dose to water from alanine ESR
signal performed after these improvements yielded a relative associated un-
certainty estimated to amount to 0.8% for dosimeters irradiated to 50 Gy
and 1.7% for dosimeters irradiated to 10 Gy. Two alanine dosimetry blind
tests were used to check the consistency of the system at 13 and 15 Gy.
The determination of dose to water from the calibration curve yielded for
these pellets values compatible with the reference values of dose delivered
to the pellets, with relative uncertainty levels amounting to 1.4% at 13 Gy
and 1.3% at 15 Gy.
This Chapter described the ﬁrst steps for the development of an alanine
dosimetry system at the Universidade de Santiago de Compostela. The
work here addressed served for the construction of an alanine calibration
curve with associated uncertainties below 2% (k=2) at 10 Gy, low enough
for applications like the determination of ionization chamber correction
factors or their use for dosimetry audits.
Some improvements could be still introduced in the system to further reduce
the uncertainty in the determination of dose to water from alanine ESR
signal, being related with the positioning of the pellets during irradiation
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and the subtraction of background from the dosimeters ESR signal at low
dose levels. Before oﬀering an alanine dosimetry service to external users,
a repeated construction of calibration curves would serve to deﬁnitively
check that the variations obtained in the determination of dose in diﬀerent
calibrations are compatible with the uncertainty estimates.
Chapter 4
Ionization chamber correction
factors in nonstandard ﬁelds:
TomoTherapy and CyberKnife
In this chapter we will apply the dosimetric formalism presented in Chapter
1 to two modern radiotherapy techniques, TomoTherapy R© Hi-Art R© and the
CyberKnife R© Robotic Radiosurgery system, both machines from Accuray
Inc., Sunnyvale, CA. For these two machines, intermediate calibration ﬁelds
will be deﬁned for the calculation of ionization chamber correction factors
following the proposal of Alfonso et al.. Clinical treatments will be also
measured to evaluate the suitability of the intermediate calibration ﬁelds
for the clinical practice.
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4.1 Introduction
4.1.1 Flattening ﬁlter free linear accelerators
Although there are many diﬀerences between the two radiotherapy tech-
niques here chosen to investigate the applicability of the new dosimetry
protocol, they both share the peculiarity of using ﬂattening ﬁlter free (FFF)
accelerators. Modern linacs that operate without ﬂattening ﬁlter became
available during the last years, like Elekta Precise R© (Elekta AB, Stockholm,
Sweden), and TrueBEAM R©, Trilogy R© and Clinac R© linacs from Varian (Var-
ian Medical Systems Palo Alto, CA), or TomoTherapy R© Hi-Art R© and the
CyberKnife R© Robotic Radiosurgery system, both machines from Accuray
Inc., Sunnyvale, CA, which shows a sustained trend in the evolution of
radiotherapy machines industry.
A ﬂattening ﬁlter (FF) is basically a conical shaped piece made of a high-Z
material that is introduced in the head of medical accelerators to com-
pensate the forward peaked angular distribution of the photons that are
generated by bremsstrahlung in the linac target. Its thickness, of several
centimeters, is chosen to provide ﬂat dose proﬁles at 10 cm depth in water,
and depends on the linac megavoltage modality. Flat dose proﬁles were used
in radiotherapy treatments as they substantially simpliﬁed treatment plan-
ning dose calculations when computers were not available. However, the
development of dose calculation engines and the emergence of radiotherapy
techniques like stereotactic radiotherapy (SRT) or IMRT, with the delivery
of ﬂuence patterns that vary across the beam yielding inhomogeneous dose
distributions, set some questions about the need of this component in the
linac heads. Then, progressively during the last 10 years, the main linac
vendors began to release Flattening Filter Free (FFF) accelerators.
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The characteristics of a linac with or without this component present some
diﬀerences in the photon beam output regarding:
1. Dose rate
The attenuation suﬀered by the forward peaked distribution of pho-
tons crossing the FF involves a strong decrease in photon ﬂuence.
The dose rate delivered by a FFF beam is therefore higher than that
of ﬂattened beams. Under these increased dose rates, that can reach
2400 cGy/min, diﬀerences in the radiobiological eﬀect of photons with
respect to conventional rates are however not observed [105], neither
the measurement of dose with air ionization chambers, ﬁlm dosimetry,
semiconductors or alanine dosimeters requires the introduction of any
correction factor.
This dose rate increment of FFF beams cannot be however directly
translated into substantial treatment time reductions as gantry and
MLC movements constitute a signiﬁcant fraction of the total treat-
ment time. Improvements in the MLC designs to get higher leaf
speeds, increasing the eﬃciencies of treatment delivery, will help to
take full advantage of the higher dose rates in FFF beams.
2. Beam spectrum (beam quality)
The attenuation suﬀered by the photons crossing the FF produces a
hardening in the photon spectrum that makes FFF beams to present a
softer spectrum when compared to that of ﬂattened beams operating
under the same accelerating potential, see Figure 4.1 (a) and (b).
This softening in the spectrum makes FFF beam percent depth dose
distributions to fall more steeply than those of FF beams, leading to
lower TPR20,10 and %dd(10) beam quality indexes than that exhibited
for the same megavoltage modality in FF linacs. In practice, 6 and 18
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Figure 4.1: Normalized energy ﬂuence in the central axis (solid line) and ﬁeld
edge (points) of a ﬂattened (a) and unﬂattened (b) 6MV 40 cm×40 cm ﬁeld
from a Elekta Precise linac, Monte Carlo simulation [106]. (c) Lateral dose
proﬁles of a 4 cm×4 cm and a 20 cm×20 cm ﬁeld from a ﬂattened (solid line)
and unﬂattened (points) 6 MV beam from a TrueBeam linac [107]. 20 cm×20
cm ﬁeld dose proﬁles at a depth of 1.5, 5, 10 and 20 cm in water are included
to show the lower variation with depth found for unﬂattened beams.
MV unﬂattened beams exhibit beam quality indexes that are typical
of 4 and 15 MV standard FF beams respectively.
The ﬂattening ﬁlter produces also an oﬀ-axis softening in the spec-
trum, and unﬂattened beams will thus present smaller energy varia-
tions across the beam. This will be translated into smaller variations
in the lateral dose proﬁles with depth and lower diﬀerences between
axis and oﬀ-axis depth dose proﬁles, which can be considered as a
simpliﬁcation for dose calculations. The lower oﬀ-axis softening in
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the FFF beams spectrum will also aﬀect phantom scatter ratios, a pa-
rameter sensitive to the photon beam quality, irradiated area and ﬁeld
shape. Namely, changes amounting to a 4% have been found between
phantom scatter ratios of FF and FFF beams with the same beam
quality indexes, and although more studies should be performed to
verify this eﬀect, this may suggest that kernel parameters employed in
convolution-superposition dose calculation algorithms of FFF beams
could diﬀer from those of FF beams [108].
3. Lateral dose proﬁles
As we just mentioned, the spectral variation associated to the removal
of the ﬂattening ﬁlter produces certain diﬀerences between FFF lat-
eral dose proﬁles and those yielded by conventional ﬂattened beams.
FFF lateral dose proﬁles exhibit a central peak that becomes increas-
ingly pronounced at higher energy modalities due to the predominant
smaller scattering angles. Under 6 MV modalities, this peak is notice-
able at large and medium ﬁeld sizes, while dose proﬁles of ﬁeld sizes
smaller than 4 cm×4 cm are very similar to those of ﬂattened beams,
Figure 4.1 (c). Variations in the shape of lateral dose proﬁles with
depth, this is, the horns and pronounced shoulders typically observed
in ﬂattened beam proﬁles at depths respectively lower and higher than
10 cm, are minimized in unatened beams due to the smaller radial
energy variation. Regarding the penumbra of dose proﬁles from FF
and FFF beams, axis rescalation using the inﬂection point of the FF
and FFF ﬁeld proﬁles is needed to enable their comparison [109], and
only slightly smaller penumbras, with ≈ 1 mm diﬀerences, are ob-
tained for the FFF beam proﬁles.
4. Scatter from the linac head
The ﬂattening ﬁlter is the element in the treatment head that con-
tributes the most to the photon scatter from the linac head, in an
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amount that depends on the material, shape and size of the ﬂatten-
ing ﬁlter. Output ratios in air, usually employed to characterize the
variations in photon ﬂuence with ﬁeld size, are a good parameter to
compare diﬀerences in the scatter produced in the head of FF and
FFF linacs. Taking as an example a Varian Clinac 2100, output ra-
tios of 6 and 18 MV ﬂattened beams increase respectively a 8% and
a 7% when the ﬁeld size varies from 3 cm×3 cm to 40 cm×40 cm,
while these values are lowered to 1% and 3% when the FF is removed
from the linac head, giving a measure of the amount of scatter that
is produced in the ﬂattening ﬁlter [110].
5. Radiation Protection
The removal of the ﬂattening ﬁlter has also certain impact in some
aspects related with radiation protection. On one hand, electron con-
tamination is reduced in FFF beams in an amount that increases with
the energy. This causes and improvement in the accuracy of treat-
ment planning system (TPS) dose calculations in the ﬁrst centimeters
of material, as most of them employ rather simple electron contami-
nation models. Regarding the dose to the surface due to photons, the
softening in the spectrum contributes to enhance it, an eﬀect that is
partially balanced with the lower electron contamination to yield a
total dose to the surface that is higher than that of ﬂattened beams
for small ﬁeld sizes, and equal or slightly lower for large ﬁeld sizes.
Regarding the peripheral, or out of ﬁeld, dose to the patient, the
reduction in photon leakage from the linac head, amounting from
50% to 60% in 10 MV FFF beams from Elekta Precise linacs [111],
will contribute to reduce it. Additionally, removal of the FF also
causes a reduction in photoneutron production1, with neutron ﬂuences
1The production of neutrons through the interaction of photons with the linac head compo-
nents is an undesired eﬀect that contributes to the peripheral dose to the patient. The neutron
production increases with the energy above certain production threshold around 6 MeV and
varies strongly with the vendor depending on the materials employed in the linac head [112].
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being 50% to 60% lower than those produced by ﬂattened beams from
Varian Clinac 2100 linacs at 18 MV and open square ﬁelds from 10
to 30 cm [113].
The high radiobiological eﬀectiveness of neutrons motivated some dis-
cussion about the hazards of high energy IMRT treatments [114], be-
ing several the clinical centers that renounced to deliver IMRT treat-
ments at 18-25 MV modalities with standard linacs. The global reduc-
tion attained in the neutron and photon leakage with the removal of
the ﬂattening ﬁlter implies lower risk of radiation-induced secondary
cancers, a result that is clearly advantageous for IMRT treatments.
Some of the above mentioned diﬀerences between ﬂattened and unﬂattened
beams have some implications that are worth to comment. First of all,
redeﬁnition of some of the parameters usually employed in the quality as-
surance of linacs, like ﬁeld ﬂatness, penumbra and homogeneity is required.
More related with the work addressed in this thesis, the diﬀerences in the
shape of dose distributions and spectra from these beams will have certain
impact on the determination of beam quality correction factors associated
to FFF linacs. On one hand, diﬀerences in the water to air stopping power
ratios amounting to 4% have been reported between ﬂattened and unﬂat-
tened beams of equal beam quality indexes [115]. This implies certain
deviations in the beam quality correction factors of FFF beams with re-
spect to those tabulated in conventional dosimetry codes of practice as a
function of the beam quality descriptor. Additionally, the dose distribution
gradient that is due to the central peaked ﬂuence of unﬂattened beams
aﬀects the suitability of some detectors for beam calibration. The aver-
age volume eﬀect can lead to under-responses in some ionization chambers
under large ﬁeld sizes, an eﬀect that can amount to 1% for Farmer type
chambers [116, 117].
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These two diﬀerences between FF and FFF beams imply that the determi-
nation of FFF beam quality correction factors using the data from conven-
tional dosimetry CoPs will have a larger associated uncertainty, as values
in these tables were derived for ﬂattened beams. Moreover, as commented
in Section 1.2.3.3, if the standard reference conditions proposed by current
dosimetry protocols cannot be established by these machines, the deﬁnition
of new conditions for the measurement of beam quality descriptors and as-
sociated ionization chamber correction factors becomes an imperative task
for the continuation with the quality assurance procedures followed until
now for the determination of absorbed dose to water. This is the case in
TomoTherapy and CyberKnife units, that we will proceed to describe next.
4.1.2 TomoTherapy
The TomoTherapy unit, developed during the 90's by Mackie et al. [10],
consists in a 6 MV compact linear accelerator mounted on a ring gantry
similar to that employed in Computed Tomography (CT), see Figure 4.2. In
this machine, the rotation of the linac around the ring, which has a radius of
85 cm, is combined with the continuous movement of the treatment couch
to perform a helical radiation delivery, while the use of a binary multileaf
collimator enables the modulation of the beam.
The collimation elements in the TomoTherapy linac head include a standard
primary collimator, a jaw, which blocks the beam in the y direction to yield
a fan beam with a length of 40 cm along the x-axis and a maximum width of
5 cm in the y-axis (the direction of couch movement), and a binary multileaf
collimator, see Figure 4.2. The jaw aperture deﬁnes the slice width, a term
used to refer to the maximum ﬁeld size in the y-axis, typically set to 1, 2.5
or 5 cm for treatment delivery (sizes given at the isocenter). Below the jaw,
a 64 leaf collimator is employed to modulate the beam in the x direction,
with leafs disposed in two separate banks traveling in the y direction to
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Figure 4.2: TomoTherapy unit design (left) and beam eye view of the To-
moTherapy binary multileaf collimator (right).
be totally opened or totally closed, Figure 4.2. A pneumatic system is
employed to move the leafs of this binary MLC in very fast transitions of
approximately 20 ms. The modulation of the beam is provided through the
selection of speciﬁc opening times during the arc segments of the rotational
delivery.
Beam modulation and treatment time are controlled through the so called
modulation factor, a parameter deﬁned as the longest leaf opening time
divided by the average opening time of all nonzero leaf opening times [118].
Another parameter used in treatment planning is the pitch, deﬁned as the
ratio of distance traveled by the couch in a complete linac rotation and the
slice width.
TomoTherapy also takes advantage of its CT structure for imaging, and it
has a detection system mounted opposite to the linac, at a distance from the
source of 145 cm, for the acquisition of pretreatment megavoltage computed
tomographies. Computed tomographies are performed under 3.5 MV linac
operation, being employed in addition to the room laser references to ensure
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correct patient positioning in the couch, further corrected if changes in
the patient's anatomy arise between treatment fractions. The tomography
system is also employed for dose reconstruction and the performance of
image guided radiotherapy.
TomoTherapy units operate at about 888 MU/min with no servo control
for the dose rate. There is however an interlock that terminates the beam
if there is more than 5% dose rate variation in the monitor chambers of the
linac head.
Regarding the dosimetric calibration of TomoTherapy, the deﬁnition of the
10 cm×10 cm ﬁeld size required for the establishment of reference condi-
tions in TRS-398 and TG-51 protocols cannot be set due to the collimation
characteristics of the machine. Additionally, the measurement of dose at
source to detector distances larger than 110 cm, needed for the measure-
ment of standard beam quality descriptors TPR20,10 and %dd(10)x, is not
allowed in the machine, as the maximum distance from isocenter to the
lowest position of the couch is 28 cm and there is not enough phantom
material to achieve the required backscatter contribution. Under this sit-
uation, several approximations can be made to determine the values that
standard beam quality descriptors would have on the machines [119, 120],
all increasing to some extent the uncertainty associated to the measurement
of dose in these machines.
4.1.3 CyberKnife
The CyberKnife unit consists on a compact x-band linear accelerator mounted
on an industrial robotic arm, operating together with two orthogonal X-
ray imaging systems to ensure good patient positioning and provide image
guidance during the treatment process. The image guidance is performed
by the Synchrony R© Tracking System, which uses a CCD camera to track
some optical markers (light emitting optical ﬁbers) attached to the patient
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during treatment. The combination of both the optical and X-ray imag-
ing systems enables the robotic manipulator to track the motion of tumors
during irradiation.
Figure 4.3: Diagram of the main components of a CyberKnife unit.
For treatment delivery, the robotic arm directs the linac beam to the region
of the imaging X-ray beams intersection, where the target to treat is placed
by a robotic automated patient couch, see Figure 4.3. All the movements
of the linac head and the treatment coach are controlled by a computer
supervised by the radiation therapist. This radiotherapy delivery scheme,
employing independently targeted (non-isocentric) and non-coplanar treat-
ment beams from diﬀerent directions, is used for both extracraneal and
frameless intracraneal image guided radiosurgery.
The CyberKnife linac operates in 6 MV modality and it has a compact de-
sign with neither bending magnet nor ﬂattening ﬁlter, like TomoTherapy.
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Besides the standard elements (primary collimator and jaws) employed in
the linac head to collimate the photon beam, the secondary collimation is
achieved in this unit through the use of twelve ﬁxed interchangeable con-
ical collimators, which yield circular ﬁelds with diameters from 0.5 to 6
cm (deﬁned at 80 cm source-to-axis distance). Typically, several collima-
tors are used in a treatment to achieve highly conformal dose distributions.
The collimators are changed either manually or automatically if the unit
is equipped with the Xchange R© Robotic Collimator Changer. Other so-
lutions are available for the CyberKnife secondary collimation: the IrisTM
Variable Aperture Collimator can provide the same set of twelve ﬁeld sizes
avoiding the need for collimation swap during treatments, and lately, in
the CyberKnife M6TM series, linacs can be equipped with the InCiseTM
Multileaf Collimator, which uses 41 tungsten leaf pairs to shape the beam,
yielding a maximum ﬁeld size of 10 cm×12 cm at 80 cm SAD. All Cy-
berKnife units equipped with this multileaf collimator could be calibrated
following standard dosimetry protocols, although the absence of FF would
increase the uncertainty as mentioned above. On the other hand, most of
the CyberKnife machines available in clinical institutions can only deliver
a maximum ﬁeld size of 6 cm diameter at 80 cm SAD, with the Iris or with
the largest ﬁxed conical collimator, not fulﬁlling the reference conditions
established in AAPM TG-51 and IAEA TRS-398 and becoming candidates
for the application of the nonstandard ﬁelds dosimetry protocol.
4.2 Correction factors determination
In the next sections, the determination of ionization chamber correction
factors associated to TomoTherapy and CyberKnife is presented. Interme-
diate calibration ﬁelds (machine and plan class speciﬁc reference ﬁelds) are
for that purpose speciﬁcally deﬁned and measured following the proposal of
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the new formalism, presented in Section 1.2.3.3. Additionally, the suitabil-
ity and usefulness of the dosimetric paths introduced by the intermediate
calibration ﬁelds is tested through the study of some clinical treatments.
The measurement of absorbed dose to water required for the determination
of correction factors was performed with alanine dosimetry in collabora-
tion with the National Physical Laboratory (Teddington, Middx, United
Kingdom) under the IAEA Coordinated research Project No. 15647/RO
Correction Factors for Ionization Chamber Dosimetry in Small Field and
Non Standard Conditions Our alanine/ESR dosimetry system was at that
time under development and thus both the supply of dosimeters as well as
their ESR readout was performed by the NPL alanine dosimetry service.
The dosimeters provided by the NPL consist of 90.9% by weight L-α-alanine
and 9.1% high melting point paraﬃn wax. Their average density is 1.23 g
cm3 and they have a nominal diameter of (5.026± 0.013) mm and a nominal
thickness of 2.5 mm, although the real thickness is 2.3 mm on average.
The alanine dosimeters were read out at the NPL following their standard
procedure for radiotherapy level alanine dosimetry, described in detail by
Sharpe et al. [82]. The spectrometer employed at the NPL is exactly
the same model (Bruker ESX with a standard Bruker ST4102 rectangular
cavity) available at the University of Santiago de Compostela (Chapter 3).
Pellets were introduced in the spectrometer using an automated loading
system with a specially constructed sample holder that provides highly
accurate positioning [121]. The spectrometer total acquisition time per
dosimeter was 120 s, consisting of six scans of 20 s with a 90◦ pellet rotation
performed between the third and fourth scan. The average ESR signal
from each pellet is then compared with that of a set of pellets, from the
same batch, irradiated by a 10 cm×10 cm 60Co ﬁeld to an interval of dose
levels arranged by the NPL with traceability to their primary standard
of absorbed dose to water. As commented in Chapter 3 Section 3.1.1, a
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correction factor of 1.006 is applied to obtain absorbed dose in the high-
energy photon beam to account for the diﬀerence in the alanine signal under
linac photon megavoltage beams and 60Co beams. The dose deposition in
both intermediate calibration ﬁelds and clinical treatments was planned to
be higher than 10 Gy, the dose level above which the lowest uncertainty
associated to the NPL alanine dosimetry system, 1.6%, can be achieved.
4.2.1 TomoTherapy
4.2.1.1 Experimental setup
The TomoTherapy unit employed in this work was a TomoTherapy R© Hi-
artII R© machine installed at Hospital Puerta de Hierro, Madrid, Spain. For
the application of the new protocol, the election of a detector being repre-
sentative of the clinical practice in TomoTherapy units is the most practi-
cal approach. The Exradin A1SL ionization chamber (Standard Imaging,
Middleton, WI), supplied by the vendor with the TomoTherapy unit, is the
detector most widely used for the dosimetry of this machine. Measurements
were thus performed with this detector, of 0.053 cm3 active volume, at an
operation voltage of 300 V using a TomoElectrometer (Standard Imaging,
Middleton, WI) for the study of the new protocol.
Two phantoms, both supplied by Accuray, Inc., were used for the measure-
ments:
1. A rectangular phantom made of 15 cm×55 cm Virtual WaterTM slabs
(Med-Cal, Verona, WI), used for the measurement of msr ﬁelds.
2. A Virtual WaterTM cylindrical water phantom (TomoPhantom) with
30 cm diameter and 18 cm length, used for the measurement of the
pcsr and the clinical ﬁelds. This phantom, which is available in all
TomoTherapy facilities, was used instead of the NPL polystyrene
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phantom adopted in previous investigations [122, 123] to ensure re-
producibility and allow the performance of measurements under the
same conditions by other institutions.
For the alanine dosimetry, a virtual water insert was machined to hold
groups of three cylindrical alanine pellets inside the mentioned phantoms.
Figure 4.4: Cylindrical Virtual WaterTM phantom employed for the mea-
surement of the pcsr ﬁeld and clinical treatments in TomoTherapy. Two A1SL
chambers employed for the measurements and for machine monitoring respec-
tively are placed at a distance of 1 cm.
The phantoms, as well as the ionization chambers stem and alanine insert,
were oriented along the y-axis according IECt coordinate system [124], see
Figure 4.2. During the measurement of all the investigated ﬁelds, an addi-
tional A1SL chamber was placed at 1 cm from the alanine or investigated
chamber position to monitor and correct for possible output variations dur-
ing the treatment, see Figure 4.4. For the static ﬁeld measurements, the
linac parallel-plate monitor ion chambers located above the jaws were used
to provide an independent measurement.
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Temperature and pressure were monitored during the measurements in or-
der to apply T-P corrections for the ionization chambers, kTP , and T cor-
rections for the alanine, kT (Section 3.1.1). Chamber leakage was carefully
measured and treatment times were considered in order to subtract such
contribution from the chamber readings.
4.2.1.2 Investigated ﬁelds
Machine Speciﬁc Reference Field
Following previous works [125127] and TG-148 recommendations [118], a
10 cm×5 cm beam size (deﬁned at SAD of 85 cm) was chosen as the To-
moTherapy machine speciﬁc reference ﬁeld. Absorbed dose measurements
were performed on axis at 5 cm depth in the rectangular Virtual Water
phantom previously described. The dose delivered to the chamber/alanine
position was planned to be above 18 Gy.
Plan Class Speciﬁc Reference Field
The plan class speciﬁc reference ﬁeld was chosen, also following TG-148 re-
port recommendations [118], to deliver a uniform dose of 2 Gy to a cylinder
of 8 cm diameter and 10 cm length, oriented along the axis of the Virtual
Water cylindrical phantom. Treatment planning parameters included a
slice width of 5 cm, a pitch of 0.287 and a modulation factor of 1.807.
Measurement positions were located within a volume of homogeneous dose,
being this veriﬁed with the TPS dose distribution. As there is no chamber
insert along the phantom axis, detectors were located slightly oﬀ-axis, at a
distance of 0.5 cm in the x direction from the phantom geometric center,
see Figure 4.5. For the irradiation of the alanine pellets, the treatment was
repeated eight times to deliver a total dose of 16 Gy to the detectors and
decrease the dose uncertainty.
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Figure 4.5: Dose distribution for the plan class speciﬁc reference ﬁeld (iso-
doses given in Gy). The positions of the investigated chamber/alanine and the
monitor chamber are shown in the left panel.
Clinical Treatments
Two clinical plans were studied in order to investigate the applicability of
the intermediate calibration ﬁelds to the relative clinical dosimetry:
• A hypofractionated lung treatment using a 2.5 cm slice width, planned
with 1.322 modulation factor and 0.100 pitch to deliver 18 Gy per
fraction.
• A head-and-neck treatment, also involving a 2.5 cm slice width, de-
livering 2 Gy per fraction with 2.167 modulation factor and 0.287
pitch.
It should be noticed that some of these planning parameters are diﬀerent
from those used in the pcsr.
The dose to the planned target volume (PTV), calculated in the cylindrical
phantom by the TPS, was determined to be 16 Gy and 1.6 Gy for the
lung and head-and-neck treatments respectively. For the irradiation of the
alanine pellets, the head-and-neck treatment was repeated seven times in
order to enhance the dose up to 11.2 Gy and improve dose uncertainty.
In all cases, investigated dosimeters and monitor ionization chambers were
placed at homogeneous PTV dose regions, as shown in Figure 4.6.
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Figure 4.6: Dose distributions for lung (top panels) and head-and-neck (bot-
tom panels) in the patient (left panels) and the cylindrical phantom (right
panels). Isodoses are given in Gy, and the positioning of the ionization cham-
ber/alanine and the monitor chamber in the cylindrical phantom is shown with
open circles.
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4.2.1.3 Reference beam quality correction factor
Although measurements with the A1SL ionization chamber and alanine
dosimeters in intermediate calibration ﬁelds and 60Co would suﬃce to de-
rive global correction factors kfmsr,frefQmsr,Q0 , k
fpcsr,fref
Qpcsr,Q0
and kfclin,frefQclin,Q0 , the formalism
proposed by Alfonso et al. [30] was conceived to appear as an extension
of previous formalisms. In this context, values of kfmsr,frefQmsr,Q , k
fpcsr,fref
Qpcsr,Q
and
kfclin,frefQclin,Q should be provided, appearing multiplied by the standard correc-
tion factor kQ,Q0 and the calibration coeﬃcient ND,w,Q0 for the determina-
tion of absorbed dose, as presented in Equation 1.11.
Since standard beam quality descriptors TPR20,10 and %dd(10)x cannot
be directly measured in TomoTherapy machines, other strategies must be
followed for the determination of kQ,Q0 . Several works have been published
reporting both Monte Carlo calculated beam quality descriptors and cor-
rection factors through simulation of TomoTherapy units with modiﬁed
geometries that reproduce reference conditions [125, 126]. Thomas et al.
obtained an expression to compute standard %dd(10) values from the per-
cent depth dose at 10 cm depth in TomoTherapy conditions, %dd(10)HT,
deﬁned as a 5 cm×10 cm ﬁeld-size and 85 cm SSD. A third-order poly-
nomial was then used to ﬁt these two magnitudes for %dd(10)HT values
ranging from 58.8% to 60.8%. However, the TomoTherapy unit at Puerta
de Hierro Hospital presents a softer beam quality, %dd(10)HT=58.5%, and
so the expression derived by Thomas et al. has to be used with caution
because our %dd(10)HT value lies oﬀ range. A direct application of such
polynomial leads to %dd(10)=57.6% for this TomoTherapy unit, with a
corresponding kQ,Q0 value of 0.9994 obtained by extrapolation of TG51
data of the A1SL ionization chamber.
Alternatively, in a previous work performed at Puerta de Hierro TomoTher-
apy unit [119], a methodology that draws some analogies with the work
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Estimation of standard beam quality correction factor
Method Thomas et al. Rodriguez-Romero et al. Palmans
Beam Quality %dd(10)=57.6% TPR20,10=0.629 TPR20,10=0.631
kQ,Q0 0.9994 0.9994 0.9993
Table 4.1: Summary of the results obtained through the diﬀerent approaches
followed for the estimation of the A1SL standard beam quality correction factor
kQ,Q0 in the TomoTherapy unit under study.
of Sauer [128] was developed for the determination of kQ,Q0 . Rodríguez-
Romero and Sánchez-Rubio demonstrated that TomoTherapy-to-LINAC
TPR20,10 ratios remain constant for equivalent square ﬁeld sizes ranging
from 5 cm to 8.9 cm. From this, an extrapolation to a 10 cm×10 cm
ﬁeld in the TomoTherapy unit yielded a TPR20,10 value of 0.629, with a
corresponding kQ,Q0 value of 0.9994 obtained from the TRS-398 CoP.
More recently, following the work of Sauer, Palmans presented a reformu-
lated expression for the calculation of standard beam quality descriptors,
TPR20,10 and %dd(10), from the values that these magnitudes yield under
square ﬁelds of a diﬀerent size, s, TPR20,10(s) and %dd(s) [120]. Palmans
proposed that the uncertainty associated to the standard beam quality de-
scriptors determined through the method of Sauer could be reduced if the
range of energies and ﬁeld sizes chosen to ﬁt the BJR25 experimental data
[129] were restricted to (4-12) MV and (4-12) cm. When the method of
Palmans is applied to our TomoTherapy unit, with a TPR20,10(6.7)2 of
0.611, the standard TPR20,10 yields a value of 0.631, leading to a 0.9993
kQ,Q0 value from the TRS-398. Although the TPR20,10(6.7) was measured
at a SCD of 85 cm instead of the 100 cm recommended, this beam quality
descriptor has been demonstrated to be insensitive to the SCD.
2Using the empirical relation s = 2ab/(a + b), employed by the ICRU for the calculation
of equivalent square ﬁelds from rectangular ﬁelds of a cm×b cm [130], a ﬁeld of 10 cm×5 cm
would be equivalent to a square ﬁeld size of 6.7 cm.
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The kQ,Q0 values estimated by these three methods exhibit a very close
agreement, and its mean value will be considered for the determination of
kfmsr,frefQmsr,Q , k
fpcsr,fref
Qpcsr,Q
and kfclin,frefQclin,Q nonstandard ﬁelds correction factors.
4.2.1.4 Uncertainty budget and corrections
The relative uncertainties associated with the measurement of A1SL ioniza-
tion chambers and alanine dosimeters in the TomoTherapy measurements
campaign are summarized in Table 4.2 with coverage factor k=2, and the
details about their evaluation are described next.
Regarding ionization chamber measurements, type B uncertainties are dom-
inated by the calibration coeﬃcient uncertainty, which amounts to a 0.8%.
Atmospheric pressure and temperature conditions were monitored for the
application of the corresponding correction factor accounting for air density
changes. A 0.2% uncertainty associated to this correction has been consid-
ered. The saturation eﬀect was found to be less than 0.3% for a 40 cm×5
cm static ﬁeld using the two-voltage method (ks=1.0029). However, recent
studies suggest that this value might be lower, and that recombination un-
der helical delivery is signiﬁcantly reduced when the slice width decreases
[131]. We decided to neglect this correction, although a 0.2% associated
uncertainty was conservatively included in the analysis. The polarization
Uncertainty source Uncertainty type A1SL(%) Alanine (%)
Calibration coeﬀ B 0.8 1.7
Ambient conditions B 0.2 0.1
Positioning B 0.2 or 0.4 0.2 or 0.4
Repeatibility A 0.1 to 0.7 0.6 to 0.8
Total uncertainty A & B 0.87 to 1.0 1.7 to 1.8
Table 4.2: Relative uncertainty contributions to ionization chamber and ala-
nine measurements with coverage factor k=2. Positioning uncertainty is 0.2%
in fmsr and 0.4% in helical deliveries.
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eﬀect was found to be lower than 0.04% (kpol=0.9996) and was neglected.
Chamber leakage current was measured to amount to 0.09 pA, leading to a
systematic eﬀect that ranged from less than 0.05% for the msr ﬁeld to up
to 1.4% for the head-and-neck treatment and was corrected for. No uncer-
tainty was assigned to this correction because the leakage current was found
to be very stable. On the other hand, type A uncertainties accounting for
chamber and machine repeatability were estimated by repeating each mea-
surement three times. Values ranging from 0.1% to 0.7% were obtained for
the diﬀerent intermediate calibration ﬁelds and clinical treatments.
The NPL alanine/ESR dosimetry methodology has an expanded relative
uncertainty associated with the calibration of the alanine dosimeters in
60Co of 1.6% at doses above 10 Gy. Type A uncertainties associated with
the variation between individual alanine pellets are estimated by statistical
methods at the NPL to be 0.1 Gy or 0.6%, whichever is larger. An indepen-
dent estimation of alanine type A uncertainty was obtained by performing
three measurements, of three pellets each, for every ﬁeld/treatment, and
consistent results were found. Finally, the correction for the alanine tem-
perature dependence was considered to contribute with a 0.1% uncertainty.
An additional uncertainty associated to both chamber and alanine mea-
surements was assigned to account for possible relative mispositionings of
the chamber and the alanine dosimeters, which was determined to be 0.2%
in the static msr ﬁeld and 0.4% in helical deliveries.
4.2.1.5 Dose values and correction factors.
Absorbed dose values measured by the ionization chamber and the alanine
dosimeters are shown in Table 4.3 for the ﬁelds under investigation, where
it can be seen that the dose values measured with the A1SL chamber are
systematically higher than those measured with alanine. This result leads
to overall correction factors lower than unity, as can be seen in Table 4.4
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Field A1SL [MQ ·ND,w,Q0 ](Gy) Alanine Dose (Gy)
fmsr 19.90 ± 0.17 19.54 ± 0.34
fpcsr 2.023 ± 0.021 1.981 ± 0.035
Lung clin treatment 15.98 ± 0.15 15.67 ± 0.028
H&N clin treatment 1.647 ± 0.015 1.620 ± 0.030
Table 4.3: Exradin A1SL ionization chamber dose measurements, alanine
dose measurements and global correction factors. Associated uncertainties are
expressed with a coverage factor k=2.
and Figure 4.7, with kfmsr,frefQmsr,Q0 =0.982, k
fpcsr,fref
Qpcsr,Q0
=0.979 and kfclin,frefQclin,Q0 =0.980,
0.984 for the lung and the head-and-neck treatments respectively. Although
each single factor is compatible with unity within uncertainties (around 2%
at k=2, with uncertainties dominated by the chamber and alanine calibra-
tion factor uncertainty), this behavior seems to be signiﬁcant when con-
sidered altogether, p = 0.02 for a hypothesis test performed assuming a
t-student distribution.
Calibration ﬁeld kfmsr,frefQmsr,Q0 k
fmsr,fref
Qmsr,Q
fmsr 0.982(19) 0.982(19)
Calibration ﬁeld k
fpcsr,fref
Qpcsr,Q0
k
fpcsr,fref
Qpcsr,Q
k
fpcsr,fmsr
Qpcsr,Qmsr
fpcsr 0.979(20) 0.980(20) 0.997(10)
Clinical treatment kfclin,frefQclin,Q0 k
fclin,fref
Qclin,Q
kfclin,fmsrQclin,Qmsr k
fclin,fpcsr
Qclin,Qpcsr
Lung 0.980(20) 0.981(20) 0.9981(93) 1.001(11)
H&N 0.984(20) 0.984(20) 1.0017(98) 1.004(12)
Table 4.4: Measured correction factors for intermediate calibration ﬁelds fmsr,
fpcsr and clinical treatments. Associated uncertainties aﬀecting last decimals
are shown in brackets with two signiﬁcant digits and coverage factor k=2.
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Regarding the dosimetric diﬀerences between the studied intermediate cal-
ibration ﬁelds, the kfpcsr,fmsrQpcsr,Qmsr correction factor was found to be very close
to unity (with a value of 0.997 and 1% uncertainty), suggesting that the
dynamic delivery does not introduce important changes in the determina-
tion of absolute dose with the A1SL chamber. We can observe that the
main contribution to global correction factors comes from the intermedi-
ate calibration ﬁelds and it seems to be independent of the route followed
(fmsr or fpcsr) for the determination absorbed dose to water (k
fmsr,fref
Qmsr,Q
=
0.982±0.019 or kfpcsr,frefQpcsr,Q = 0.980±0.020).
On the other hand, kfclin,fpcsrQclin,Qpcsr and k
fclin,fmsr
Qclin,Qmsr
correction factors, which ac-
count for the diﬀerences between intermediate calibration ﬁelds and the
investigated clinical treatments, also yielded values compatible with unity,
ranging from 0.9981 to 1.004 with relative uncertainty values around 1%
(k=2). In these clinical treatments, ﬁeld factors for relative clinical dosime-
try, Equation 1.15, could therefore be easily computed from chamber read-
ings ratios, using either the msr or the pcsr :
Ω
fclin,fmsr(pcsr)
Qclin,Qmsr(pcsr)
' M
fclin
Qclin
M
fmsr(pcsr)
Qmsr(pcsr)
(4.1)
This should be considered with caution though, as only two clinical treat-
ments have been studied here and other publications present treatments
that behave diﬀerently.
4.2.1.6 Review
Once that the results yielded by our study [132] have been analyzed, com-
parison with those from other works dealing with the application of the new
dosimetric formalism to TomoTherapy will help us to draw more realistic
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conclusions about the role that the intermediate calibration ﬁelds can play
for TomoTherapy.
Figure 4.8: Summary of A1SL beam quality correction factors kfmsr,frefQmsr,Q0 (a),
and k
fpcsr,fref
Qpcsr,Q0
(b), published to this date versus the TPR20,10 value yielded by
every TomoTherapy unit under nonstandard conditions (10 cm×5 cm ﬁeld and
85 cm SAD). Squares are included in subplot (b) showing the kfmsr,frefQmsr,Q0 factors
measured by every author for comparison.
Figure 4.8 collects the results of the published (updated by Spring of 2013)
global correction factors, kfi,frefQi,Q0 , associated to TomoTherapy msr and pcsr
ﬁelds as a function of the beam quality of the units where the diﬀerent works
were performed, uncertainties given with a coverage factor k=2. The beam
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quality descriptor chosen for the comparison is the TPR20,10(6.7) mentioned
in Section 4.2.1.3, which can be directly measured in the machine.
If we focus on the calibration through static intermediate ﬁelds, Figure 4.8
(a), all the works deﬁned as fmsr a 10 cm×5 cm ﬁeld, although measurement
conditions slightly varied from work to work: Sterpin et al. [133], SSD= 85
cm and SCD= 95 cm; De Ost et al. [134], SSD= 75 cm and SCD= 85 cm;
Zeverino et al. [135], SSD= 85 cm and SCD= 95 cm; Bailat et al. [127],
SSD= 80 cm and SCD= 85 cm and Jeraj et al. [126], SSD= 85 cm and
SCD= 95 cm. The resulting kfmsr,frefQmsr,Q0 A1SL correction factors do not follow
a clear trend with the TPR20,10(6.7), which may be to some extent related
with the diﬀerent measurement conditions. The correction factors relative
uncertainties, around 2% for all the experimental measurements (smaller
uncertainties were obtained in full Monte Carlo simulations), make all the
values to be compatible among them, making impossible the establishment
of any trend. Chung et al. also published a study about TomoTherapy
k
fmsr,fref
Qmsr,Q0
correction factors [136], which has not been included here as cor-
rection factors were determined in this study through the measurement of
the conventional reference ﬁeld (10 cm×10 cm) in a standard linac and no
information is given about the beam quality of this unit or that of the Tho-
motherapy unit. Correction factor values presented in the work of Chung
et al. are also compatible with those included in this review. Regarding the
plan class speciﬁc calibration ﬁelds, diﬀerent helical deliveries were chosen
as fpcsr candidates in the diﬀerent works. Again, some work has been also
performed by Chung et al on this matter [137], also involving the mea-
surement of the conventional reference ﬁeld in a standard linac but giving
no information about the linacs beam quality. Chung planned a cylindri-
cal pcsr ﬁeld with some avoidance structures deﬁned within the cylindrical
phantom and diﬀerent pcsr ﬁelds were planned exhibiting diﬀerent levels of
dose homogeneity within the pcsr PTV. kfmsr,frefQmsr,Q values ranging between
0.980 and 1.002 were obtained for the A1SL chamber in this study. Bailat et
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al. [127] deﬁned the fpcsr as a cylindrical dose distribution with 8 cm diam-
eter and 10 cm length (same size of ours), delivered to the TomoPhantom.
The dependence of kfmsr,frefQmsr,Q0 correction factors with the slice width (2.5 and
5 cm slice widths were employed for pcsr1 and pcsr2 ), as well as the eﬀect
of delivering the dose distribution 13 cm oﬀ axis (pcsr3 ) were investigated
in this study. Equivalent kfpcsr,frefQpcsr,Q0 correction factors were obtained for
pcsr1 and pcsr2 (0.987 and 0.988 values respectively), while pcsr3 yielded
a correction factor closer to unity, 0.995. Finally, the work of De Ost et
al. [134] included three pcsr plans being delivered to a cylindrical water
phantom with 20 cm diameter and 30 cm length. The pcsr1 was deﬁned
as a rotational delivery of the 10 cm×5 cm msr ﬁeld, while for pcsr2 and
pcsr3 cylindrical dose distributions were planned, with 8 cm diameter, 10
cm length and 2.5 cm slice width in pcsr2 and 10 cm diameter, 5 cm length
and 2.5 cm slice width in pcsr3. Correction factors associated to these three
pcsr ﬁelds exhibited very similar values. Figure 4.8 (b) shows that all cor-
rection factors associated to these pcsr ﬁelds are again compatible among
them within uncertainty.
This compatibility can be also found when all the correction factors, asso-
ciated to both msr and pcsr ﬁelds, are compared, which indicates a small
dosimetric diﬀerence between them. Moreover, the pcsr ﬁelds studied by
every author led to correction factors lying very close (much closer than
the 2% tolerance due to uncertainty) to the values obtained by that same
author for the msr ﬁelds, as shown Figure 4.8 (b), further supporting the
equivalence of msr and pcsr ﬁelds for TomoTherapy. In spite of the need for
more measurements in clinical treatments, these results would pose some
doubts about the necessity of deﬁning a composite intermediate calibra-
tion ﬁeld for TomoTherapy, as the msr ﬁelds yield a dosimetry route that
is equivalent to that obtained with the pcsr ﬁelds, only much more simple.
On the other hand, the systematic 2% overestimation of dose in A1SL
measurements at TomoTherapy was also observed by Bailat et al. [127]
Chapter 4. Ionization Chamber Correction Factors in Nonstandard Fields 187
and Duane et al. [138], although no numerical values are available for
this work. Other studies reported A1SL measurements closer to absorbed
dose to water, leading to corrections factors closer to unity, either through
the experimental approach based on radiochromic ﬁlm by Zeverino et al.
[135], or through Monte Carlo simulation, Sterpin et al. [133] and Jeraj
et al. [126]. Trying to ﬁnd an explanation for a systematic departure
from unity of nonstandard beam quality correction factors, Bouchard et
al. [139] suggested that by taking into account that CPE re-establishment
should be achieved in a time-averaged sense for plan class speciﬁc reference
ﬁelds, both kfpcsr,frefQpcsr,Q and k
fpcsr,fmsr
Qpcsr,Qmsr
correction factors could be reduced to
the inverse of the gradient perturbation eﬀect in the ionization chamber
[139]. This would lead to correction factors higher than one, contrary to
the 0.980 and 0.997 values obtained in this study. Our values are however in
agreement with other previous measurements, Figure 4.8, and a theoretical
study on CPE violation in composite ﬁelds lately presented by Bouchard
et al. [29] demonstrated that the conditions for CPE re-establishment in a
time-averaged sense are not met and the expression of the correction factor
given in [139] is not applicable.
4.2.2 CyberKnife
Regarding CyberKnife machine study, the work addressed in this case in-
cluded an experimental and a Monte Carlo determination of correction
factors associated to the ﬁelds proposed by the new formalism and two clin-
ical treatments. Two ionization chambers were chosen for the study, and
the measurement of absorbed dose to water was again performed through
alanine dosimetry. The experimental work will be ﬁrst here presented,
proceeding next to describe the Monte Carlo simulation and compare the
results obtained.
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4.2.2.1 Experimental setup
The CyberKnife unit employed in this work for the application of the new
dosimetry protocol is a CyberKnife R© G4 R© machine installed at Hospital
Ruber International in Madrid, Spain. Regarding the choice of appropriate
detectors for this study, the AAPM report TG-106 on accelerator beam
data commissioning, equipment and procedures recommends the use of
microchambers for the measurement of small ﬁelds in radiosurgery because
of the volume averaging eﬀects that can arise in detectors with large active
volumes [140]. According to this, the ionization chambers chosen for the
determination of correction factors in the CyberKnife machine were the
PTW31014 (PTW-Freiburg, Germany) and Scanditronix-Wellhofer CC13
(IBA Dosimetry GmbH, Schwarzenbruck, Germany), with active volumes
of 0.015 cm3 and 0.13 cm3 respectively, being these detectors used in many
radiotherapy departments for the dosimetry of small ﬁelds.
On the other hand, the alanine dosimeters employed for the determination
of absorbed dose to water were again provided and read out by the NPL as
described in section 4.2.1.1. Perspex and Solid Water inserts were machined
to hold groups of three cylindrical alanine pellets in the diﬀerent ﬁelds and
phantoms.
Ionization chambers were operated at a voltage of +400 V with a PTW
T10009 UNIDOS E electrometer (PTW-Freiburg, Germany). Room tem-
perature and pressure were monitored during the measurements in order
to apply T -P corrections to the ionization chambers readings and T cor-
rections to the alanine readings. The chamber leakage current was again
carefully measured and subtracted from the chamber measurements. Po-
larity and saturation correction factors were also measured according to the
recommendations of IAEA TRS-398.
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Figure 4.9: Changes registered in the CyberKnife machine output due to
heating eﬀects in the linac head and open (vented) monitor chambers, mea-
surements performed with PTW31014 chambers in steps of 300 MU.
Regarding the stability of the linac, the CyberKnife G4 unit is equipped
with vented monitor ionization chambers. This implies that changes in
the temperature of the monitor chambers due to the machine warm-up
and changes in pressure in the treatment room can induce machine output
variations. This type of unit has to go through a warm-up of approxi-
mately 6000 MU to achieve a stable temperature and output before clinical
use [141]. Our unit was given such warm-up before every set of measure-
ments, however small output variations still arise due to pressure changes
and residual machine warm-up, see Figure 4.9. Such small changes may
lack clinical signiﬁcance, but they can aﬀect the determination of chamber
correction factors.
In order to minimize this, a multiplicative factor, p/p0, was used to correct
the machine output, where p is the measured pressure and p0 is the reference
pressure at which the unit was calibrated. Temperature variations in the
head of the CyberKnife unit were monitored with a PT100 probe inserted
between the primary and secondary collimators (oﬀ-ﬁeld to avoid ﬂuence
perturbations). Correlations between the machine output, registered with
an external ionization chamber placed at 5 cm depth in a water phantom,
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and the gantry temperature were measured to have a positive slope of a
0.5% per degree after the warm-up irradiation. This output correction
factor was applied to all the measurements with a successful reduction of
the relative standard deviation in the measurements of absorbed dose with
both ionization chambers and alanine dosimeters within every investigated
ﬁeld.
Figure 4.10: a) Spherical Solid Water Leksell R© Gamma Knife Dosimetry
Phantom employed for the measurement of the pcsr ﬁelds and one of the clinical
treatments and b) Anthropomorphic CIRS IMRT Thorax Phantom employed
for the measurement of one clinical treatment, the ionization chamber was
placed inside the upper insert of the left lung.
Three phantoms were used depending on the ﬁeld to be studied:
1. The 3D Blue Phantom water tank (Wellhofer, IBA Dosimetry GmbH,
Schwarzenbruck, Germany) of 67.5 cm×64.5 cm×56 cm, used for the
measurement of the msr ﬁeld in water.
2. The 8 cm radius spherical Solid Water Leksell R© Gamma Knife Dosime-
try Phantom [142] (Elekta AB, Stockholm, Sweden), used for mea-
surements in the pcsr ﬁelds and one of the clinical ﬁelds.
3. The anthropomorphic CIRS IMRT Thorax Phantom Model 002LFC
(CIRS Norfolk, VA, USA), used for measurements in the other clinical
ﬁeld.
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DICOM orientation standards [143] were adopted here for the speciﬁcation
of the coordinate system by considering head-ﬁrst supine (HFS) patient
position and [100, 010] image orientation; i.e. when the patient is positioned
HFS on the couch, +x points to the patient's left side, +z points to towards
the patient's head, and +y points to the patient's posterior side, see Figure
4.3. The orientation of the detectors depended on the phantom used. In
the spherical phantom the detector stem as well as the alanine insert were
on the sagittal plane, oriented at an angle of 44◦ with the z axis. The
detectors reference point was placed at the phantom center; speciﬁc inserts
had to be manufactured for this purpose as this phantom does not support
PTW31014 nor CC13 detectors. The anthropomorphic phantom was placed
head-ﬁrst supine on the couch, with the detectors placed along the z axis
with their reference points at 10 cm from the bottom of the phantom.
4.2.2.2 Investigated Fields.
Machine speciﬁc reference ﬁeld.
Considering that achievement of lateral charged particle equilibrium is a
desired condition for the measurement of msr ﬁelds, the widest collimator
available for the CyberKnife machine, deﬁning a 6 cm diameter circular ﬁeld
at 80 cm SAD, was chosen as machine speciﬁc reference ﬁeld for this unit.
A dose of approximately 14.5 Gy was delivered to the alanine/chamber
position at a SSD of 75 cm and a SCD of 80 cm in a water phantom,
following the setup of previous publications for the sake of comparison
[144, 145].
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Figure 4.11: Plan class speciﬁc reference ﬁeld scheme: beam incidences on
the spherical phantom, top left panel, and transversal, sagittal and coronal
isodoses map on the ionization chamber/alanine plane (top right, bottom left
and bottom right panels respectively) for the pcsr2 ﬁeld.
Plan class speciﬁc reference ﬁelds.
Regarding composite ﬁeld dosimetry, two plan-class-speciﬁc reference ﬁelds
were proposed, both of them delivering a spherical dose distribution to the
spherical Solid Water Leksell R© Gamma Knife Dosimetry Phantom (Elekta
AB, Stockholm, Sweden).
• In pcsr1, the 1.5 cm diameter collimator was employed to deliver a
homogeneous dose to a 32 mm diameter sphere centered in the phan-
tom. The treatment involved 174 ﬁelds and a total delivery time of
42 minutes.
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• For pcsr2 (Figure 4.11), the 1.25 and 2 cm diameter collimators were
chosen to deliver a spherical dose distribution with 48 mm diameter,
also centered in the phantom. The plan involved 140 ﬁelds from the
1.25 cm collimator and 80 ﬁelds from the 2 cm collimator in a total
delivery time of 61 minutes.
These pcsr ﬁelds match the set of collimators and PTV sizes of the in-
vestigated clinical treatments (see following section) but with a simpler
geometry, which allows us to explore a possible dependence of correction
factors on the set of collimators used in pcsr ﬁelds. Both treatments were
planned to deliver a dose of 11.3 Gy by CyberKnife Multiplan R© TPS.
Clinical treatments
The usefulness of intermediate calibration ﬁelds for the relative clinical
dosimetry of CyberKnife was investigated for two representative clinical
treatments, chosen among real treatments employed at the clinical institu-
tion.
• Firstly, a clinical brain treatment of 192 ﬁelds involving the use of
the 1.5 cm collimator was chosen. The dose delivered to the spherical
Solid Water phantom at the detectors reference point was 12.1 Gy,
calculated by the TPS, being the dosimeters placed to have their
reference point at the phantom center.
• Secondly, a lung clinical treatment of 250 ﬁelds was studied. For this
treatment, the CIRS anthropomorphic phantom was irradiated using
the 1.25 cm collimator in 141 ﬁelds and the 2 cm collimator in 109
ﬁelds. The detectors were placed in a rod insert available to perform
measurements in the right lung of the phantom, receiving a dose of
approximately 12 Gy, Figure 4.12.
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Figure 4.12: Scheme of the lung clinical treatment: Beam incidences on the
anthropomorphic phantom, top left panel, and transversal, sagittal and coronal
isodoses map on the ionization chamber/alanine plane (top right, bottom left
and bottom right panels respectively).
4.2.2.3 Reference beam quality correction factor
The estimation of the values that standard kQ,Q0 correction factors associ-
ated to the two studied ionization chambers would have if reference con-
ditions could be achieved in our CyberKnife unit was performed by three
diﬀerent methods:
Chapter 4. Ionization Chamber Correction Factors in Nonstandard Fields 195
• On one hand, a measurement of the %dd(10) at 100 cm SSD was
performed using the largest collimator available3, yielding a value of
64.5% at 80 cm SCD. From this value, tables in Supplement 25 of
the British Journal of Radiology [129] can be used to calculate the
%dd(10) for the 10 cm×10 cm2 standard ﬁeld size, yielding a value of
66.6%. PTW31014 and CC13 chambers are however not considered in
TG-51 dosimetry protocol and TRS-398 has to be consulted instead.
Using the expression included in TRS-398 to derive TPR20,10 values
from %dd(10), we can obtain the TPR20,10 for this CyberKnife unit,
which is 0.665, leading to correction factors of 0.994 and 0.996 for
PTW31014 and Scanditronix-Wellhofer CC13 respectively, calculated
through interpolation from the values tabulated in TRS-398 for these
chambers.
• If the expression of Palmans [120] is employed to calculate the %dd(10)
for the 10 cm×10 cm ﬁeld, a value of 67.1% is obtained, leading to a
TPR20,10 value of 0.669 using the expression from TRS-398, and 0.993
and 0.996 correction factors for the PTW31014 and Scanditronix-
Wellhofer CC13 respectively.
• Finally, a direct measurement of the TPR20,10 at SCD 80 cm with the
6 cm collimator ﬁeld yielded a value of TPR20,10(5.4) equal to 0.637,
which can be again converted to a value of TPR20,10(10) of 0.663 using
the expression of Palmans. This value of beam quality descriptor leads
to correction factors amounting to 0.994 and 0.996 for the PTW31014
and Scanditronix-Wellhofer CC13.
We can see in Table 4.5 that the diﬀerent procedures followed for the esti-
mation of correction factors consistently lead to very similar values, 0.994
3Following the formula of Sauer for the calculation of equivalent square ﬁeld for circular
ﬁelds, s=0.9×2×r [128], the 6 cm diameter circular ﬁeld deﬁned at 80 cm would be equivalent
to a square ﬁeld size of 5.4 cm at 80 cm SAD, or 6.75 cm at 100 cm SAD.
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Estimation of standard beam quality correction factor
Method BJR Supp. 25 Palmans Palmans
Beam Quality %dd(10)=66.6% %dd(10)=67.01% TPR20,10=0.663
Chamber PTW31014/CC13 PTW31014/CC13 PTW31014/CC13
kQ,Q0 0.994 / 0.996 0.993 / 0.996 0.994 / 0.996
Table 4.5: Summary of the results obtained through the diﬀerent approaches
followed for the estimation of the PTW31014 and CC13 standard beam quality
correction factor kQ,Q0 in the CyberKnife unit under study.
and 0.996 mean values will be taken for the calculation of intermediate cor-
rection factors for PTW31014 and Scanditronix-Wellhofer CC13 ionization
chambers respectively.
4.2.2.4 Uncertainty budget and corrections
The relative uncertainties associated to the measurement with CC13 and
PTW 31014 ionization chambers and alanine dosimeters in the CyberKnife
unit are summarized in Table 4.6. Details about their evaluation will be
described next.
Uncertainty source Unc. type CC13(%) PTW31014(%) Alanine (%)
Calibration coeﬀ B 0.8 1.4 1.7
Ambient conditions B 0.2 0.2 0.1
Positioning B 0.08 to 0.36 0.06 to 0.54 0.09 or 0.50
Machine Output B 0.2 0.2 0.2
Repeatability A 0.12 to 0.39 0.03 to 1.1 0.4 to 0.6
Total uncertainty A & B 0.86 to 0.94 1.4 to 1.9 1.7 to 1.8
Table 4.6: Relative uncertainty contributions to ionization chamber and ala-
nine measurements with coverage factor k=2.
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Regarding the ionization chamber measurements, uncertainties are again
dominated by the uncertainty of calibration coeﬃcients, 0.8% and 1.4% for
Scanditronix-Wellhofer CC13 and PTW31014 detectors respectively, deter-
mined in the Radiation Physics Laboratory at the Universidade de Santiago
de Compostela.
Atmospheric pressure and temperature conditions were monitored and the
correction factor accounting for air density changes was applied. The un-
certainty associated to this correction has been considered to amount to a
0.2%. The polarization eﬀect was found to be negligible for Scanditronix-
Wellhofer CC13 and ' 0.5% for PTW31014 in a 10 cm×10 cm ﬁeld of a
linac, although variations of approximately 0.5% are observed for smaller
ﬁeld sizes [146]. In composite ﬁelds, ionization chambers are irradiated
under diﬀerent conditions (in and oﬀ-ﬁeld) and with smaller ﬁeld sizes,
which can involve changes in the polarity eﬀect that cannot be properly
corrected for. However, the overall eﬀect is expected to be negligible and
was therefore ignored.
Measurements of the saturation eﬀect ks were performed (the eﬀect of
charge multiplication, which can be important for the operation voltages
here used [147], was included in the analysis), yielding values of unity within
estimated uncertainties for both ionization chambers in the 60 mm collima-
tor machine speciﬁc reference ﬁeld measurements. Taking into account the
lower dose rates associated with smaller ﬁeld sizes and oﬀ-axis positioning,
saturation corrections were considered to be also negligible for each of the
investigated ﬁelds. The chamber leakage current was measured to be 5 fA
for Scanditronix-Wellhofer CC13 and 15 fA for PTW31014. This contri-
bution would lead to a systematic eﬀect ranging from 0.002% to 0.04% for
the measurements with the CC13 and from 0.04% to 1.2% for PTW31014
for the diﬀerent ﬁelds under study. The leakage current was found to be
very stable and was substracted oﬀ-line to the ionization chamber readings,
with an associated uncertainty below 0.02% that was therefore neglected.
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Type A uncertainties were estimated by repeating each measurement three
times. Values ranging from 0.05% to 0.2% for Scanditronix-Wellhofer CC13
and from 0.01% to 0.6% for PTW31014 were obtained for the diﬀerent
calibration ﬁelds and clinical treatments.
The uncertainies associated to the NPL alanine/ESR dosimetry methodol-
ogy are the same than those presented in Section 4.2.1.4. The independent
estimation of alanine type A uncertainties was again obtained by perform-
ing three measurements, of three pellets each, for every ﬁeld/treatment.
Finally, the uncertainty associated to alanine dosimeters and ionization
chamber positioning has to be included. For the static msr ﬁeld, this un-
certainty was estimated to be ' 0.2% for lateral detector displacements
of 0.1 mm. For composite ﬁelds, the eﬀect of small dosimeter spatial mis-
positionings on the detector readings was evaluated from the TPS dose
distributions and the geometry of the detectors. Dose deposition in the
detectors was calculated for detector mispositionings following a σ = 0.1
mm Gaussian distribution, which corresponds to the positioning accuracy
of the CyberKnife X-ray imaging system. Relative standard deviations in
the average dose to the detectors ranging from 0.08% to 0.36%, from 0.06%
to 0.54% and from 0.08% to 0.5% were obtained for Scanditronix-Wellhofer
CC13, PTW31014 and the set of three alanine pellets respectively. These
values were assumed as positioning uncertainties for the composite ﬁelds.
4.2.2.5 Dose values and correction factors.
Dose values measured with ionization chambers and alanine dosimeters are
shown in Table 4.7. No systematic trends are observed between any of the
detectors and the alanine dosimeter measurements and thus corrections
factors are below or above unity depending on the studied ﬁeld. How-
ever, larger discrepancies with respect to alanine are encountered in the
PTW31014 measurements, probably due to the diﬀerent volume averaging
Chapter 4. Ionization Chamber Correction Factors in Nonstandard Fields 199
Field CC13 PTW31014 Alanine Dose
fmsr 14.51 ± 0.13 14.73 ± 0.21 14.43 ± 0.25
fpcsr1 11.64 ± 0.11 11.74 ± 0.19 11.83 ± 0.21
fpcsr2 11.82 ± 0.11 11.77 ± 0.22 11.90 ± 0.21
Lung clin treatment 13.21 ± 0.12 13.00 ± 0.24 13.21 ± 0.24
Brain clin treatment 11.92 ± 0.11 12.01 ± 0.20 11.86 ± 0.21
Table 4.7: Ionization chamber [MQ ·ND,w,Q0 ], and alanine measurements of
absorbed dose to water expressed in Gy. Associated uncertainties are expressed
with a coverage factor k=2.
eﬀect of this detector compared to that of the alanine dosimeters and the
CC13.
Table 4.8 shows experimental correction factors obtained for the CC13 and
PTW31014 ionization chambers for the intermediate calibration ﬁelds and
clinical treatments under study, with expanded uncertainties expressed with
a coverage factor k=2.
For the intermediate calibration ﬁelds, overall correction factors are com-
patible with unity within uncertainties. Small diﬀerences are however en-
countered between static and composite ﬁeld dosimetry, and correlation
is observed for the behavior of the two detectors, with associated correc-
tion factors being above or below unity for both chambers depending on
the investigated ﬁeld. While fmsr exhibits a correction factor lower than
one (kfmsr,frefQmsr,Q0 equal to 0.979±0.022 and 0.994±0.020 for PTW31014 and
CC13 detectors respectively) correction factors associated with compos-
ite calibration ﬁelds are higher than one (kfpcsr,frefQpcsr,Q0 equal to 1.008±0.025
and 1.012±0.026 for PTW31014 in fpcsr1 and fpcsr2, and 1.016±0.020 and
1.007±0.020 for the CC13 detector in fpcsr1 and fpcsr2 respectively).
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PTW31014
Calibration kfmsr,frefQmsr,Q0 k
fmsr,fref
Qmsr,Q

fmsr 0.979(22) 0.985(22) 
k
fpcsr,fref
Qpcsr,Q0
k
fpcsr1&2,fref
Qpcsr,Q
k
fpcsr,fmsr
Qpcsr,Qmsr
fpcsr1 1.008(25) 1.014(25) 1.029(12)
fpcsr2 1.012(26) 1.018(26) 1.033(15)
Treatment kfclin,frefQclin,Q0  k
fclin,fref
Qclin,Q
kfclin,fmsrQclin,Qmsr k
fclin,fpcsr1&2
Qclin,Qpcsr1&2
brain 1.016(27)  1.022(27) 1.037(16) 1.008(17) & 1.005(19)
lung 0.987(24)  0.993(24) 1.008(12) 0.980(14) & 0.976(16)
CC13
Calibration kfmsr,frefQmsr,Q0 k
fmsr,fref
Qmsr,Q

fmsr 0.994(20) 0.998(20) 
k
fpcsr,fref
Qpcsr,Q0
k
fpcsr,fref
Qpcsr,Q
k
fpcsr,fmsr
Qpcsr,Qmsr
fpcsr1 1.016(20) 1.020(20) 1.0220(92)
fpcsr2 1.007(20) 1.011(20) 1.0124(94)
Treatment kfclin,frefQclin,Q0  k
fclin,fref
Qclin,Q
kfclin,fmsrQclin,Qmsr k
fclin,fpcsr1&2
Qclin,Qpcsr1&2
brain 1.000(21)  1.004(21) 1.005(10) 0.984(11) & 0.993(11)
lung 0.995(20)  0.999(20) 1.000(10) 0.979(10) & 0.988(10)
Table 4.8: Measured correction factors for intermediate calibration ﬁelds fmsr,
fpcsr1 and fpcsr2 and clinical treatments. Associated uncertainties aﬀecting last
decimals are shown in brackets with two signiﬁcant digits and coverage factor
k=2.
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Focusing on the clinical treatments, Figure 4.13 is included to facilitate the
interpretation of results. Scanditronix-Wellhofer CC13 yielded overall cor-
rection factors being very similar among them and close to unity for both
treatments: kfclin,frefQclin,Q0 equal to 1.000±0.021 and 0.995±0.021 for the brain
and lung treatments respectively. In this case, the fmsr ﬁeld is the inter-
mediate calibration ﬁeld leading to clinical to intermediate ﬁeld correction
factors closer to unity, kfclin,fmsrQclin,Qmsr equal to 1.000±0.010 and 1.005±0.010, al-
though compatibility with unity is also found for kfclin,fpcsr2Qclin,Qpcsr2 , with 0.993±0.011
and 0.988±0.010 values for the brain and lung treatments respectively. The
pcsr1 ﬁeld leads to kfclin,fpcsr1Qclin,Qpcsr1 equal to 0.984±0.010 for the brain treatment
and, departing more drastically from unity, 0.979±0.010 for the lung treat-
ment.
Deviations from unity in correction factors associated to clinical treatments
arise more often for the PTW31014 detector, although given the uncertain-
ties, results are again compatible with unity: kfclin,frefQclin,Q0 equal to 1.016±0.027
and 0.987±0.027 for the brain and lung treatment respectively. In this case,
pcsr ﬁelds would remain closer to the brain treatment: kfbrain,fpcsrQbrain,Qpcsr equal
to 1.008±0.017 and 1.005±0.019 for pcsr1 and pcsr2, while kfbrain,fmsrQbrain,Qmsr is
equal to 1.037±0.016. For the lung treatment, the msr ﬁeld would be the
intermediate calibration ﬁeld closer to the treatment, kflung,fmsrQlung,Qmsr equal to
1.008±0.012, while the correction factors associated to the pcsr ﬁelds would
deviate more importantly from unity: kflung,fpcsrQlung,Qpcsr equal to 0.980±0.014 and
0.976±0.016 for pcsr1 and pcsr2.
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4.2.2.6 Monte Carlo Simulation
Monte Carlo simulation of the CyberKnife machine treatment head was
performed with the BEAMnrc code [61], using the information about ge-
ometry and materials provided by the manufacturer, see Figure 4.14, while
the deposition of dose was simulated with the DOSXYZnrc code and the
C++ based EGSnrc code cavity [59, 148].
Transport Parameters.
All simulations were performed considering spin eﬀects, bound Compton
scattering, photoelectron angular sampling, Rayleigh scattering, atomic re-
laxations, triplet production and radiative Compton corrections. NIST
cross sections were employed for bremsstrahlung interactions and Koch
Motz for bremsstrahlung angular sampling.
BEAMnrc simulations were performed to score, at a distance of 70 cm from
the electron source, particle phase spaces registering information about the
energy, position and velocity of the particles propagated through the linac
geometry. The objective of these simulations is to obtain a phase space with
a number of statistically independent particles high enough to later yield
statistical noise free Monte Carlo calculated values of absorbed dose. The
number of phase space particles estimated to suﬃce for this purpose was
considered to be 600000 cm−2 in this work. The Directive Bremsstrahlung
Splitting (DBS) technique was employed with an splitting number of 1000
in order to to generate the maximum number of statistically independent
particles from the minimum number of initial particles. The DBS radius
was changed from ﬁeld to ﬁeld being, at 80 cm SAD, equal to the radius of
the ﬁeld plus 1.5 times the continuous slowing down approximation (CSDA)
range of an electron of maximum energy, so that ﬁeld penumbras were
lying inside the bremsstrahlung splitting region. The range rejection (RR)
variance reduction technique was applied, through the whole geometry, to
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electrons with energies below 1 MeV, and photon and electron transport
cut-oﬀ energies of 0.01 MeV and 0.7 MeV were respectively used (electron
rest mas, 0.511 MeV, is not substracted from electron energies), see Table
4.9.
Particles from BEAMnrc phase spaces were then propagated through dif-
ferent phantoms in which absorbed dose was calculated. DOSXYZnrc sim-
ulations of absorbed dose to water were performed using again the RR
variance reduction technique on particles with energies below 1 MeV and
photon and electron transport cut-oﬀ energies of 0.01 MeV and 0.7 MeV
respectively, through the whole geometry. Water slabs were placed around
calculation voxels using dsurround variables to avoid an excessive number
of regions in the geometry, and the photon splitting variance reduction
technique was applied with a splitting number of 10.
Monte Carlo transport or Variance Reduction Technique
BEAMnrc DOSXYZnrc cavity
Maximum energy for RR 1 MeV 1 MeV 1 MeV
Electron transport cut-oﬀ energy 0.700 MeV 0.700 MeV 0.521 MeV
Photon transport cut-oﬀ energy 0.010 MeV 0.010 MeV 0.010 MeV
DBS number 1000  
Photon splitting number  10 80
Medium to calculate ranges for RR That of every region Air
Table 4.9: Monte Carlo transport and variance reduction parameters used
to simulate the CyberKnife linac (BEAMnrc), to calculate absorbed dose to
water during the linac commissioning process (DOSXYZnrc) and to calculate
absorbed dose to water, to ionization chambers and to alanine for the determi-
nation of beam quality correction factors (cavity).
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EGSnrc calculations of dose delivered to water, to ionization chambers and
to alanine were performed using photon and electron transport cut-oﬀ ener-
gies of 0.01 MeV and 0.521 MeV respectively through the whole geometry.
The photon splitting variance reduction technique was applied with a split-
ting number of 80. Additionally, electron RR was applied outside the cavity
with a survival probability of 1/125, using air as the medium to calculate
the ranges. Simulation eﬃciencies, deﬁned as 1/(tσ2), with t standing for
the CPU simulation time in seconds and σ the relative standard deviation
of the simulation, were calculated for the composite ﬁeld simulations, ob-
taining values ranging from 0.01 s−1 to 0.74 s−1 depending on the cavity
volume and dose deposition medium.
Machine Commissioning
Simulation of the treatment unit requires a commissioning process to ﬁne-
tune the sensitive parameters of the X-ray beam, which are [149]:
• Energy of the electron beam impinging the linac target.
• Spatial distribution of the electron beam.
Monoenergetic spectra and Gaussian spatial distributions of diﬀerent full
widths at half maximum (FWHM) were employed in the BEAMnrc simu-
lation of the treatment head for the scoring of phase spaces with at least
8×104 particles per square cm. DOSXYZnrc calculated dose distributions
were then obtained for diﬀerent combinations of beam parameters and com-
pared with measured dose distributions in order to select the optimum beam
parameters. The dose distributions employed for comparison with Monte
Carlo simulations were measured with a PTW60012 diode detector (PTW-
Freiburg, Germany) as recommended by Accuray Inc. for commissioning
procedures.
Chapter 4. Ionization Chamber Correction Factors in Nonstandard Fields 206
Figure 4.14: Geometry of the CyberKnife linac head in the xz plane as
seen with the BEAMnrc graphical user interface. Dimensions are not realistic
and materials are not given due to the non disclosure agreement signed with
Accuray to preserve this information.
For the election of the optimal source parameters, a procedure based on the
method of Pena et al. [150] was followed, in which two cost functions are
deﬁned comparing measured and simulated dose distributions. A ﬁrst cost
function, given by the distance between ﬁeld edges, DBFE, of measured
and simulated proﬁles is employed for the determination of the size of the
electron source that results optimal at diﬀerent energies. DBFE is calcu-
lated as the sum of the squared diﬀerence between the position of 80%,
60%, 50%, 40% and 20% dose levels, with respect to the maximum, from
measured and simulated proﬁles.
This ﬁrst step involved in our case the comparison of lateral proﬁles from
collimators, coli, of 1, 1.5 and 3 cm diameters, measured and simulated at
1.5, 5 and 10 cm depth in water. Electron spatial distributions with 1.5,
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2 and 2.5 mm FWHM were tested in these simulations for electron source
energies, Ej, of 6.3, 6.5, 6.6 and 6.7 MeV, an energy range similar to that
reported in other works of Monte Carlo simulation of CyberKnife units
[28, 145, 151]. The FWHM yielding the minimum cost function is obtained
for every energy and ﬁeld size, as:
FWHMcoli(Ej) = arg min
FWHMk
DBFEcoli(Ej, FWHMk) (4.2)
A weighted average is then obtained for each energy Ej as:
FWHM(Ej) =
∑
coli
ωcoliFWHMcoli(Ej) (4.3)
In our case, weight factors, ωcol, of 3, 3 and 1 were chosen for 1 cm, 1.5 cm
and 3 cm collimators respectively. Higher weights were given to the smaller
collimators due to the small ﬁeld sizes that are involved in the simulation
of pcsr and clinical ﬁelds. The average FWHM took the same value, 0.197
mm, for all the investigated energy values. In order to build the second cost
function, measured lateral and percent depth dose proﬁles are compared,
now in terms of the Gamma function [63], with the simulations obtained at
each energy using the optimal electron source spatial dose distribution, with
0.197 mm FWHM, as calculated above. The Γ function has the following
form:
ΓEj =
∑
coli
ωpcoliγpcoli + ωdcoliγdcoli (4.4)
Where γpcoli and γdcoli represent the sum of Gamma values for the lateral
and depth dose proﬁles comparisons respectively, and ωp and ωd are their
weight factors (here set to one). The optimal energy is the one that mini-
mizes Equation 4.4.
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DBFEs and values of the global cost function obtained for the diﬀerent
combinations of energy and FWHM are shown in Figure 4.15. The optimal
combination of source parameters was determined to be 6.5 MeV and a
0.197 mm FHWM.
Figure 4.15: Distance between ﬁeld edges of measured and simulated lateral
proﬁles calculated for diﬀerent electron source energies and FWHM for the
collimators with 1cm (a), 1.5 cm (b) and 3 cm (c) diameters. d) Global Gamma
function obtained from the comparison of measured and simulated lateral and
depth dose proﬁles for 6.3, 6.5, 6.6 and 6.7 MeV electron sources with 0.196
FWHM.
Finally, an additional test for the beam energy was performed through the
comparison of measured and calculated tissue phantom ratios for the above
mentioned collimators at 1.5, 5 and 10 cm depths for 6.5, 6.6 and 6.7 MeV
beam energies, obtaining again better agreement with the experimental
measurements through the simulation involving a 6.5 MeV electron source.
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Figure 4.16: Comparison of the dose distributions measured with a PTW
60012 diode detector in the CyberKnife unit of the Hospital Ruber Interna-
tional with Monte Carlo calculated dose distributions simulated with an elec-
tron source of 6.5 MeV and 0.197 mm FHWM. Comparison of central axis
depth dose proﬁle for the 60 mm collimator ﬁeld a), and lateral proﬁles for 10
mm, 15 mm and 30 mm ﬁelds at 85 cm SAD and 1.5 cm b), 5 cm c) and 10
cm d) depth in water.
Figure 4.16 shows the comparison of measured and Monte Carlo calculated
lateral and percent depth dose proﬁles for an electron beam incident on
the X-ray target with an energy of 6.5 MeV and 0.197 mm FWHM Gaus-
sian spatial distribution. Under these beam parameters, the Monte Carlo
calculated TPR20,10 at 80 cm source to detector distance for the 60 mm col-
limator yielded a value of 0.640±0.012 (k=2), which is in agreement within
uncertainties with the measured value of 0.637.
Chapter 4. Ionization Chamber Correction Factors in Nonstandard Fields 210
Correction factors calculation
Monte Carlo correction factors were obtained after treatment unit commis-
sioning by calculating the dose imparted to the detectors by the interme-
diate calibration ﬁelds, msr and pcsr, a 60Co conventional reference ﬁeld
and the brain clinical treatment. The geometry of the anthropomorphic
phantom is much more complicated, and since the detailed geometry was
not available, the clinical lung treatment was not simulated. A geometri-
cally detailed simulation of detectors and phantoms was performed with
the EGSnrc code and the C++ class library [60], see Figure 4.17. Dose to
water was also calculated in a spherical voxel of 1.5 mm radius for the de-
termination of correction factors and in three cylindrical voxels emulating
the alanine pellets' geometry for the study of volume averaging eﬀects and
alanine to water stopping power ratios.
Figure 4.17: Scheme of the phantom and ionization chamber geometries
employed for the Monte Carlo simulation of correction factors. Left, Solid
Water spherical phantom with the ionization chamber (here PTW31014) ref-
erence point placed at the center of the sphere. Right, geometry and materi-
als employed for the simulation in cavity of Scanditronix-Wellhofer CC13 and
PTW31014 ionization chambers.
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Additionally, Monte Carlo simulation of a conical collimator deﬁning a
ﬁeld of 8.88 cm diameter, d, at 80 cm SAD, which is equivalent to a square
ﬁeld size of 10 cm at SSD = 100 cm (Seq = 0.9 × d × 100/80) [128], was
performed to crosscheck the values of kQ,Q0 estimated in Section 4.2.2.3.
Dose to water and dose to ionization chambers under this 8.88 cm circular
beam and the standard 60Co reference ﬁeld served for the calculation of
kQ,Q0 correction factors, yielding values of 0.991±0.016 and 0.996±0.011
(k=2) for the PTW31014 and the Scanditronix-Wellhofer CC13 ionization
chambers, which are in good agreement with the 0.994 and 0.996 values
estimated in section 4.2.2.3.
Composite ﬁeld simulation.
The simulation of composite ﬁelds involved a procedure similar to that
adopted by Ma et al. [151]. Information about composite ﬁelds, such as
monitor units, collimator size and beam incidence direction per beam were
obtained from Accuray CyberKnife treatment plan XML ﬁles.
Beams were propagated with the EGSnrc code and the C++ library along
the z axis, and thus for each beam the whole geometry (phantom and
detectors) was rotated to align the beam propagation with the simulation
z axis. Rotation matrices were calculated, for each beam propagation axis,
from the position of two points, node and target, provided in the treatment
XML ﬁle in the patient CT coordinate system [141].
Dose to water and dose to air in the cavity of the ionization chambers
were then calculated to compute correction factors as described in Equa-
tion 1.16. The large number of segments involved in composite ﬁelds made
simulations very costly in terms of computation time and thus uncertainty
levels, ranging from 0.28% to 0.94% (k=2) were set as a compromise be-
tween simulation time and the level of accuracy desired for the correction
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factors calculation. Monte Carlo correction factors associated with the in-
termediate calibration ﬁelds and the brain treatment ﬁeld, shown in Table
4.10 and Figure 4.18, present associated uncertainties ranging from 0.8%
to 1.4% (k=2).
Figure 4.18: Experimental and Monte Carlo overall correction factors,
kfi,frefQi,Q0 , relating intermediate calibration ﬁelds and clinical ﬁelds, fi, and con-
ventional reference conditions, fref , for a) PTW31014 and b) CC13 ionization
chambers. Uncertainty bars are presented with a coverage factor k=2.
Monte Carlo calculated correction factors are in agreement with the mea-
sured values within measurement uncertainties for both PTW31014 and
Scanditronix-Wellhofer CC13 ionization chambers, with the exception of
pcsr1 for CC13, where a discrepancy of 2.4% is found, being the uncer-
tainty of the experimental correction factor of a 2%. Discrepancies be-
tween simulation and measurements were found to be generally higher for
the composite ﬁelds, which could be related with dose inhomogeneities in
the treatment PTV. These discrepancies may not be signiﬁcant if we take
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PTW31014
Calibration kfmsr,frefQmsr,Q0 k
fmsr,fref
Qmsr,Q

fmsr 0.987(14) 0.993(22) 
k
fpcsr,fref
Qpcsr,Q0
k
fpcsr,fref
Qpcsr,Q
k
fpcsr,fmsr
Qpcsr,Qmsr
fpcsr1 0.993(12) 0.999(12) 1.006(11)
fpcsr2 0.987(12) 0.992(12) 0.999(12)
Treatment kfclin,frefQclin,Q0  k
fclin,fref
Qclin,Q
kfclin,fmsrQclin,Qmsr k
fclin,fpcsr1&2
Qclin,Qpcsr1&2
brain 1.025(13)  1.031(13) 1.038(12) 1.032(10) & 1.039(10)
CC13
Calibration kfmsr,frefQmsr,Q0 k
fmsr,fref
Qmsr,Q

fmsr 0.990(10) 0.994(10) 
k
fpcsr,fref
Qpcsr,Q0
k
fpcsr,fref
Qpcsr,Q
k
fpcsr,fmsr
Qpcsr,Qmsr
fpcsr1 0.992(10) 0.996(10) 1.0024(88)
fpcsr2 0.994(10) 0.998(10) 1.004(10)
Treatment kfclin,frefQclin,Q0  k
fclin,fref
Qclin,Q
kfclin,fmsrQclin,Qmsr k
fclin,fpcsr1&2
Qclin,Qpcsr1&2
brain 0.994(13)  0.998(13) 1.0041(88) 1.0017(81) &1.0004(90)
Table 4.10: Monte Carlo calculated correction factors for intermediate cali-
bration ﬁelds fmsr, fpcsr1 and fpcsr2 and the brain clinical treatment. Associated
uncertainties aﬀecting last decimals are shown in brackets with two signiﬁcant
digits and coverage factor k=2.
into account that only type A uncertainties were considered in the calcula-
tion of Monte Carlo correction factors. Some works [145, 152] propose the
introduction of type B uncertainties in the uncertainty budget of Monte
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Carlo calculated absorbed dose, which would increase our expanded uncer-
tainties.
It should be noted that Monte Carlo calculations lead to correction factors
associated to the CC13 chamber that are very similar among them and
compatible with unit for all the investigated ﬁelds. For PTW31014, similar
correction factors, also compatible with unity, were obtained associated
to intermediate calibration ﬁelds, but a 3.1% deviation was found between
absorbed dose to water and the chamber measurement for the brain clinical
treatment.
Water to alanine dose ratios calculated from simulations yielded values
between 0.969 and 0.972, which agree well with previously reported data
on water to alanine mass energy absorption coeﬃcient and stopping power
ratios for the photon beam energies under investigation [82].
4.2.2.7 Discussion
The applicability of the studied intermediate calibration ﬁelds for the rel-
ative dosimetry of clinical treatments has to be studied considering the
dosimetric paths proposed for that purpose by the new formalism, Section
1.2.3.3. In Equation 1.15, kfclin,fiQclin,Qi values close to unity would imply a better
representation of the clinical ﬁeld by the corresponding intermediate refer-
ence ﬁeld. In this context, and as we said in Section 4.2.2.5, measurements
with PTW31014 chamber yielded clinical overall correction factors that
would make fmsr a more representative ﬁeld for the lung treatment, while
both fpcsr1 and fpcsr2 would stand closer to the brain treatment. Although
measured kfclin,fmsrQclin,Qmsr and k
fclin,fpcsr
Qclin,Qpcsr
are not compatible within uncertain-
ties these diﬀerences may not be however signiﬁcant, as results obtained
through Monte Carlo simulation for the static and composite calibration
ﬁelds for both chambers suggest the dosimetric equivalence between fmsr
and any of the studied pcsr ﬁelds. Moreover, instabilities exhibited by the
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PTW31014 ionization chamber might put under question the relevance of
the diﬀerences observed in the measurements.
On the other hand, no signiﬁcant correlation was found between the com-
posite and clinical ﬁelds employing the same set of collimators, as correction
factors associated to such ﬁelds were not found to be closer to unity than
those associated with intermediate calibration ﬁelds delivered by other col-
limators.
Regarding clinical dosimetry, it should be again noted that general conclu-
sions should not be drawn because other clinical treatments could be found
to behave diﬀerently. Inhomogeneities arising in dose distributions and
mispositionings aﬀecting composite ﬁeld measurements may be responsible
in part for the discrepancies encountered between the diﬀerent investigated
ﬁelds, as these eﬀects can cause substantial correction factor variations.
Additionally, machine output variations due to the vented monitor cham-
bers in the CyberKnife unit were corrected for, but small residual eﬀects
may persist.
Dose Inhomogeneities
Composite intermediate calibration ﬁeld dosimetry can have high associ-
ated uncertainties due to the combination of measurement conditions with
steep dose gradients or low dose regions (under which detectors may give
misleading results) and the positioning of both the CyberKnife robotic arm
and the detectors.
In order to estimate the eﬀect that dose inhomogeneities can have in the
determination of correction factors, absorbed dose in every alanine pellet
was calculated by Monte Carlo simulation to estimate the averaging eﬀect
introduced by the use of three pellets for the determination of absorbed
dose to water in every measurement. Relative standard deviations of the
dose imparted to the three pellets were observed to be around 0.7% and
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0.6% for fpcsr1 and fpcsr2, while standard deviations compatible with zero
within uncertainties were obtained for fmsr and the brain clinical treatment.
Alternatively, the analysis of TPS dose distributions of the composite ﬁelds
under investigation revealed dose inhomogeneities contributing to an aver-
age eﬀect in the alanine that amounted to a 0.7% and a 0.5% for fpcsr1 and
fpcsr2 and to a 0.5% and a 0.7% for the brain and lung clinical treatments
respectively.
In an attempt to study the eﬀect of dose inhomogeneities in plan class
speciﬁc reference ﬁelds dose distributions, Chung et al. [137] proposed the
quantiﬁcation of dose homogeneity in pcsr ﬁelds target volumes by a ho-
mogeneity index, HI, deﬁned as the ratio of D2% − D98% to the average
dose in the target volume, where D2% and D98% are the maximum values of
dose achieved by at least 2% and 98% of the target volume. In this work,
the study of correction factors versus the homogeneity index revealed that
correction factors associated to Farmer type chambers depart more dras-
tically from unity as the homogeneity index increases, due to the growing
importance of gradient eﬀects in large active volumes as the HI increases.
Small volume chambers exhibit correction factors closer to unity but with
higher variability due to the eﬀect of positioning as the HI increases.
When TPS dose distributions from the CyberKnife pcsr ﬁelds proposed
here were analyzed, HIs calculated in a spherical central target volume of
10 mm radius exhibited values of 13.8% and 6.9% for pcsr1 and pcsr2,
both above the 5% that was considered by Chung in TomoTherapy to be
the value above which low homogeneity in the target volume may involve
noticeable gradient eﬀects or correction factors varying strongly with the
positioning. We have to consider however that the establishment of such a
threshold for acceptable homogeneity in pcsr ﬁelds may be delicate and can
depend on the treatment technique. Since pcsr ﬁelds should deliver homo-
geneous dose distributions in order to ensure measurement reproducibility
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and minimize detector perturbation factors, the two composite ﬁelds pro-
posed here, planned by the Accuray TPS with parameters and constraints
described in section 4.2.2.2, may not perfectly match the requirements of
an ideal intermediate calibration ﬁeld as deﬁned in the proposal for new
protocol [30], although given the intrinsic characteristics of the CyberKnife
delivery, they are probably a good example of the pcsr ﬁelds that can be
established for this technique.
4.2.2.8 Review
As we made for Tomotherapy, an overview of the work that has been pre-
sented about the application of the new formalism to CyberKnife results
useful to gain a more complete perspective and will be also presented here
for CyberKnife.
Previous works on CyberKnife dosimetry studied total scatter factors for
diﬀerent detectors and collimators [28, 116], Monte Carlo calculated kQmsr,Q0
values for diﬀerent beam energies and detectors [117] and kfmsr,frefQmsr,Q correc-
tion factors associated with diﬀerent ionization chambers [144, 145]. Plan
Class Speciﬁc reference ﬁeld have not been proposed nor measured by other
authors and thus the comparison will be restricted to msr ﬁelds, see the
kQmsr,Q0 correction factors presented in Figure 4.19.
All the authors employed the 6 cm diameter collimator for the deﬁnition
of the msr ﬁeld, all measured at 80 cm SCD but with some diﬀerences in
the SSD: 70 cm in the work of Kawachi et al. [117], 75 cm in the work of
Francescon et al. [145] and 78.5 cm in the work of Pantelis et al. [144],
while our study was performed at 75 cm SSD.
In our study [153], both simulations and measurements yielded overall cor-
rection factors departing from unity by approximately 2%, with results for
the PTW31014 chamber that are in agreement with those recently pre-
sented by Francescon et al. [145] for the fmsr, although the CC13 chamber
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Figure 4.19: Summary of kfmsr,frefQmsr,Q0 correction factors published to this date
for CC13 (a), and PTW31014 (b) ionization chambers versus the estimated
value of CyberKnife TPR20,10 under reference conditions (10 cm ×10 cm ﬁeld
at 100 cm SCD).
was not studied in that work. Monte Carlo calculated correction factors
presented by Kawachi et al. [117] for both PTW31014 and CC13 chambers
and diﬀerent beam qualities are also consistent with those presented here.
In the work of Pantelis et al. [144], correction factors for these ionization
chambers can be obtained from the kQmsr,Q0 correction factor for a Farmer
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type chamber and Farmer to PTW3104 and CC13 dose ratios, ﬁnding also
agreement with our results.
All the correction factors associated with the msr ﬁelds exhibit values sis-
tematically below unity, although the uncertainties associated to the ex-
perimental measurements (only available in our work and that by Pantelis
et al.) are high enough and do not discard compatibility with unity.
4.2.3 Conclusions.
In our studies about TomoTherapy and CyberKnife we have found that
depending on the clinical treatment ﬁeld and ionization chamber used, ei-
ther the msr or pcsr ﬁelds proposed result in associated correction factors
kfclin,fiQclin,Qi that are slightly closer to unity. Considering the uncertainties as-
sociated to our measurements, these diﬀerences do not seem to be signiﬁ-
cant, as all the measurements in clinical ﬁelds, with the exception of those
performed in the lung treatment with PTW31014 in CyberKnife, yielded
kfclin,fmsrQclin,Qmsr and k
fclin,fpcsr
Qclin,Qpcsr
correction factors that are compatible with each
other within uncertainties. This agreement was also found between all the
Monte Carlo calculated correction factors.
We cannot therefore see any strong indication showing the pcsr ﬁeld as a
more suitable intermediate calibration ﬁeld for nonstandard ﬁeld dosime-
try than the msr ﬁeld, both in TomoTherapy and CyberKnife. Taking into
account that the requirement to have highly homogeneous PTV dose dis-
tributions on pcsr ﬁelds for the measurement of correction factors with low
associated uncertainties is not always easily fulﬁlled, msr ﬁelds would seem
to be a better intermediate calibration ﬁeld candidate for the measurement
of associated correction factors with low uncertainties.
The initial proposal of plan class speciﬁc intermediate calibration ﬁelds as
composite ﬁeld conﬁgurations lying closer to the clinical treatment condi-
tions has not been demonstrated, at least for the cylindrical and spherical
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pcsr here studied. Measuring such simple composite ﬁeld conﬁgurations
could still result very useful for dosimetry quality assurance in certain tech-
niques, as many treatment delivery features are included in pcsr ﬁelds but
not in msr ﬁelds. However, the advantage obtained through their use for
clinical dosimetry is not clear.
Further measurements of clinical ﬁelds and the study of their relationship
with both pcsr and msr ﬁelds will of course help to strongly conﬁrm that
msr ﬁelds are an optimum path for the performance of clinical dosimetry in
non standard ﬁelds. Reports will be published in the near future, hopefully
by the beginning of 2014, by IAEA and AAPM that will compile all the
results presented by the scientiﬁc community since 2008 on the application
of the new dosimetry formalism to diﬀerent radiotherapy techniques. The
role that both msr and pcsr ﬁelds will ﬁnally play on the dosimetry of non
standard beams will be then probably clariﬁed.
Alternative strategies are also being studied and recommendations are be-
ing elaborated by other institutions like DIN, the German Institute for
Standardization, which prefers the election of the most appropriate detec-
tors, i.e. those that require the minimum correction, for each technique.
This institution advocates for the use of an unshielded diode for the mea-
surement of small ﬁelds. Diodes would be in this case cross-calibrated with
an ionization chamber in a small reference ﬁeld, large enough though to
have associated kQ factors not departing signiﬁcantly from those published
in conventional CoPs (4 cm×4 cm ﬁeld for example). Measurements on
smaller ﬁelds would be then performed with this diode once the change of
response for smaller ﬁelds has been studied. For the measurement on clin-
ical ﬁelds, DIN dispenses with the use of pcsr ﬁelds and recommends the
use of exhaustive dosimetric veriﬁcation through diﬀerent methods includ-
ing detector arrays, ﬁlm dosimetry with an absolute dose measurement,
etc.
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On the other hand, the European Metrology Research Programme of EU-
RAMET has some research lines under the project Metrology for radio-
therapy using complex radiation ﬁelds exploring new quality indexes and
calibration methods for Stereotactic Radiosurgery, covering static and dy-
namic ﬁelds and studying the option for a TPS beam model parameter.
Other work packages include for example a proposal to verify TPS dose
distributions in anthropomorphic phantoms following a methodology, sim-
ilar to that proposed by González-Castaño [62] et al., that includes the
convolution of TPS dose distributions with the spatial response function of
the detector employed in veriﬁcation measurements.

Appendix A
Resumen
El trabajo realizado en esta tesis abarca un conjunto de estudios relaciona-
dos con la dosimetría en radioterapia externa de fotones, presentando en
primer lugar sus fundamentos, objetivos, procedimientos y las técnicas y
maquinas empleadas en la radioterapia externa de fotones. En este contexto
se analizarán diversos aspectos de la dosimetría en campos de radioterapia
no estándar.
La magnitud empleada para cuantiﬁcar el efecto de la radiación ionizante
en el tejido biológico es la dosis, deﬁnida como la energía depositada en
el material por unidad de masa. La dosis depositada en agua se usa ge-
neralmente en radioterapia dado el buen conocimiento del transporte de
radiación en este material, que permite obtener resultados con baja incer-
tidumbre. Además, la dosis en agua está estrechamente relacionada con
la dosis en tejido, dado que el cuerpo humano, formado en un 70% por
agua y con una densidad media de 1 g cm−3, muestra coeﬃcientes másicos
de absorción de la radiación muy similares a los del agua. Las bases de la
dosimetría se presentan en el trabajo, resumiendo las carácterísticas ideales
de un dosímetro y describiendo los mecanismos empleados por distintos de-
tectores para la medida de dosis. Se pormenoriza también la dosimetría
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de haces de fotones en condiciones de referencia. Los procedimientos de
este tipo de dosimetría son establecidps en protocolos internacionales como
el TRS398 del Organismo Internacional de Energía atómica (OIEA), o el
TG-51 de la Sociedad Americana de físicos médicos (AAPM). Este tipo de
protocolos dictan recomendaciones estandarizadas para la medida de dosis
en agua en los haces clínicos de radioterapia, contribuyendo a la aplicación
de procedimientos dosimétros uniﬁcados en los hospitales y a una deter-
minación de dosis en agua trazable a patrones (primarios o secundarios)
de esta magnitud. La dosimetría de referencia en haces de radioterapia
externa de fotones, provenientes de aceleradores lineales de electrones de
megavoltage o unidades de colbaltoterapia, consiste en la determinacón de
la dosis depositada en agua por un haz de radiación en un tanque de agua en
condiciones de referencia, siendo éstas establecidas en los citados protocolos
de dosimetría.
La dosis en condiciones de referencia debe ser conocida por el radiofísico
hospitalario con una incertidumbre relativa que no supere el 1.5% para que
éste pueda llevar a cabo las planiﬁcaciones de tratamientos cumpliendo
las prescripciones del oncólogo y las recomendaciones de los organismos
nacionales e internacionales competentes que establecen las normas regu-
ladoras del control de calidad en radioterapia.
La dosimetría de referencia se realiza con cámaras de ionización de aire,
donde la carga eléctrica generada en el volumen activo del detector por
el campo de radiación es convertida en dosis depositada en agua a partir
de un coeﬁciente de calibración y una serie de factores de corrección. Los
coeﬁcientes de calibración se determinan en laboratorios de calibración me-
diante la comparación de la carga registrada por la cámara con la dosis
en agua, conocida mediante otro procedimiento de precisión, en igualdad
de condiciones (las de referencia). Las condiciones de referencia permiten
asegurar la reproducibilidad del procedimiento por parte de otro usuario
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o laboratorio de calibrabción, así como la ﬁdelidad del valor obtenido con
respecto al valor convencionalmente verdadero.
Los haces de radiación utilizados en los laboratorios de calibración para la
determinación de los coeﬁcientes de calibración son habitualmente haces de
fotones de cobalto-60, dada la reproducibilidad del haz de un radioisótopo
y la similitud entre la energía media del espectro de cobalto-60 y la energía
media de los haces de fotones generados en los aceleradores lineales de elec-
trones. Sin embargo, las diferencias espectrales entre el haz del laboratorio
de calibración y los haces empleados en radioterapia, habitualmente haces
de megavoltage, hacen necesaria la aplicación de un factor de corrección
para la determinación de dosis en agua en los haces clínicos. Este factor,
denominado factor de corrección por calidad de haz, depende no sólo del
espectro del haz utilizado en la clínica, si no también de la cámara de io-
nización empleada para la medida (de la geometría y materiales de los que
está compuesta). Los factores de corrección por calidad de haz aparecen
tabulados en los protocolos de dosimetría para distintas cámaras de ioni-
zación y distintas calidades de haz. De este modo, la determinación de
la dosis depositada en agua por un haz clínico se puede obtener como el
producto de la carga registrada por la cámara en condiciones de referen-
cia, el coeﬁciente de calibración y el factor de corrección por calidad de
haz correspondiente al espectro de la máqina y a la cámara de ionización
utilizada.
La evolución de la radioterapia externa de fotones ha dado lugar a técnicas
que emplean campos de radiación de intensidad modulada, o campos más
pequeños que el tamaño de campo utilizado en las condiciones de referencia
de los protocolos de dosimetría convencionales anteriormente mencionados
(de 10 cm x 10 cm). Estas técnicas permiten suministrar dosis más elevadas
y conﬁnadas al volumen del tumor que las técnicas de radioterapia confor-
mada previamente existentes. Además, existe un conjunto de máquinas de
radioterapia que utilizan este tipo de campos en la práctica clínica y que
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no pueden reproducir, por construcción, el campo de referencia establecido
en los protocolos de dosimetría convencionales. La medida de dosis abso-
luta en los campos suministrados por este tipo de máquinas, denominados
campos no estándar, está sujeta a mayores incertidumbres ya que no ex-
iste un procedimiento dosimétrico establecido para ser aplicado en estas
condiciones de medida. Esto compromete la calidad de la planiﬁcación de
los tratamientos de radioterapia al no conocerse con exactitud el error que
se comete en la determinación de la dosis suministrada al paciente. Esta
situación desencadenó la puesta en marcha de un Grupo de Trabajo de
dosimetría en Campos de Radioterapia no Estándar, fruto de la colabo-
ración de la OIEA y la AAPM, que publicó unas recomendaciones para el
desarrollo de un nuevo protocolo de dosimetría: A new formalism for refer-
ence dosimetry of small and non-standard ﬁelds Medical Physics Volume
35, Issue 11, pp. 5179-5186 (November 2008). La realización de un nuevo
protocolo exige la redeﬁnición de condiciones de medida adecuadas para la
dosimetría de referencia en las máquinas de radioterapia que lo requieran
y la realización de medidas y simulaciones para el cálculo de los factores de
corrección asociados a distintas cámaras de ionización en las calidades de
haz habituales en dichas máquinas.
El cálculo de factores de corrección por calidad de haz en un campo de
radiación implica la determinación de la desviación existente entre el valor
absoluto de dosis depositada en agua por el campo de radiación y el valor
de dosis depositada en agua obtenido a partir de la carga registrada en
la cámara y el coeﬁciente de calibración en cobalto-60. En condiciones de
no referencia, la falta de equilibrio transitorio de partículas cargadas y la
importacia del promediado por efecto volumen en los dosímetros hacen que
la medida de dosis absorbida en agua esté sometida a altas exigencias. El
dosímetro empleado para esta medida debe ser de pequeño tamaño, pre-
sentar poca dependencia energética y ser equivalente a agua. La dosimetría
de alanina es un patrón secundario de dosis en agua en radioterapia, em-
pleado en laboratorios primarios como el National Physical Laboratory de
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Inglaterra (NPL), el National Institute of Santards and Technology de Esta-
dos Unidos (NIST) o el Physikalisch-Technische Bundesanstalt de Alemania
(PTB). Este sistema dosimétrico cumple los requerimientos anteriormente
mencionados, siendo ampliamente utilizado para la medida de dosis en
campos de radiación pequeños.
La dosimetría de referencia es tan sólo uno de los pilares del control de
calidad en radioterapia. El control de calidad en radioterapia engloba una
serie de procesos cuyo objetivo es asegurar el cumplimiento de la prescipción
médica mediante la deposición de la dosis en el volumen objetivo dentro de
una tolerancia, que habitualmente ronda el 5% de la dosis prescrita. Entre
los objetivos centrales se encuentra además minimizar la dosis depositada
en tejido sano y la exposición del personal sanitario, tratando de asegurar
una adecuada monitorización del paciente que permita lograr y determinar
el resultado del tratamiento. El control de calidad pretende la minimización
general de las incertidumbres asociadas a todo el proceso radioterápico, in-
tentando corregir y reducir la incidencia de errores. Para ello se establecen
programas de control de calidad en los servicios de radioterapia de los hos-
pitales a partir de las guías y recomendaciones publicadas por organismos
como la Organización Mundial de la Salud, la Sociedad Europea de Ra-
dioterapia y Oncología o la Asociación Americana de Física Médica. Los
programas de control de calidad de radioterapia deﬁnen las responsabilida-
des del personal y establecen protocolos documentados, el registro y control
de fallos y procedimientos de auditoría interna y externa, promoviendo la
educación y entrenamiento continuado.
Estos programas se dividen en pasos de control de calidad individuales,
relacionados con cada uno de los pasos que forman parte del proceso ra-
dioterápico, donde se requieren determinados niveles de incertidumbre para
lograr el cumplimiento de las tolerancias globales exigidas. En lo que
concierne al físico médico, las actividades de control de calidad incluyen:
Resumen 228
• La protección radiológica.
• El control de calidad del equipamiento tanto de diagnóstico como de
tratamiento, donde se incluye la dosimetría de referencia.
• El control de calidad de la planiﬁcación de tratamientos.
• El control de calidad de la suministración del tratamiento.
Este último paso, generalmente denominado veriﬁcación del tratamiento,
es un proceso de control de calidad ﬁnal que trata de asegurar que las dis-
tribuciones de dosis suministradas coinciden con las planiﬁcadas. Además
de todos los procedimientos realizados para comprobar los haces sumin-
istrados por la máquina y su consistencia con los simulados en el software
de planiﬁcación de tratamientos, la veriﬁcación dosimétrica fue extensi-
vamente incorporada a los programas de control de calidad debido a la
complejidad de las técnicas de radioterapia modernas.
Los haces altamente conformados utilizados en las técnicas de radioterapia
de intensidad modulada involucran campos pequeños de radiación y altos
gradientes de dosis, con falta de equilibrio lateral de particulas cargadas
e importantes efectos de promediado en volumen asociados a la medida
de dosis con camára de ionización. Como los protocolos de dosimetría in-
cluyen factores de corrección por calidad de haz asociados a campos de
referencia estándar, la medida de dosis en las condiciones anteriormente
descritas está sometida a incertidumbres relativas superiores, pudiendo al-
canzar valores de hasta un 10%. Las técnicas modernas exigen además
un control más estricto en la colocación del paciente y del posicionado
colimadores multiláminas utilizados en las máquinas de radioterapia. Los
algoritmos de cálculo de dosis utilizados en el software de planiﬁcación de
tratamientos complejos deben presentar también una precisión mayor que
la requerida por la radioterapia conformada tradicional. Esta situación au-
menta la importancia y necesidad de una veriﬁcación dosimétrica previa a
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la suminstración del tratamiento al paciente, donde se evalúan los efectos
de la propagación de incertidumbres asociadas a todos los pasos del proceso
en la distribución de dosis ﬁnalmente suminsitrada.
Entre los distintos sistemas de dosimetría empleados para la veriﬁcación de
tratamientos, las matrices de detectores son dispositivos que permiten una
veriﬁcación exhaustiva y agilizan el proceso, un factor clave dada la alta
demanda asistencial de los servicios de radioterapia. Estos dispositivos, de
lectura directa, son fáciles de usar y posibilitan la rápida comparación de
las distribuciones de dosis medidas con las calculadas por el planiﬁcador.
Distintas matrices de detectores comerciales aparecieron a lo largo de la
última década respondiendo a la demanda clínica, estando formadas por
un número determinado de detectores embebidos en posiciones ﬁjas en un
material equivalente a agua. Los mecanismos de detección más extendidos
en las matrices de veriﬁcación son la cámara de ionización y el diodo, dada
su robustez, facilidad de calibración y la baja incertidumbre asociada a sus
medidas.
El trabajo presentado en esta memoria se divide en cuatro capítulos, cuyo
contenido se resume a continuación.
- En el capítulo uno se realiza una introducción a la radioterapia externa
de fotones, presentando sus fundamentos, objetivos y las máquinas y téc-
nicas de radioterapia empleadas. Las bases de la dosimetría son descritas,
incluyendo los procedimientos de la dosimetría de referencia en haces de ra-
dioterapia externa de fotones, y presentando la propuesta de un nuevo pro-
tocolo para haces de radioterapia no estándar. Se pone además en contexto
el control de calidad en la suministración de tratamientos, describiendo los
sistemas de dosimetría empleados en dicha tarea.
- En el capítulo dos se realiza un estudio sobre el uso de matrices de detec-
ción para la veriﬁcación dosimétrica de tratamientos de radioterapia. Tres
soluciones comerciales, PTW729 (PTW-Freiburg, Alemania), MatriXX (IBA
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Dosimetry, Louvain-La-Neuve, Bélgica) y MapCHECK2 (Sun Nuclear Cor-
poration, Melbourne FL) son analizadas bajo una metodología común que
permitirá la comparación de sus características y la obtención de conclu-
siones sobre el diseño óptimo de este tipo de detectores.
La respuesta espacial, Fψ, de los detectores empleados en las distintas ma-
trices, cámaras de ionización en los dos primeros casos y diodo en el caso de
la última matriz, es deﬁnida como la respuesta registrada por el detector,
estando éste situado a cierta profundidad z en un material equivalente a
agua, ante la incidencia de un haz de ﬂuencia inﬁnitesimal. La función de
respuesta Fψ asociada a los tres detectores estudiados fue medida a cierta
profundidad, z, mediante la irradiación del detector con un haz de pincel
con un espectro de haz de megavoltaje de 6 MV y fue simulada mediante
el método Monte Carlo. Para analizar el efecto de esta función de res-
puesta en la medida de distribuciones de dosis hemos de tener en cuenta
que la deposición de dosis producida a cierta profundidad en un material
ante la incidencia de una ﬂuencia de radiación se puede calcular a partir
de la convolución de esta ﬂuencia con el kernel de deposición de dosis en
el material. Este kernel describe la deposición de dosis a cierta profundi-
dad, considerando las contribuciones de radiación dispersa, el transporte
primario y secundario de electrones en el material y el ensanchamiento del
haz a medida que éste penetra en el material. Cuando un detector es em-
pleado para medir una distribución de dosis, la señal registrada por éste
se puede obtener como la convolución de la distribución de dosis a cierta
profundidad con una respuesta del detector, FD(x, y), que puede ser a su
vez calculada a partir de la deconvolución de la función Fψ del detector
con el kernel de deposición de dosis correspondiente al haz de radiación
empleado para la medida de Fψ a profundidad z. Esta metodología, veriﬁ-
cada en el trabajo, permitió modelizar la respuesta de los detectores ante
la incidencia de ﬂuencias arbitrarias, cuantiﬁcar las desviaciones existentes
entre la distribución de dosis real y la medida por el detector y comparar los
efectos introducidos por los distintos detectores estudiados en la medida de
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distribuciones de dosis representativas de tratamientos de radioterapia de
intensidad modulada. Se observó una mayor ﬁdelidad en la medida de dosis
con diodo, aunque los efectos introducidos por las cámaras de ionización re-
sultaron no ser signiﬁcativos teniendo en cuenta los criterios de aceptación
habituales de los programas de veriﬁcación de radioterapia, donde un 5%
de puntos en la distribución mostrando desviaciones mayores que un 1.5%
o 3% (dependiendo del servicio) con la distrución de referencia se suele
considerar aceptable.
El trabajo realizado analizó también la capacidad de las distintas matrices
para la detección de variaciones de ﬂuencia, objetivo central de la veri-
ﬁcación de tratamientos de radioterapia. En este estudio se observa que las
matrices que utilizan cámaras de ionización, con respuestas espaciales, Fψ,
de 0.6 a 0.7 cm de anchura a mitad de altura y espaciado entre detectores
de 0.8 a 1 cm, presentan una mayor capacidad para la detección de varia-
ciones de ﬂuencia que las matrices de diodos, cuya función Fψ presenta una
anchura a mitad de altura de 0.083 cm, siendo el espaciado entre detectores
es de 0.7 cm. Esto es debido a la mayor área sensible efectiva presente en
las matrices de detección que involucran detectores de mayor tamaño, lo
que permite suponer un diseño optimizado para las matrices con tamaños
de detetores de un área v 0.25 cm2 y distancia entre detectores que dé
lugar a un área sensible por encima de un 50% del área total de la matriz.
- En el tercer capítulo se presenta la puesta en marcha de un sistema
de dosimetría con alanina en el rango de dosis de la radioterapia (1 a 20
Gy), pionero en España, involucrando la Resonancia Paramagnética Elec-
trónica del servicio de Resonancia Magnética de la Red de Infraestructuras
de Apoyo a la Investigación y al Desarrollo Tecnológico de la Universidad de
Santiago de Compostela y trazado al patrón secundario de dosis absorbida
en agua del Laboratorio de Radiofísca de la misma institución.
La alanina es uno de los aminoácidos más simples presentes en la natu-
raleza, con estructura molecular CH3CH(NH2)COOH. La incidencia de
Resumen 232
radiación ionizante produce la formación de radicales en este material, en
una concentración proporcional a la energía depositada en un amplio rango
de dosis (de 0.5 Gy a 5 kGy). La presencia de radicales en la alanina puede
ser medida con resonancia paramagnética electrónica (RPE). La cantidad
de radicales presentes en un dosímetro de alanina por unidad de masa se
cuantiﬁca a partir de su intensidad de señal en RPE, relacionando ésta con
la dosis absorbida en agua, lo que permite la calibración de este sistema de
dosimetría.
El capítulo presenta una introducción a los fundamentos teóricos de detec-
ción en Resonancia Paramagnética Electrónica (RPE), así como un estudio
sobre el funcionamiento de este tipo de espectrómetros. La sensibilidad
y estabilidad requeridas en el espectrómetro para obtener uncertidumbres
por debajo de un 1% en la cuantiﬁcación de la señal de RPE de dosímetros
de alanina irradiados en el rango de dosis de radioterapia son superiores
a los necesarios en otras aplicaciones de RPE. Los parámetros óptimos de
operación del espectrómetro pueden de este modo diferir de los empleados
en otras aplicaciones donde se estudia la forma de los espectros en vez de
quantiﬁcar su intensidad de señal.
Con el ﬁn de mejorar la calidad de la cuantiﬁcación de señal RPE de los
dosímetros de alanina se llevaron a cabo varias pruebas, lo que permitió
optimizar la estabilidad y la sensibilidad del espectrómetro en la aplicación
que nos ocupa. Además, se desarrolló e instaló en la unidad un sistema
de posicionamiento especíﬁco para asegurar la optimización de la sensibi-
lidad y un posicionamiento reproducible de los dosímetros de alanina en
la cavidad de la RPE. La optimización de los parámetros de operación del
espectrómetro y el estudio de la anisotropía en la señal RPE de la alanina
permitió la deﬁnición de un protocolo de medida.
Una primera calibración de intensidad de señal de RPE de dosímetros de
alanina en términos de dosis absorbida en agua se realizó mediante la irra-
diación de un lote de dosímetros en seis niveles de dosis en agua en la
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unidad60 Co en el Laboratorio de Radiofísica de la Universidad de Santiago
de Compostela. Se investigaropm dos métodos de cuantiﬁcación de señal de
RPE, y se realizó la substracción de la señal de fondo presente en dosímetros
de alanina no irradiados para garantizar la calidad de la calibración. La es-
timación de las incertidumbres asociadas a todo el procedimiento permitió
determinar la incertidumbre relativa asociada a la calibración, situándose
ésta entre un 2.8% y un 1.2% (k=2) para dosímetros irradiados a una dosis
en agua entre 10 y 50 Gy.
Varias mejoras fueron introducidas en el sistema tras esta calibración, in-
cluyendo la instalación de un dispositivo de control de la temperatura en el
sistema de refrigeración por agua del espectrómetro para mejorar la esta-
bilidad. También se llevó a cabo una determinación más precisa de la dosis
en agua correspondiente a la irradiación de los dosímetros.
Tras estas mejoras se construyó una nueva curva de calibración de dosis
en agua frente a señal de RPE de dosímetros de alanina. En este caso se
incluyeron dos pruebas ciegas en la irradiación de los dosímetros para com-
probar la consistencia del sistema de dosimetría. La incertidumbre relativa
asociada a esta calibración arrojó valores estimados entre un 1.7% y un
0.8% (k=2) para dosímetros irradiados entre 10 Gy y 50 Gy. Resultados
satisfatorios fueron obtenidos en las pruebas ciegas, ya que se encontrÃ³
acuerdo entre los valores de dosis determinados con el sistema y los valores
dosis en agua correspondientes a la irradiación de los pellets, con incer-
tidumbres relativas de un 1.4% a 13.34 Gy y 1.3% a 15.19 Gy (k=2).
Posibles mejoras en el sistema de medida incluirían el diseño de un sistema
de posicionado más adecuado para la irradiación o el reﬁnamiento de la
metodología empledada para la sustracción de fondo de la señal de ESR de
los dosímetros, tareas que podrían ser abordadas en futuras calibraciones.
La implantación de un servicio de dosimetría con alanina en la Universi-
dad de Santiago de Compostela, requeriría establecer la variabilidad de las
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incertidumbres asociadas al sistema mediante la repetición continuada de
la construcción de la curva de calibración.
- En el cuarto capítulo se estudia la aplicación de la propuesta del
nuevo protocolo de dosimetría para campos de radiación no estándar a dos
máquinas modernas de radioterapia, TomoTherapy y CyberKnife, ambas
fabricadas por Accuray Inc., Sunnyvale, CA, Estados Unidos.
El objetivo de este trabajo consiste en la determinación de los factores
de corrección asociados a distintas cámaras de ionización para la determi-
nación de dosis absorbida en agua en unos campos de calibración interme-
dios, deﬁnidos en las máquinas con el propósito de establecer para ellas un
nuevo protocolo de dosimetría. Dos tipos de campos de calibración inter-
medios son propuestos para cada una de las máquinas, siendo el primero
de éstos un campo estático, especíﬁco para cada máquina y lo más cercano
posible al campo de referencia deﬁnido en los protocolos de dosimetría con-
vencionales. El segundo campo de calibración intermedio es un campo com-
puesto, denominado campo de plan de clase, que deposita una distribución
de dosis homogénea con una forma sencilla (geometría cilíndrica en el caso
de TomoTherapy y esférica en el caso de CyberKnife) en un maniquí equiva-
lente a agua de geometría adecuada (cilíndrica y esférica para TomoTherapy
y CyberKnife respectivamente). El campo de calibración compuesto se in-
trodujo en la propuesta del protocolo con el objetivo de determinar la dosis
absorbida en agua en condiciones más próximas a las de los tratamientos,
ya que dada la complejidad de las técnicas de radioterapia asociadas a estas
máquinas, éstas podrían diferir substancialmente de las correspondientes a
los campos de calibración intermedios estáticos.
Los factores de corrección asociados a la medida de dosis en agua con cá-
mara de ionización en los campos de calibración intermedios se determinó
a partir de la relación entre la dosis absoluta absorbida en agua, obtenida
mediante dosimetría de alanina, y el producto de la lectura corregida de la
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cámara y el coeﬁciente de calibración de la misma en cobalto-60. Los fac-
tores de corrección fueron también calculados mediante simulación Monte
Carlo para el caso de CyberKnife. La dosimetría de alania se realizó en
colaboración con el NPL de Inglaterra, ya que el sistema de dosimetría
estudiado en el capítulo tres fue desarrollado de modo simultáneo a la re-
alización de este trabajo.
Distintos tratamientos clínicos reales fueron investigados, determinando los
factores de corrección asociados a la medida de las cámaras de ionización
para la determinación de dosis absoluta en agua en un punto de una región
de dosis homogénea del volumen planiﬁcado en cada uno de tratamientos.
La relación entre los factores de corrección obtenidos en los tratamientos
clínicos y en los campos intermedios de calibración permitió evaluar, aunque
con estadística limitada, la idoneidad de los distintos campos de calibración
para la práctica clínica.
En el estudio de TomoTherapy, los factores globales, kfi,frefQi,Q0 , asociados a
la cámara de ionización estudiada (Exradin A1SL de Standard Imaging)
arrojaron valores por debajo de la unidad en todos los campos investigados,
con desviaciónes entre un 1.6% y un 2.1%. Las incertidumbres relativas
asociadas a estas medidas se situan sin embargo entorno al 2% (k=2), lo
que hace que los valores sean compatibles entre sí y compatibles con la
unidad, aunque la desviación sistemática resulta signiﬁcativa en un test de
hipótesis involucrando la t de student.
En el caso de CyberKnife no se encontraron desviaciones sistemáticas en los
factores de corrección globales asociados a las cámaras estudiadas (CC13
de Scanditronix-Wellhofer y PTW31014 de PTW-Freiburg), que arrojaron
valores por encima y por debajo de la unidad dependiendo del campo. Los
factores de corrección para la cámara CC13 tomaron valores desviándose de
la unidad entre un 0.6% y un 1.6% en las medidas experimentales, mientras
que en la simulación Monte Carlo estas desviaciones variaron entre un 0.6%
y un 1%. En el caso de la PTW31014, las desciaciones de la unidad medidas
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estuvieron entre un 0.8% y un 2.3%, y entre un 0.7% y un 2.5% según las
simulaciones Monte Carlo.
La mayor desviación con respecto a la unidad observada en las medidas
de la cámara PTW31014 son debidas a la mayor diferencia en el prome-
diado por efecto volumen entre este detector y la alanina. Los factores
obtenidos para los distintos campos son compatibles entre sí (excepto uno
asociado a la medida de PTW31014 en un tratamiento clínico) dadas las
incertidumbres relativas de las medidas, que rondan el 2% para la CC13 y
el 2.4% para la PTW31014 (k=2), siendo ésta última ligeramente superior
debido a la mayor intestabilidad de este detector. Los resultados obtenidos
mediante cálculo Monte Carlo mostraron acuerdo dentro de incertidumbres
con las medidas, siendo también equivalentes entre sí los factores asociados
a distintos campos estudiados.
A raíz de estos resultados no se encuentra evidencia para aﬁrmar que los
campos intermedios de calibración compuestos (planes de clase) suponen
una calibración intermedia más adecuada que los campos de intermedios de
calibración estáticos para la dosimetría de campos no estándar estudiados,
tanto en TomoTherapy como en CyberKnife.
Por otro lado, una alta uniformidad en las distribuciones de dosis de los
planes de clase es requerida para la medida de factores de corrección con
incertidumbres asociadas bajas, pero se ha visto que esto resulta, depen-
diendo de la técnica, difícil de cumplir. Este factor apoya la reivindicación
de los campos intermedios de calibración estáticos como mejores candidatos
para la calibiración en el marco del nuevo protocolo, ya que éstos permiten
la medida de factores de corrección con incertidumbres asociadas más bajas.
La consideración inicial de campos de intermedios calibración compuestos
como conﬁguraciones más cercanas a las condiciones de tratamiento clínico
no ha podido ser veriﬁcada, al menos para las propuestas de distribuciones
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de dosis cilíndricas y esféricas aquí estudiadas. La medida de las conﬁgura-
ciones de campo compuesto simple propuestas en los planes de clase podría
resultar útil para el control de calidad de dosimetría en ciertas técnicas, al
incluir éstos muchas características del suministro de tratamiento propio
de cada técnica. Sin embargo, las ventajas obtenidas a meidante su uso
como campos de calibración intermedios para la dosimetría clínica no ha
sido demostrada.
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